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Introduction 
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1.  Introduction  
 
I. Trypanosoma brucei 
 
1.1 Trypanosoma brucei, the cause of African sleeping sickness 
 
Human African Trypanosomiasis (HAT), also known as sleeping sickness, is a vector-borne 
parasitic disease which primarily affects the poorest rural populations in some of the least 
developed countries of Central Africa. (Berriman et al., 2005). Trypanosoma brucei is a 
unicellular eukaryote that causes sleeping sickness in humans and nagana in livestock. It lives 
exclusively as an extra-cellular parasite unlike other members of this family of 
Trypanosomatidae, such as Trypanosoma cruzi and Leishmania species, which possess intra-
cellular stages. T. brucei parasites undergo a complex life cycle through the bloodstream of 
their mammalian host and the blood-feeding insect vector, the tsetse fly (Glossina spp.)  
(Hellemond and Tielens, 2006). 
 
1.2   Epidemiology 
 
Sleeping sickness threatens millions of people in 36 countries of sub-Saharan Africa. The 
number of new cases is currently between 50,000 and 70,000 per year. The parasites 
concerned are extracellular protozoa belonging to the Trypanosoma Genus. They are 
transmitted to humans by tsetse fly (Glossina Genus) bites which have acquired their 
infection from human beings or from the animals’ reservoir. Tsetse flies are found in Central 
Africa and only certain species transmit the disease. Different species have different habitats. 
They are mainly found in vegetation by rivers and lakes, in gallery-forests and in vast 
stretches of wooded savannah. Sleeping sickness occurs only in those regions where there are 
tsetse flies that can transmit the disease (Figure 1.1) (http://www.eanett.org/whatis/). 
 For reasons that are so far unexplained, there are many regions where tsetse flies are found, 
but sleeping sickness is not. HAT takes two forms, depending on the parasite involved. T. 
brucei gambiense is found in West and Central Africa. This form represents more than 90% 
of reported cases of sleeping sickness and causes a chronic infection. A person can be infected 
for months or even years without major signs or symptoms of the disease. When symptoms do 
emerge, the patient is often already in an advanced disease stage when the central nervous 
system is affected. T. brucei rhodesiense is found in Eastern and Southern Africa. This form 
represents less than 10% of reported cases and causes an acute infection. First signs and 
symptoms are observed after a few months or weeks. The disease develops rapidly and 
invades the central nervous system. (http://www.who.int/mediacentre/factsheets/fs259/en/) 
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Other parasite species and sub-species of the Trypanosoma Genus are pathogenic to animals 
and cause animal Trypanosomiasis in many wild and domestic animal species (in cattle the 
disease is called Nagana, a Zulu word meaning “to be depressed”). Animals can host the 
human pathogen parasites, especially T.b. rhodesiense; thus domestic and wild animals are an 
important parasite reservoir. Animals can also be infected with T.b. gambiense, however the 
precise epidemiological role of this reservoir is not yet well known. This disease kills live 
stock and is a major obstacle to the economic development of the rural areas affected (WHO 
report, 2006). 
 
 
                                                                                                                                                             
Figure 1.1 Distribution of Trypanosomiasis in countries considered endemic in Africa 
(W.H.O.). 
 
 
1.3 Classification  
 
Trypanosomes are protozoans which belong to the order of Kinetoplastida. They contain a 
range of ubiquitous free-living species which are pathogens of invertebrates, of vertebrates 
and even of some plants. Trypanosoma species cause sleeping sickness and Chagas disease, 
whereas the leishmaniases kill and debilitate hundreds of thousands of people worldwide each 
year. The taxon Kinetoplastida was created by uniting two groups: Bodonidae and 
Trypanosomatidae (Simpson et al., 2006). Organisms of the former group are characterized 
by the presence of two flagella and a quite large kinetoplast. This group is formed by both 
free living organisms and parasites of fish and snails. Trypanosomatidae have only a single 
flagellum and a smaller kinetoplast than Bodonidae. The former comprise, Trypanosomatidae, 
of which all members are parasites of invertebrates, all classes of vertebrates or plants. The 
genus Trypanosoma is further divided into two sections, according to the place of where the 
Introduction                                                                                                                               
                                                                                                                                                                                                                  
                                                                                                      
3 
parasite develops in the insect host. Salivaria develop in the anterior portion of the digestive 
tract and within the salivary gland, while the stercoraria develop in the hindgut. T. brucei 
belongs to the salivaria sub-genus (Levine et al., 1980). 
 
                            
 
 
 
                               
                                  Figure 1.2 Phylogenetic tree of T.brucei according to Simpson et al., 2006      
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1.4 Morphology 
 
T. brucei live in the blood and tissue fluid of a mammalian host; the bloodstream form 
trypomastigotes are relatively long (about 20 µm), with a flagellum that emerges from the 
posterior end (defined relative to the direction of motion) and is attached along the body of 
the parasite. The cell surface is protected by a thick layer of variant surface glycoprotein 
(VSG) which is changed at frequent intervals: this antigenic switching enables the parasite to 
survive indefinitely in the face of recurrent immune responses. Stumpy, nondividing forms 
may survive preferentially when the parasites are taken up by a feeding tsetse fly. The 
parasites in the fly midgut differentiate into the procyclic form which is morphologically quite 
similar to bloodstream forms, although the kinetoplast is relatively nearer to the nucleus. 
Before entering the mammalian bloodstream, procyclic trypanosomes differentiate into 
epimastigotes and then into VSG- bearing metacyclic forms in the tsetse fly salivary glands 
(Figure 1.3). The major cell surface protein (VSG) in African trypanosomes are linked to the 
plasma membrane via glycosyl phosphatidylinositol (GPI) anchors whose composition varies 
according to the antigenic variant and life cycle stage (Clayton et al., 1995). 
                                                                                                                 
                                                                                                                            
 
 
         Figure 1.3 Major cellular forms of trypanosomatids defined by cell shape, flagella 
presence and position of the basal body, kinetoplast and nucleus (Gull, 1999). 
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        Figure 1.4 Trypanosome cell architecture with locations of the major features of the cell 
(Matthews, 2005). 
 
Membrane transport functions are important both in terms of interaction with insect vectors 
and mammalian hosts as well as recycling VSGs. Trypanosomes have a polarized 
endomembrane system which restricts both exocytosis and endocytosis, which occur 
exclusively through the flagellar pocket (Overath et al., 2004; Field et al., 2004). They appear 
to have a reduced dependence on the acto-myosin network balanced by an elaboration of the 
tubulin-based cytoskeleton. These organisms have six members of the tubulin superfamily 
especially δ- and ε- tubulin presence is characteristic for basal bodies and flagella. There is no 
actin-based motility known so far and acto-myosin may even not be necessary for cytokinesis 
(Berriman et al., 2005). The following organelles of the trypanosomes i.e. kinetoplast and 
nucleus are precisely positioned between the posterior end and the centre of the cell (Figure 
1.4). The motility of the parasite is dependent upon its single flagellum, which has a 
conventional axonemal structure (9 X 2 + 2) plus an associated paraflagellar rod. The 
mitochondrion is a single elongated structure that runs from the posterior to the anterior of the 
cell. Bloodstream form mitochondrion is simple tubular structure largely devoid of cristae and 
does not contain a functional respiratory chain. Thus energy generation is dependent on 
glycolytic reactions compartmentalized within glycosomes. The kinetoplast (i.e. the mtDNA) 
consists of mass of catenated DNA molecules. The positioning of kinetoplast is different in 
bloodstream form and procyclic form. The kinetoplast has many other unusual features and is 
composed of two classes of circular DNA molecules: maxicircles, containing genes that 
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encode mitochondrial proteins and minicircles which encode short guide RNAs (Matthews, 
2005). The Golgi complex is more extensive in the bloodstream form as compared to the 
procyclic form, the lysosome and the endosomes are all located in the posterior region of the 
cell. The endoplasmic reticulum (ER), the mitochondria, acidocalcisomes and the glycosomes 
are all dispersed throughout the cell volume (Field et al., 2004) 
 
1.5 Life cycle 
 
The T.brucei has exquisite co-ordination of events occurring as the parasites proceed through 
their life cycle. They make a series of transitions between three major environments: 
mammalian host, tsetse midgut and tsetse salivary gland. The life cycle is characterized by 
changes in cell shape, cell cycle, metabolism, surface coat, etc. At two of these transition 
points, bloodstream to tsetse midgut and tsetse salivary gland to mammalian bloodstream, 
there is a specific pattern of events. In each case, the transmitted parasite (stumpy form and 
metacyclic, respectively) exhibits particular differentiated attributes useful to its survival in 
the next environment. On reaching that environment, in each situation, the cell enters a 
proliferative cell cycle and colonizes the midgut or bloodstream, respectively. In one of the 
other transitions, tsetse midgut to the salivary gland, the parasite differentiates to an 
epimastigote form (Gull, 2001). 
 
Figure 1.5 Life cycle stages of T.brucei in insect vector and mammalian host. Arrowheads 
represent differentiation events in the trypanosome life cycle (Barrett et al., 2007) 
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The trypanosome is transmitted between mammalian hosts by the tsetse fly, Glossina spp, in 
which it initially establishes in the midgut after a blood meal but then migrates to the salivary 
glands in preparation for transmission to a new mammalian host (Figure 1.5). In mammals, 
the parasite survives free in the bloodstream, being able to evade antibody responses through 
antigenic variation (McCulloch, 2004; Pays et al., 2004). Trypanosomes proliferate in the 
mammalian system as morphological slender form, these being replaced by the non-
proliferative stumpy form as parasite numbers increase (Matthews et al., 2004).  
The accumulation of division-arrested form limits the increase in parasite numbers and 
thereby prolongs host survival and disease transmission. The uniform arrest of stumpy form in 
G1 phase of the cell cycle ensures that the morphological changes that occur upon 
transmission to the tsetse fly can be coordinated with re-entry into the cell cycle. This is 
important because correct organelle positioning is crucial for successful completion of the cell 
cycle of tsetse midgut procyclic forms. Upon uptake by the tsetse, bloodstream trypanosomes 
replace the VSG coat with a less-dense surface coat composed of procyclin, which is also GPI 
anchored (Roditi and Linger, 2002). Energy generation also switches from being exclusively 
based on glycolysis to a mitochondrion-based respiratory system, which requires structural 
elaboration and metabolic activation of the organelle. After proliferation in the tsetse midgut, 
the parasite migrates to the salivary gland. The epimastigote forms generated there attach to 
the gland membrane through elaborations of the flagellar membrane. After further 
multiplication, the parasite undergoes division arrest, reacquires a VSG coat and is released 
into the salivary gland lumen, in preparation for inoculation into a new mammalian host 
(Matthews, 2005). 
 
1.6. Metabolism of parasite 
 
An adaptive evolution shapes the metabolism of parasites which results in the development of 
novel pathways that are integral for parasite subversion of host defenses. Yet the availability 
within the host of an assortment of metabolites which includes small organic molecules for 
energy generation or building blocks for assembling macromolecular structures. The parasites 
lack various core pathways of metabolism that are present in many other organisms (Borza et 
al., 2005). 
T.brucei resides in the bloodstream within an aerobic environment, but use glycolysis (i.e. 
without oxidative phosphorylation) for energy generation (Figure 1.6). In bloodstream forms, 
glucose catabolism is aerobic, requiring an oxygen-dependent alternative terminal oxidase for 
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regeneration of the NAD+ reduced during glycolysis, and pyruvate is the end-product of 
metabolism. These parasites compartmentalize many of their glycolytic enzymes behind the 
peroxisomal membrane, giving rise to glycosomes. In bloodstream form, approximately 90 % 
of the peroxisomal or glycosomal, matrix proteins are glycolytic enzymes (Moyersoen et al., 
2004).  
Bloodstream form contains cytoplasmic phosphoglycerate kinase which means it needs 
multiple pathways in order to maintain a balance of ATP and ADP concentrations inside the 
glycosomes (Misset and Opperdoes, 1987). The glycerol-3-phosphate shuttle, which is 
essential in bloodstream form, is again operative but there is a second route for maintaining 
glycosomal NAD+/NADH homeostasis. This pathway utilizes NADH-dependent fumarate 
reductase to generate succinate from the phosphoenol pyruvate intermediate of glycolysis. 
This fumarate reductase activity is present on a modular multifunctional protein, which also 
has the NADH-dependent cytochrome c reductase activity (Besteiro et al., 2002). There is 
also pyruvate phosphate dikinase, a glycosomal protein, for which the functional role is not 
known (Bringaud et al., 1998; Coustou et al., 2003).  
The sugars are not thought to be readily available in the digestive tract of the tsetse fly. The 
glucose content of the blood meal is depleted rapidly following ingestion. The tsetse flies 
unlike many other invertebrate vectors do not acquire nutrients by feeding on sugar-rich plant 
sap (Tetaud et al., 1997; Vedrenne et al., 2000). The shift towards mitochondrial energy 
generation in procyclic form can therefore be considered to reflect a predominance of peptides 
and amino acids. These are liberated by digestion of the blood meal, as the primary carbon 
source available for ATP production. In the presence of glucose, the end-products of proline 
catabolism are equimolar amounts of CO2 and succinate. The enzymes required for this 
catabolism result in the generation of ATP through substrate-level phosphorylation, and 
NADH and FADH2 which both provide electrons for the respiratory chain (van Weelden et 
al., 2003, 2005). 
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                                                  Figure 1.6 Energy metabolism in bloodstream T.brucei 
 
 
Procyclic form relies on mitochondrial energy generation (Figure 1.7) for its viability 
(Bochud-Allemann and Scheneider 2002; van Weelden et al., 2003). These form express a 
cohort of unusual enzymes, some of which are more characteristic of anaerobic metabolism 
(Riviere et al., 2004; Coustou et al., 2005). At least in procyclic form acetate is an end-
product of energy metabolism because; despite the presence of a complete cohort of Krebs 
cycle enzymes. This observation does not of course preclude a role for the Krebs cycle in 
these parasites energy generation at some point during the transmission cycle through tsetse 
(van Weelden et al., 2003, 2005). In the absence of glucose, the procyclic forms are critically 
dependent upon oxidative phosphorylation for energy generation (Lamour et al., 2005). 
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                                            Figure 1.7 Energy metabolism in procyclic form 
 
T.brucei also retains an ability to synthesize carbohydrates as evidenced by the presence in 
the genome of the key gluconeogenic enzyme fructose-1, 6-bisphosphatase (Morris et al., 
2002; Hannaert et al., 2003). It is known that many of the enzymes found in T.brucei, 
including components of the branched respiratory chain acetate:succinate CoA-transferase, 
NADH-dependent fumarate reductase and pyruvate phosphate dikinase, are expressed 
(Bringaud et al., 1998; Van Hellemond et al., 1998 A,B; Besteiro et al.,2002). The evidence 
indicates that differences in the expression of these enzymes, between different forms are 
always likely to reflect the environment in which that cell type lives (Ginger, 2006). 
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1.7 Pathogenesis 
The infection is initiated after the bite of a trypanosome-infected tsetse-fly, the metacyclic 
trypanosomes in saliva of fly, differentiate to the bloodstream stage and spread via the local 
draining lymph node into the vascular system. In some but not all infections, a local skin 
reaction or chancre occurs at the site of inoculation, which is caused by a local inflammatory 
response to the parasites, and subsides after 4 weeks. The early (or hemolymphatic stage) 
commences 1-3 weeks after an infective fly bite and presents with periods of fever, lasting 1-7 
days and generalized lymphadenopathy. During this period, the parasites proliferate within 
the blood and lymphatic system. Symptoms include general malaise, anemia, headache, 
pyrexia, weight loss and weakness. Immune-activation is evident from lymph node 
enlargement, hepatomegaly, and splenomagaly. The late (meningoencephalitic) stage of 
infection coincides with the invasion of the CNS by parasites and is associated with 
psychiatric, motor and sensory disorders, along with sleep abnormalities. If untreated, late-
stage patients progress to a final stage involving seizures, somnolence, coma and death.  
Both T.b. rhodesiense and T.b. gambiense infections follow this sequence of infection stages, 
but with a marked difference rate of progression. T.b. gambiense presents as a chronic 
infection, in which progression to late stage may take several months or longer, and late-stage 
CNS infection may last several years. On the other hand, T.b. rhodesiense is generally 
regarded as an acute infection, with progression to late stage occurring in a matter of weeks 
and the late-stage CNS infection leading to death within 3 months, although this may not 
always be the case. 
Trypanosomes primary immune-evasion strategy is antigenic variation. The parasites are 
covered with a coat of 107 VSG molecules attached to the trypanosome cell membrane via 
GPI anchor (Magez et al., 2002). VSG is an immunodominant antigen, capable of eliciting 
both T-cell dependent and independent B-cell responses, depending on its conformation. 
Antibody opsonized trypanosomes are effectively cleared by the host lymphoreticular system 
(Macaskill et al., 1981). Thereafter the parasite undergoes antigenic variation. For this 
purpose the VSG occupy 10 % of the trypanosomes genome and has a repertoire of more than 
1000 transcriptionally inactive VSG genes but only a single active transcription site. VSG 
molecule plays a pivotal role in host responses as it elicits polyclonal B-cell activation, and in 
human infection this manifests in the generation of auto-antibodies and immune complex 
disease. Phospholipase C is responsible for the cleavage of the GPI anchor through release of 
VSG molecule in a soluble form. Given the central role of inflammatory immune responses in 
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sleeping sickness pathogenesis, it is possible that immunogenetic variation in host populations 
may influence disease progression and outcome (Sternberg, 2004). 
The changes in the cell of the parasite as it traverses from the mammalian bloodstream to the 
tsetse fly and back again must be highly regulated and interconnected. Mapping of the events 
that occur during synchronous transition from bloodstream stumpy forms to procyclic form 
has revealed that the developmental program of the parasite is temporally ordered (Matthews, 
1999). Inappropriate migration of the kinetoplast during or after segregation of that organelle 
would be likely to disrupt the highly orchestrated events required for successful cell division. 
The mitochondrion and the mitochondrial genome clearly have a central role in the 
development of the cell; this is evident from the importance of mitochondrial metabolism in 
surface antigen regulation (Vassella et al., 2004).  
 
1.8. Diagnosis 
Trypanosomes are variable and inconstant characters and the clinical symptoms are 
insufficient for diagnosis of sleeping sickness. Through detection of trypanosome specific 
antibodies by agglutination assays, immunoflourescence or ELISA, diagnosis of mainly T.b. 
gambiense sleeping sickness is facilitated. The card agglutination test for trypanosomiasis, 
CATT/T.b. gambiense (Magnus et al., 1978) is used in T.b. gambiense endemic areas for 
mass screening of the population at risk. Due to treatment cost and risks, definite diagnosis 
should be obtained by demonstration of the parasite in body fluids. Unfortunately, simple 
parasitological techniques such as microscopic examination of a lymph node aspirate, or of a 
wet or thick blood film are insensitive, especially for diagnosis of T.b. gambiense infection, 
where the number of parasites in the blood can be low. Due to the workload, parasitological 
examination is in practice limited to clinical or serological suspects. 
Due to the selective permeability of the blood-brain barrier and the high toxicity of second 
stage drugs, accurate determination of the respective disease stage is important for optimal 
treatment. There are no specific clinical signs except in very advanced cases or any clear 
changes at blood level indicating the evolution from the hemolymphatic to the 
meningoencephalitic stage (Bisser et al., 1997). According to the W.H.O., stage determination 
should be performed by examination of the cerebrospinal fluid (CSF) for the presence of 
trypanosomes, the white blood cell count and the total protein concentration (W.H.O., 1998). 
For follow-up after treatment, the blood and the CSF of the patient is re-examined on several 
occasions (ideally 3, 6, 12, 18 and 24 months after the end of treatment). A patient is 
considered cured when during this 2 year follow-up period no trypanosomes are detected in 
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the blood, lymph or CSF (W.H.O., 1998). Thus, CSF examination plays a key role in 
diagnosis, selection of treatment and post-treatment follow-up of sleeping sickness patients 
(Van Meirvenne, 1999; Buscher and Lejon, 2004; Kennedy, 2004). 
 
1.9. Treatment 
 
Therapy is complicated by the different disease stages. In the meningoencephalitic stage, the 
selective permeability of the blood-brain barrier protects trypanosome in the brain against the 
action of several drugs, effective in the hemolymphatic compartment. Treatment of 
meningoencephalitic stage sleeping sickness requires toxic drugs and hospitalization (Van 
Nieuwenhove, 1999; Legros et al., 2002; Burri and Brun, 2003). First stage T.b. rhodesiense 
infection is treated with suramin, gambiense infection with pentamidine. Pentamidine is 
usually well tolerated, whereas suramin may have severe adverse effects (Lejon and Buscher, 
2005). 
Treatment of the meningoencephalitic stage relies almost exclusively on melarsoprol, an 
arsenicum derivative. It is administered intravenously and requires hospitalization for at least 
10 days for the short, accepted standard course (Burri et al., 2000; Schmid et al., 2004), or 35-
36 days for the old treatment schedule. The worst adverse effect is treatment associated 
encephalopathy, which occurs in 5-10 % of patients and is fatal in 50-100 % of them (Pepin et 
al., 1994). Alternatives for late stage T.b.gambiense sickness treatment are 
difluoromethylornithine (eflornithine) and nifurtimox. Both drugs are used for treatment of 
melarsoprol refractory cases, but difluoromethylornithine has been introduced as first-line 
drug by some organizations. In view of the observed increase in melarsoprol resistance, 
clinical trials on combination therapy are ongoing (Lejon et al., 2005).   
Eflornithine was developed over 20 years ago, and was registered for the treatment of 
gambiense disease in 1990. While the drug is safer than melarsoprol, eflornithine does have 
side effects; fever, unusual bleeding, weakness, diarrhea, nausea, stomach pain, and vomiting 
are common, while rarer side effects such as convulsions, loss of hearing, hair loss, headache, 
anemia, leucopenia and thrombocytopenia have also been observed. The administration of 
eflornithine, which requires multiple daily infusions, limits its use in the context of rural 
Africa, despite the determination of some program to use it as a first-line drug. 
With the development of parasite resistance to some of the available drugs, a number of 
studies have attempted to combine existing drugs to overcome treatment failures. The major 
challenge in developing a new drug that can ensure sustainable disease control will be to find 
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a safe and affordable, orally administered drug that is effective against both forms of the 
disease, in both disease stages, and that does not require any particular skills or care to 
administer. The ideal regimen should not last more than a few days, thus making it 
manageable by peripheral health staff in an out-patient context (Simarro et al., 2008). 
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II. Phospholipases A2 
 
2.1. Lipases 
 
2.1.1 General Feature 
 
Lipases [EC 3.1.1.3] are a family of hydrolase enzymes cleaving glycerol esters of long chain 
fatty acids (water insoluble). They are different from esterases [EC 3.1.1.1], which hydrolyze 
esters of short chain fatty acids (water soluble) (Shimada et al., 1989). Lipases are serine 
hydrolases which act at the lipid-water interface. The catalytic triad is composed of Ser-
Asp/Glu-His and usually also a consensus sequence (Gly-X-Ser-X-Gly) is found around the 
active site.  The lipases are a versatile group of enzymes and often co-express other activities 
like phospholipase, lysophospholipase, cholesterol esterase, cutinase, amidase and other 
esterases. Generally, lipases have preference for the substrate type, whether it is a 
triacylglyceride or a diacylglyceride, and therefore have diacylglyceride and 
monoacylglyceride as products, rather than glycerol and fatty acids. The regioselectivity is 
often rather high for the positions sn-1 and sn-3 and less frequently for sn-2. The lipases 
belong to the α/β hydrolase family (Svendsen, 2000). Interfacial activation of lipases can be 
traced to the unique structural characteristics of this class of enzymes. Lipases contain a 
helical oligopeptide unit that shields the active site. The movement of the oligopeptide flap 
probably occurs when the enzyme docks to the phospholipid surface which facilitates 
translocation of the substrate to the cleavage site. Lipases have biological functions in 
bacteria, fungi, plants, higher animals in addition they function as biocatalysts in numerous 
industrial processes including such areas as oils and fats, detergents, baking, cheese making, 
leather and paper processing. Moreover, lipases are the most used enzymes in synthetic 
organic chemistry, catalyzing the chemo-, region- and/or stereoselective hydrolysis of 
carboxylic acid esters or the reverse reaction in organic solvents (Reetz, 2002). 
 
2.1.2 Classification 
The lipase enzymes consist of a large family showing the same overall structural fold but 
which has versatility of loop structures in contact with the substrate, and exhibits versatile 
substrate specificities. The lipases can be grouped into subfamilies by analysis based on 
sequence homology, thus dividing them into two main families. 
The mammalian lipase family includes pancreatic lipase, hepatic lipase, lipoprotein lipase and 
pancreatic lipase –related protein. Within microbial lipases, several families have now been 
found, the bacterial lipases, containing the Staphylococcus lipase family, Pseudomonas lipase 
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family, Bacillus lipases and others, and the fungal lipases with the Rhizomucor miehei lipase 
family, Candida rugosa lipase family and other subfamilies (Svendsen, 2000). 
 
 2.1.3 Substrate specificity 
 
Lipases may be divided into three categories depending on substrate specificity like 
nonspecific, regiospecific and fatty acid-specific. Nonspecific lipases act at random on the 
triacylglyceride molecule and result in the complete breakdown of triacylglyceride to fatty 
acid and glycerol. Regiospecific lipases are 1,3-specific lipases which hydrolyze only primary 
ester bonds (i.e. ester bonds at atoms C1 and C3 of glycerol) and thus hydrolyze 
triacylglyceride to give free fatty acids, 1,2 (2,3)-diacylglyceride and 2-monoacylglyceride. 
The fatty acid-specific lipases exhibit a pronounced fatty acid preference ranging from 
triacylglycerides with long-chain fatty acids, small or medium-chain fatty acids and 
unsaturated fatty acids. 
Another important property of lipases is their enantio-/stereoselective nature, wherein they 
possess the ability to discriminate between the enantiomers of a racemic pair. Such 
enantiomerically pure or enriched organic compounds are steadily gaining importance in the 
chemistry of pharmaceutical, agricultural, synthetic organic and natural products. The 
stereospecificity of a lipase depends largely on the structure of the substrate, interactions at 
the active site and the reaction conditions (Gupta et al., 2004).  
 
2.2 Phospholipases 
 
2.2.1 General characteristics of phospholipases 
 
Phospholipids are present in all living organisms and are a major component of all biological 
membranes along with glycolipids and cholesterol. Enzymes aimed at modifying 
phospholipids, namely phospholipases, are consequently widespread in nature, playing very 
diverse roles from one of common component in snake venom to signal transduction and 
digestion in humans. The phospholipases are a complex and crucially important group of 
enzymes that hydrolyze phospholipids (PLs) releasing a variety of products, like for example 
lysophospholipids, free fatty acids (FFAs), diacylglycerols (DGs), choline phosphate and 
phosphatidates, depending on the site of hydrolysis. They play crucial roles in many 
biochemical processes related to, among others, digestion and inflammation. They are used 
for industrial applications like bread making, emulsification for different applications and 
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degumming (De Maria et al., 2007). Apart from these roles, phospholipases play a critical 
role in generating lipid-derived second messengers. Because their products are often second 
messengers, they are highly regulated by the cell. For a given ester bond, there are separate 
secreted as well as cytoplasmic phospholipases with different substrate specificities and 
modes of regulation. Phospholipases also have a wide and complex array of regulatory 
mechanisms involving cytoplasmic proteins, as well as different effector lipids (e.g., 
phosphatidylinositol 4,5-biphosphate, or PIP2) or Ca2+ . Many of these enzymes are water 
soluble while their substrates are insoluble and organized in a 2-dimensional matrix. They 
have thus evolved unique strategies for carrying out and regulating catalysis at an interface. 
They have a large increase in activity toward a substrate organized in an aggregate (e.g.  
micelle) compared to the same substrate presented as a monomer in solution which is known 
as interfacial activation (Roberts, 1996). 
 
2.2.2 Family of phospholipases (PLA, PLB, PLC, PLD) 
 
Phospholipases are classified according to the bond cleaved in a phospholipid. The IUBMB 
enzyme nomenclature for respective phospholipase is stated below and with substrate 
specificity for each (Figure 1.8) 
 
Phospholipase A1 (PLA1)  3.1.1.32 
Phospholipase A2 (PLA2)  3.1.1.4 
Phospholipase C (PLC)  3.1.4.3 
Phospholipase D (PLD)  3.1.4.4 
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                                   Figure 1.8  Reactions catalyzed by PLA1, PLA2, PLC and PLD 
 
 
Phospholipase A1 (PLA1) 
 
PLA1 activities have been detected, by measuring hydrolysis of phosphatidyl choline (PC) to 
lysophosphatidyl choline, in many cells and tissues from various organisms. PLA1 from 
different sources (Figure 1.9 a-e) show considerable sequence similarity to human hepatic and 
pancreatic lipases (HHL and HPL) and the pancreatic lipase-related protein 2. All these 
enzymes have the typical Ser-His-Asp catalytic triad. The activity of most of these lipases 
increases in the presence of Ca2+, while with EDTA correspondingly acts as an inhibitor.  
 
Phospholipase A2 (PLA2) 
 
PLA2s (Figure 1.9 f-j) are the most widely studied phospholipases which are subdivided into 
four categories:  
1. Secreted PLA2s   (sPLA2s) 
2. Cytosolic PLA2s (cPLA2s) 
3. Ca2+-independent PLA2s (iPLA2s) 
4. Platelet-activating factor acetyl hydrolase (PAF-AH) 
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These overall categories are further subdivided into 15 different groups.  
sPLA2s have a large number of disulphide bridges (5-7) which is consistent with working in 
an extracellular environment and require millimolar concentrations of Ca2+ ions for optimum 
catalytic activity. cPLA2s preferentially hydrolyze phospholipids containing arachidonic acid 
and play a key role in the biosynthesis of eicosanoids. Full activation of these enzymes 
requires Ca2+ binding to an N-terminal C2 domain and phosphorylation on serine residues. 
iPLA2s contain 7 to 8 ankyrin repeats (one of the most common sequence motif), contain the 
consensus lipase motif GXSXG. PAF-AH acts on platelet-activating factor (PAF) and not on 
long chain phospholipids. PAF-AH has implications in infammation and atherosclerosis. 
 
Phospholipase C (PLC) 
PLCs (Figure 1.9 k) belong to a large superfamily of enzymes called phosphoinositide-
specific phospholipases (PI-PLCs). The EC number 3.1.4.11 is associated with 
phosphatidylinositol phospholipase C activity. PI-PLCs molecules were found in a broad 
spectrum of organisms including bacteria, simple eukaryotes, plants and animals. Whereas the 
eukaryotic PI-PLCs play a central role in most signal transduction cascades, the prokaryotic 
enzymes act as virulence factors in some pathogenic bacteria. There is large structural 
similarity between them. Both the eukaryotic and the prokaryotic enzymes need cofactors, 
calcium and zinc, respectively, for optimum catalytic activity. 
 
Phospholipase D (PLD) 
PLD is a ubiquitous enzyme found in bacteria, fungi, plants and mammals. The PLD 
superfamily (Figure 1.9 l) includes enzymes that are involved in phospholipid metabolism, 
nucleases, toxins and virus envelope proteins of unknown function. Phosphatidic acid (PA), 
one of the reaction products is involved in signal transduction (Leiros et al., 2000). The PLD 
enzymes have a characteristic modular structure in which a common catalytic domain is 
flanked by regulatory sequences. These include lipid-binding PX and PH domains and motifs 
that are unique to the PLD enzymes. The active site region of the PLD superfamily consist of 
a conserved sequence motif, the HXK(X)4D motif (or the HKD motif), members of this 
superfamily share two copies of such a motif (De Maria et al., 2007). 
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Figure 1.9 Phospholipase structural diversity. Cartoon representation of the structures of the 
enzymes a. T. lanuginosus phospholipase A1. b Homology model of the vespid venom PLA1. 
c Guinea pig pancreatic lipase-related protein 2. d S. hyicus P1 lipase. e Outer membrane 
PLA. sPLA2s from different origins, f Pig pancreatic. g Human synovial fluid. h Taiwan cobra 
venom. i A. mellifera. j S.violaceoruber. k Phospholipase C from Bacilllus cereus. l 
Phospholipase D from Streptomyces sp. Strain PMF (De Maria et al., 2007). 
 
 
2.3 Phospholipase A2 (PLA2) 
 
The phospholipase A2 (PLA2) superfamily consists of a broad range of enzymes defined by 
their ability to catalyze specifically the hydrolysis of the ester bond (sn-2) of substrate 
phospholipids. The products of the PLA2 reaction are free fatty acid and lysophospholipid. 
The fatty acids released are arachidonic acid (AA) and oleic acid (OA) which are important 
stores of energy but more importantly AA can also function as a second messenger and as the 
precursor of eicosanoids, which include prostaglandins and thromboxanes generated through 
the cyclooxygenase reaction, and the leukotrienes, generated through the lipoxygenase 
reaction. The other product of PLA2 action, lysophospholipid, is important in cell signaling, 
phospholipid remodeling, and membrane perturbation. The actions of these enzymes can be 
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important for down-regulating cell signals, as seen in case of the PLA2 -catalyzed hydrolysis 
of the bioactive phospholipid, platelet activating factor (PAF), to its inactive lysophospholipid 
form. The progress in genomics has observed an expansion in the number of PLA2 subgroups. 
This has lead to the characterization of new subgroups with the expectation of even more in 
the future  (Six and Dennis, 2000). 
 
2.4 Classification of PLA2 
 
PLA2   have been systematically classified on the basis of their nucleotide and amino acid 
sequence. The diverse PLA2 enzymes have been classified into Groups from I to XV thus far 
(Table 1 and 2 according to Six and Dennis, 2000; Schaloske and Dennis, 2006). A broader 
classification of the PLA2 that has historically been used to describe PLA2 activities for which 
sequence data are not available. 
 
Table 1 
PLA2 groups utilizing a catalytic histidine 
Group Initial/common sources Size (kDa) Disulfide 
bridges 
I A Cobra, krait venom 13-15 7 
 B Mammal pancreas 13-15 7 
II A Human synovial fluid, platelets, rattlesnake, viper venom 13-15 7 
 B Gaboon viper venom 13-15 6 
 C Rat/mouse testis 15 8 
 D Human/mouse pancreas/spleen 14-15 7 
 E Human/mouse brain/heart/uterus 14-15 7 
 F Human/mouse testis/skin 16-17 7 
III  Bee/lizard/scorpion/human 15-18 5 
V  Mammal heart/lung/macrophage 14 6 
X  Human spleen/thymus/leukocyte 14 8 
IX  Snail venom (Conodipine-M) 14 6 
XI A Green rice shoots (PLA2 -I) 12.4 6 
 B Green rice shoots (PLA2-II) 12.9 6 
XII  Mammal heart/kidney/skin, Muscle 18.7 7 
XIII  Parvovirus < 10 0 
XIV  Symbiotic fungus/Streptomyces 13-19 2 
 
This classification has numerous caveats, e.g. the Group IV-C PLA2 is generally referred to as 
cPLA2-γ, despite its being a Ca2+-independent enzyme. However, the system remains useful 
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for making generalizations when describing properties of multiple PLA2 groups or when the 
specific identity of a PLA2 is unknown. With the expansion of the superfamily of these 
enzymes, it has become increasingly difficult to generalize the properties of the PLA2s. 
However, in general, the mammalian sPLA2s (Groups I-B, II-A, C-F, III, V, X, XII) have low 
molecular masses (13-19 kDa) and lack specificity for arachidonate-containing phospholipids. 
The cPLA2s (Group IV, comprising three subgroups) have higher molecular masses (> 60 
kDa), and preferentially hydrolyze arachidonate-containing phospholipids (although Group 
IV-C PLA2 exhibits only a marginal preference). Finally, the iPLA2 (Group VI) have high 
molecular masses (about 85 kDa) but are not selective for arachidonate-containing 
phospholipids. The Ca2+ requirements of the PLA2s do not distribute within this classification 
system as most of them require millimolar concentrations of Ca2+ for enzymatic activity while 
others require µM levels. Some only on the other hand, require Ca2+ for translocation to 
membranes but not for activity. Except Group IV-C which requires no Ca2+ similar to the 
iPLA2s (Balsinde et al., 2002). 
 
Table 2  
PLA2 groups utilizing a catalytic serine 
Group 
 
Initial/common sources Alternate names employed Size 
(kDa) 
Ca2+ 
effects 
IV A Human U937 cells/platelets, RAW 
264.7/rat kidney 
cPLA2α 85 < mM 
 B Human pancreas/liver/heart/brain cPLA2β 114 < mM 
 C Human heart/skeletal muscle cPLA2γ 61 None 
VI A-1 P388D1 macrophages, CHO iPLA2 or iPLA2-A 84-85 None 
 A-2 Human B-lymphocytes, testis iPLA2-B 88-90 None 
 B Human heart/skeletal muscle iPLA2γ or iPLA2-2 88 None 
VII A Human/mouse/porcine/bovine plasma PAF-AH 45 None 
 B Human/bovine liver/kidney PAF-AH(II) 40 None 
VIII A Human brain PAF-AH Ib α1 (subunit of 
trimer) 
26 None 
 
 
B Human brain PAF-AH Ib α2 (subunit of 
trimer) 
 
26 None 
 
XV 
  
Human,murine,bovine 
 
ACS,lysosomal PLA2 
(LPLA2), LLPL 
42 None 
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2.5 Catalytic mechanism of PLA2s 
 
Mechanistic studies have shown that catalysis by sPLA2s does not take place via the 
formation of the classical acyl-enzyme intermediate of serine esterases. Instead, the sPLA2s 
use a His residue, assisted by an Asp to polarize a bound H2O which then attacks the carbonyl 
group. The Ca2+ ion bound to the conserved Ca2+ loop is required to stabilize the tetrahedral 
transition state intermediate, which for this class of PLA2s plays an active role in catalysis. 
On the other hand, the catalytic mechanism of the Group IV cPLA2 is completely independent 
of Ca2+ and interacts with the membrane where its substrate is localized. The cPLA2 appears 
to function as a serine hydrolase, acting via an acyl-enzyme intermediate. Although its 
catalytic mechanism has not been fully clarified, they can be defined as serine hydrolases 
because a role for His, as in the classical Ser/His/Asp triad has not been demonstrated so far. 
The iPLA2 also appears to function as a serine hydrolase, with the active Ser residue located 
in the middle of the consensus sequence GXSXG, which is common to many other lipases as 
well. These enzymes function via an acyl-enzyme intermediate (Balsinde et al., 1999). 
 
2.6 Interfacial catalysis of PLA2s 
 
The phospholipase A2 acts on the aggregated form of its substrate phospholipids and is 
probably one of the best characterized examples of interfacial catalysis. The catalysis occurs 
on the substrate interface and the enzyme remains bound to the interface during several 
catalytic turnover cycles. It is proposed that binding of PLA2 to its substrate is part of a lipid-
water interface such as a micelle or membrane. The enzyme (E) first binds to the interface 
itself but not to any individual phospholipid molecules. This produces an interfacially 
activated enzyme (E*), which subsequently binds a phospholipid substrate (S) as shown in 
equation: 
 
                                             E                    E*                 E*S             E*P                E*+P 
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          Figure 1.10 sPLA2 catalytic mechanism on phospholipid substrate (Haas et al., 1974) 
 
To work on a bilayer vesicle, PLA2 (Figure 1.10) stays associated with the interface while it 
hydrolyzes successive phospholipid substrate molecules (scooting mode). Alternatively, it 
dissociates from the interface after each catalytic event (hopping mode). Use of anionic 
vesicle substrates forces the equilibrium toward the scooting mode. Only about 9-10 carbons 
of the sn-2 acyl chain interact with the enzyme. The remainder of the chains presumably 
remains buried in the interface (Dennis, 1994). Apart from this mechanism, this process is 
regulated by diverse factors including the membrane charge, fluidity, mode of membrane 
binding (insertion, orientation) and allosteric conformational effects (Ray et al., 2007).  
 
2.7 Role of PLA2s in arachidonic acid metabolism  
 
In general, not one but several PLA2s are involved in cellular regulation and lipid messenger 
formation. This mechanism includes participation of at least two different PLA2s namely, 
cPLA2 and sPLA2, for generation of arachidonic acid (AA) in cells. Activation of the cPLA2 
is the foremost event and may be mediated by several signals, such as phosphorylation 
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cascades, intracellular Ca2+ elevations and perhaps phosphatidylinositol 4,5-bisphosphate 
levels. The synchronous coupling between these signals may converge to produce a prolonged 
activation of the cPLA2. In cells not expressing sPLA2, the cPLA2 probably contributes most 
of AA mobilized during cellular activation. However, in those cells that contain sPLA2, the 
bulk of AA release appears to be mediated by the sPLA2, not the cPLA2. Many types of 
eicosanoid-producing cells (e.g. phagocytes, mast cells, platelets) synthesize and secrete 
sPLA2. Once secreted, it associates with the other outer surface of the surrounding cells and 
releases AA which can be captured by these cells to produce eicosanoids. Despite its lack of 
AA specificity, the sPLA2 releases AA in preference to other fatty acids. sPLA2 action 
appears to be dependent on cPLA2. Thus, cPLA2 is key for AA signaling even in those 
settings where the sPLA2 is the major effector of the response.   
Although iPLA2  does not appear to be directly involved in effecting stimulated AA release, it 
is important for the AA metabolism, in particular for phospholipid fatty acid remodeling. 
Thus, the iPLA2 participates in the main pathway through which the cells incorporate AA and 
other fatty acids into membrane phospholipids. The AA-releasing PLA2s use different AA 
pools for the release. Thus, by regulating fatty acid remodeling reactions, the iPLA2 may 
influence the subcellular distribution of AA among different compartments and the relative 
amount of fatty acid present in each compartment (Balsinde, 1999). 
Free arachidonic acid (Figure 1.11) is then converted into potent bioactive mediators by the 
action of various cyclooxygenases (COX), lipoxygenases (LO), and cytochrome P450s. The 
eicosanoid production cascade often works in a nonlinear fashion, with multiple enzymes 
creating a single product and multiple products acting as a substrate for a single enzyme. 
COX activity produces prostaglandins (PG) and hydroxyeicosatetraenoic acids (HETEs) 
whereas lipoxygenases can create leukotrienes (LT), HETEs, and lipoxins. Cytochrome P450s 
catalyze the production of HETEs and epoxy-eicosatetraenoic acids, as well as ω-oxidation of 
various eicosanoids. Other enzymes can further act on eicosanoids by catalyzing hydration, 
dehydration, and β-oxidation reactions. Eicosanoid-producing enzymes and their biological 
receptors are differentially expressed among various cell and tissue types, enhancing 
signalling specificity (Buczynski, 2007).           
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Figure 1.11 Arachidonic acid metabolism and biosynthesis of prostaglandins (Kubata et al., 
2000) 
 
In resting cells, arachidonic acid is stored within the membranes usually esterified to glycerol 
in phospholipids. A receptor-dependent event, requiring a transducing G protein, initiates 
phospholipid hydrolysis and releases the fatty acid into the intracellular medium. PLA2 
catalyzes the hydrolysis of phospholipids at sn (stereospecific numbering)-2 position. 
Therefore, this enzyme can release arachidonate in a single-step reaction. On the other hand, 
PLC and PLD do not release free arachidonic acid directly. Rather, they generate lipid 
products containing arachidonate (diacylglycerol and phosphatidic acid). After they are 
released, free arachidonate has possible fates like reincorporation into phospholipids and 
metabolism by distinct enzyme pathways like COX, LO and cytochrome P450. The end 
products of these pathways modulate different activities in the cell like ion channels, protein 
kinases and ion pumps. The eicosanoids may also exit the cell of origin and the action may be 
terminated by uptake into phospholipids, or enyzmatic degradation (Piomelli, 2001). 
 
 
2.8 Importance of phospholipase A2 in eukaryotes 
 
Phospholipase A2s presence in pancreatic juices and in cobra venom was discovered around 
the beginning of the twentieth century.  The role of these secreted PLA2s in digestion and 
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snake venom has since been well documented. Evidence began to appear in the last several 
decades that PLA2s are also present in most types of cells and that they are involved in many 
different cellular functions including general lipid metabolism and membrane homeostasis.  
During the same period, the view about PLA2’s substrate, phospholipids and their metabolites 
which are involved in a large number of cellular control systems including signal transduction 
and eicosanoid production has also been changed. Due to PLA2s actions, which affect a wide 
range of human physiological functions and diseases including asthma and allergy, the 
initiation and maintenance of parturition, blood clotting, atherosclerosis, sepsis, inflammatory 
bowel disease, arthritis and other inflammatory diseases (Dennis, 2000). 
 
                       
 
Figure 1.12 Signal transduction mechanism of phospholipases.iPLA2 which regulates 
phospholipid reacylation, cPLA2 is activated by external stimuli, precedes with activation 
and/or secretion of  sPLA2 .LPS (lipopolysaccharide) (Balsinde et al., 2002). 
 
Signal transduction (Figure 1.12) mediates changes in cellular metabolism and function. 
Phospholipases are required for transduction of extracellular signals across the cellular plasma 
membrane. Several signal activated phospholipases (SAPs) may be activated by a given 
agonist in a given cell. This signalling cascade begins with one or more phospholipases that 
are directly coupled to the receptor. These phospholipases may be PtIns-PLC, PLC, PLD, 
PLA2 or a combination of all depending on cell type and agonist. Some phospholipases e.g.  
Introduction                                                                                                                               
                                                                                                                                                                                                                  
                                                                                                      
28 
PLCs are induced and provide very long-term signals for processes such as cell proliferation 
and differentiation. The exact sequence in which these SAPs are activated appear to be highly 
cell-type specific. The activated hydrolysis of phosphatidylinositol-4,5-bisphosphate 
[PtIns(4,5)P2] by a phosphoinositide-specific phospholipase C (PtIns-PLC) is involved in 
signal transduction pathway. The products inositol-1,4,5-triphosphate [Ins(1,4,5)P3] and 
diacylglycerol (DAG) intracellular targets are Ca+2-storage organelles and protein kinase C 
(PKC) respectively. The activated protein kinase C phosphorylates the lipocortin moiety of 
the lipoprotein-PLA2 complex and PLA2 is liberated. In the presence of elevated cytosolic 
Ca+2 ions, PLA2 is activated and splits phospholipids into lysophopholipid and arachidonic 
acid. Different cells express a different complement of enzymes for metabolizing lipid-
derived messengers which indicates that this signalling pathway is considerably complex 
(Liscovitch, 1992).     
 
2.9 Phospholipases in trypanosomes 
 
Phospholipids constitute the major proportion of total lipids in African trypanosomes. Both 
procyclic and bloodstream form of T.brucei contain phospholipids of all classes present in 
mammalian cells, such as phosphatidylcholine (PC), phosphatidylethanolamine (PE), 
phosphatidylserine (PS), phosphatidylinositol (PI), phosphatidylglycerol (PG), cardiolipin and 
sphingomyelin. Trypanosomes do not obtain intact phospholipids from their hosts, but instead 
synthesize their own phospholipids using headgroups (such as choline, ethanolamine, and 
inositol) acquired from the host and fatty acids which are then often modified. Fatty acid 
composition of these lipids of the parasite differs during life cycle (van Hellemond and 
Tielens, 2006). Both elongation and desaturation of fatty acids in trypanosomes has been 
observed. T.brucei uses three of its elongases (elongases 1-3) in bloodstream form and 
procyclic form to elongate pre-existing fatty acids to myristate (C14:0) and stearate (C18:0) 
respectively; therefore, elongase 4 shown to elongate polyunsaturated fatty acids may be the 
only elongase which may play a role in arachidonic acid synthesis from unsaturated fatty 
acids (Lee et al., 2006) 
Eukaryote cells experience various environmental challenges (e.g. thermal, osmotic, 
oxidative, glucose deprivation, and extremes of pH) in normal processes, some of which may 
be associated with cell differentiation. To these transient changes in the extracellular 
environment, cells have developed several response pathways including the activation of 
phospholipases after osmotic stress. In the trypanosomatid Leishmania donovani, a 
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phospholipase D is activated during hypotonic shock. With T.brucei, the life cycle of which 
involves alternating sojourns in vertebrates and tsetse flies, environmental differences 
encountered by the cells include temperature variation, glucose deprivation, and osmotic 
differences (Subramanya and Mensa-Wilmot, 2006). Phospholipases play important roles in 
generating lipid second messengers. One of the best characterized is phosphatidylinositol 
(PI)-specific phospholipase (PL) C (PI-PLC). Phosphatidylcholine (PC)-degrading activities 
have been the subject of a number of studies in African trypanosomes (Bertello et al., 2000).  
Glycosylphosphatidylinositols (GPIs) are glycolipids in eukaryotes. T.brucei has a surface 
coat which comprises predominantly , the GPI-anchored variant surface glycoprotein (VSG). 
Free GPIs that are not linked to proteins exist in large amounts in the protozoan parasites, 
T.brucei, Leishmania major and in vertebrates (McConville and Menon, 2000). The free 
glycolipids, glycolipid A (also termed P2; EtN-phospho-Man3-GlcN-PtdIns) and glycolipid C 
(or P3; EtN-phospho-Man3-GlcN-(2-acyl)-PtIns) are produced in bloodstream form T.brucei 
(Masterson et al., 1989; Mayor et al., 1990). Some free GPIs (e.g. glycolipid A) are 
precursors of protein-linked GPIs (McConville and Menon, 2000). T.brucei expresses a GPI-
specific phospholipase C (GPI-PLC). The enzyme is not secreted but associated with 
intracellular vesicles (Bulow et al., 1989). There are two possible substrates for GPI-PLC in 
vivo: GPI-anchored proteins (e.g. VSG)  and free intracellular GPIs. There is no evidence that 
free GPIs are cleaved in T.brucei. In differentiating parasites, GPI-PLC contributes to the 
release of VSG from the plasma membrane (Gruszynski et al., 2003). The biological 
functions of GPI-PLC in non-differentiating bloodstream form T.brucei is not resolved. In 
addition it is not clear how the enzyme is prevented from digesting intracellular GPIs. They 
accumulate at the endoplasmic reticulum (ER) whereas GPI-PLC associates with glycosomes 
(Zheng et al., 2004). GPI-PLC is a membrane protein, which lacks peptide signals that direct 
soluble proteins to glycosomes (Parsons, 2004; Subramanya and Mensa-Wilmot, 2006). 
In four different species, calcium-independent phospholipase A1 was the predominant PC-
degrading activity. The levels of PLA1 varied widely, with very high activity in T. brucei and 
relatively low activity in T.lewisi. T. brucei PLA1 appears to bear lysophospholipase activity 
and as such it participates in the supply of fatty-acyl and polar-head moieties for the synthesis 
of cellular phospholipids. In T. cruzi, due to mechanism of membrane-lipid adaptation 
suggests the action of phospholipase A activity as part of a deacylation-reacylation cycle 
(Wainszelbaum et al., 2001). It was observed that T. congolense possessed a mixture of free 
fatty acids and lysolecithin produced by the action of phospholipases and phospholipase A2 
on phospholipids ( Nok et al., 1993). In trypanosomes, the process of Ca2+ influx is controlled 
Introduction                                                                                                                               
                                                                                                                                                                                                                  
                                                                                                      
30 
with products of PLA2 and is not initiated by depletion of intracellular pools. Arachidonic 
acid stimulates Ca2+ influx in a process that cannot be mimicked by short chain saturated fatty 
acids. Metabolic processing of arachidonic acid to prostaglandin D contributes to growth 
arrest. T. brucei bloodstream forms produce prostaglandins (Kubata et al., 2000) and 
therefore, phospholipases may play a pivotal role in its regulation (Ridgley and Ruben, 2001). 
The fate of unsaturated fatty acids liberated from lipids in T.brucei is not certain, but free fatty 
acid has been implicated on regulating calcium mobilization in the cells (Eintracht et al., 
1998: Catisti et al.,2000). The fatty acids have been shown to serve as a precursor for 
prostaglandin biosynthesis in T.brucei. Presence of PLA1 activity in T.brucei was observed 
after cleavage of fatty acid at sn-1 of phosphatidylcholine (GPCho, after new nomenclature) 
(Fahy et al., 2005). TbPLA1 has been cloned, identified and characterized in T.brucei, which 
is intracellularly localized within the cytosol and whose preferred substrate is GPCho which 
are the major phospholipids in T.bruei. TbPLA1 is constitutively expressed in both procyclic 
and bloodstream forms trypanosomes. Lysoglycerophosphatidylcholine (lysoGPCho) 
synthesis is mediated by TbPLA1, whose level is 3-fold higher in bloodstream form as 
compared to procyclic form. This enzyme does not require metal co-factors for activity, but it 
does require interfacial activation prior to catalysis. Furthermore, this enzyme appears not to 
be essential for cell viability or for virulence in a mammalian host (Richmond and Smith, 
2007 A, B). 
 
2.10 GPI-phospholipase C (GPI-PLC) and variable surface glycoprotein 
(VSG) in T. brucei 
  
During the parasitemia, the majority of the dividing parasites (e.g. long slender form) belong 
to the same antigen type, called the homotype, expressing each 107 densely packed identical 
VSG molecules on their surface. GPI-linked VSG represents 10 % of the total trypanosome 
protein content, and on every peak of infection, the host is confronted with the release of an 
enormous quantity of these molecules (Paulnock et al., 2001).The molecular structure of 
trypanosome GPI show the presence of a trypanosome-specific galactose modification on the 
molecule (Ferguson et al., 1985; 1988). Based on the VSG N-linked carbohydrate, VSGs has 
been categorized into three groups (Ferguson et al., 1989). Group I VSGs encompass a 
collection of molecules carrying a single conserved glycosylation site, about 50 amino acid 
residues from the C-terminus (Zamze et al., 1990). In contrast, group II VSGs have a 
conserved glycosylation site five or six residues from the C-terminus as well as an additional, 
second less conserved glycosylation site (Zamze et al., 1991). Finally, group III, thus far, is 
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represented only by one single trypanosome variant, i.e. T.brucei MITat 1.5. While this VSG 
variant is characterized by the presence of three glycosylation sites, it is so far the only VSG 
known that lacks the trypanosome-specific galactose modification of the VSG-GPI anchor 
(Magez et al., 2002). 
The parasite has a repertoire of about 1000 different VSG genes, can switch expression from 
one VSG to another that has a different amino acid sequence. It is this mechanism of 
antigenic variation that enables trypanosomes to evade the host’s immune response (Cross, 
1990). The trypanosome VSG anchor is unique in that its fatty acids are strictly myristate, a 
14 –carbon saturated fatty acid. The VSG anchor is constructed as free GPI, which is 
subsequently attached to the newly synthesized VSG in the endoplasmic reticulum (ER). 
Glycolipid A itself is synthesized in a pathway in which glucosamine, mannose, and 
phosphoethanolamine are sequentially added to phosphatidylinositol (Englund, 1993). This 
undergoes a myristate-specific fatty acid remodelling reaction to replace its longer chain fatty 
acids with myristate (Masterson et al., 1990). The myristate exchange involves attachment of 
myristate at both sn-1 and sn-2 positions of GPI. Remodelling generates the dimyristoylated 
GPI which is then added to newly synthesized VSG. Fatty acid remodelling reaction 
involving deacylation and reacylation, which seemed to provide an adequate explanation for 
the exclusive presence of myristate on the VSG anchor. The myrsitates are added in the final 
stages of GPI biosynthesis in a remodeling reaction. (Morita et al., 2000). Myristate exchange 
and fatty acid remodelling appear to occur in different subcellular compartment. Myristate 
exchange may be a proofreading or a repair mechanism for VSG, ensuring that VSG are fully 
myristoylated (Buxbaum et al., 1996). 
These parasites express up to 107 copies of GPI anchor and/or GPI-related glycolipids per cell 
(Ferguson et al., 1994). VSG is liberated as a soluble molecule by means of a GPI-PLC (Fox 
et al., 1986). When VSG is cleaved by a GPI-PLC, the dimyristoylglycerol (DMG) of the GPI 
anchor is left in the membrane while VSG is released in a soluble form (Zamze et al., 1988). 
Cleavage of the VSG-GPI anchor correlates with the induction of an enhanced inflammatory 
response during chronic trypanosome infections due to which the role of GPI-PLC activation 
on the interaction between trypanosomes and the host immune system is established (Magez 
et al., 2002).  
Procyclic trypanosomes express a different cell surface coat, made up of 106 procylcin 
glycoproteins (Roditi et al.,1987; Mowatt et al., 1987; Richardson et al., 1988) and a smaller 
number (106) of poly-N-acetyllactosamine containing free GPIs (Lillico et al., 2003; Vassella 
et al., 2003; Nagamune et al., 2004; Roper et al., 2005). The procyclins are polyanionic, rod-
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like proteins encoded by procyclin genes (Roditi and Clayton, 1999). T.brucei contains (per 
diploid genome) two copies of the GPEET1 gene encoding 6 GPEET repeats, one copy each 
of the EP-1 and EP-2 genes, encoding EP1 procyclins with 30 and 25 consensus repeats, 
respectively, two copies of the EP2-1 gene, encoding EP2 procyclin with 25 EP repeats, two 
copies of the EP3-1 gene, encoding EP3 procyclin with 22 EP repeats (Acosta-Serrano et al., 
1999). The EP1 and EP3 procyclins contain a single N-glycosylation site, occupied 
exclusively by a conventional Man5GlcNAc2  oligosaccharide, at the N-terminal side of the 
EP repeat domain (Treumann et al., 1997; Acosta-Serrano et al., 1999). Whereas neither EP2 
nor GPEET procyclin is N-glycosylated. GPEET1 procyclin is phosphorylated on six of seven 
T residues (Butikofer et al., 1999; Mehlert et al., 1999; Schlaeppi et al., 2003). GPEET and 
EP procyclins contain similar GPI membrane anchors (Guther et al., 2006) .  Procyclic form 
express an abundant stage-specific GPI anchored glycoprotein, the procyclic acidic repetitive 
protein (PARP) which contains palmitate esterified to inositol, and stearate at sn-1, in a 
monoacylglycerol moiety. Addition of GPI anchor moiety to PARP is dependent on de novo 
protein synthesis, excluding the possibility that incorporation of fatty acids into PARP can 
occur by a remodelling of pre-existing GPI anchors (Field et al., 1991).  
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III. Aim of this study
  
 
The parasites lack the ability to synthesize arachidonic acid (AA) from acetate (Frayha and 
Smyth, 1983). Nonetheless, they acquire fatty acid from their environment and utilize it into 
their AA and prostaglandin (PG) synthesis. T.brucei, T.cruzi, leishmania species and Crithidia 
fasciculata convert AA and PGH2 to PGs (Kubata et al., 2007). Trypanosomes produce 
different prostaglandins like PGD2, PGE2 and PGF2 which possibly interfere with the host’s 
immune response (Kubata et al., 2000). In T.brucei, a PGF2α synthase activity has been 
identified which is capable of specifically converting PGH2 to PGF2 (Kubata et al., 2000). 
Figarella et al. (2005) reported the effect of PGD2 on the population density regulation of the 
T.brucei bloodstream form. The PGD2 induced a programmed cell death (PCD) with 
characteristic features of apoptosis which is also known to be induced by PGs in higher 
eukaryotes. 
It has been reported by Eintracht et al. (1998) that free AA can regulate Ca2+ flux across the 
plasma membrane and inhibits cell growth in a process that appears to involve metabolic 
processing of AA into prostaglandins. One part of AA is stored within membrane 
phospholipids of both bloodstream and procyclic forms. Richmond and Smith (2007) reported 
the identification and characterization of cytosolic phospholipase A1 in T.brucei. This enzyme 
deacylates GPCho containing long polyunsaturated and highly unsaturated fatty acids.  
T. brucei bloodstream forms produce prostaglandins (Kubata et al., 2000) and therefore, 
phospholipases may play a pivotal role in its regulation (Ridgley and Ruben, 2001). So, 
several attempts had been made to identify and characterize phospholipase A2 activity in 
T.brucei. Until now, there is no success on proposed search for phospholipase A2 activity 
instead PLA1/LysoPLA activity has been reported. As reported by our group (Figarella et al., 
2005; 2008), the PGs induces apoptosis and cell density regulation in T. brucei. So, it was 
imperative to search for PLA2 activity in these parasites.  
The object of this study was to identify, clone and characterize PLA2 from T.brucei. A search 
of T.brucei genome database revealed a putative phospholipase A2 –like gene which urged to 
identify and characterize this protein. The cloning and biochemical characterization of this 
protein was carried out by heterologous expression in E. coli and Sf9 insect cells. The 
localization of TbPLA2 in T.brucei bloodstream form and procyclic form was also attempted.  
The objective achieved in this study was the cloning and expression of this protein. On the 
other hand, localization and functionality of this protein was attempted. In addition, the 
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detection of PLA2 in T. brucei can be utilized as potential target in inhibition studies and for 
understanding the metabolic pathway of arachidonic acid and prostaglandins in T. brucei. 
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2. Materials and methods 
I. Materials 
1. General 
1. Cloning  
1.1 DNA sequence of T. brucei phospholipase A2 (TbPLA2) 
 
The following gene sequence of TbPLA2 was selected from GeneDB for cloning experiments 
 
Tb 09.211.3650, phospholipase A2-like protein, putative, T. brucei, chr 9 
 
5´ATGGTAACGT GGGCGCTGAA GTATTTTGTT CGCGTAGTCC GATGGTCGAC AGAAGCATTC 
  CTAATTTGGC CCACACGGCC ACTTTTTGAC TATGCCACCT CATTGCATTG TGTTCCCATA 
  AGCGGCACAT TTATTACTTC GGTTCTGCTC TGCTTCTACG GGTTCCCACT TTTCTGGTCT 
  ACCGCCATGG TTGCTGTCGG GTTTATCATC TCCGGTGTGT TATTTCTTGT GAGCCCTCTT 
  CCACTATTGA AACCCATTGG CGGTCGCTAT AGCGTGGGCC TTGTGCATAT GAACGGCTGC 
  CGTTCCCAAT CCATACCACC AGTAGCTGTG TTTTATCCTA CTAATATGGT CCCAGAGAAA 
  AAGGGACTAC CGTATGTCCC GTTTGGAGAT GACCGTTTTC TTCGGGGCGT GGCGGCGTAT 
  GCAAACGTGC CATTTTTCTT CATAAGGGAT TTCTCCTTTG TTCGCATCAG TGCGTCCCGA 
  AACGCGGTGC CCGCCGCTTT GCTCAACCAA TATGAGAGAG TGCCACCTAT TGTTGTGTTC 
  AGTCACGGTC TTGCCGGATA CCATTTGTTC TACAGTTGCT TTGCGTTGGA TCTTGCGGCG 
  CGGGGTGCAA TCGTGATTTG TCTTGGCCAT TGCGACAATA GTGCTTCTTT CATGCGTGAC 
  AGTAGCGGTA AGGAAAGTGA AGTTCCGCTC AAGGACTATG GATGGGAGGT ACCCGCACGT 
  GAAGCCCAAG TTGCACAAAG GGTAAGCGAG GTGAGGGGAA CACTTCAACG CCTAACGGAA 
  AAGGACTTTT GGACAACTTT GGGCTACATT AATTCAGATA TTGACAAGTT TCTTAGCAAA 
  CCGTTGCAGG TACATCTTGC GGGTCATTCA TTTGGCGGTG CCACTGTACT CGCGGCTGCA 
  TTAGAAGAGA ACCAAAATCC CGTGAAGGGA GTCAGCGTAA AGAGCGTGTA TACGTTTGAC 
  CCATGGATGG TACCAATACA AAATGAACAT TTTTGCAACC CGCTTTCTGA TGGCCGTAAA 
  TCCTATACTG TTCCAACGGT TACTGTGCAT TCAGACGACT GGGTAAAAGA TTCTGAGAGT 
  TGGGAATTCT TTAAAAGGAT GAAAGCGCTG GTGTTAGAAC AATCTGCATA TGCTTCGCTC 
  AATGAAGTGG AGAAACAAGC GCTCTTTGGT ATTGTGGTCA CGAAGAATAC GAACCACCTT 
  TCTCTTGTAG ATGTCTCTGT ACTCAGTCCC GTCATGCATG GAAATATCTG GGCCACAGTG 
  TCACCGCGAG TACAAATTAT GGAGTGGTGT AATGCACTTC TTCGCTTCGC AAAGCAAAAT 
  ACCGAAGTGT GTTCAACGTG TTAG ´3 
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1.2 Primers 
 
Primers for cloning                                                                            (Invitrogen) 
 
Both primers were chosen according to the gene sequence above and plasmids multiple 
cloning restriction sites. The sense primer has a restriction site for BamH1 only and the anti-
sense primer has a Pst1 restriction site only which are indicated below by inverted arrows. 
The primers were designed to include the signal peptide, transmembrane sequence and 
termination codon of protein using the OligoPerfectTM designer from Invitrogen. The 
following was the primer sequences for both sense and anti-sense respectively: 
 
 
Sense primer                 5’ -TAT G↓GA TCC ATG GTA ACG TGG GCG CTG A- 3’ 
                                                Primer length: 28 
                                                Tm 58°C 
 
Anti-sense primer        5’ -ATA ACT GCA ↓GCT AAC ACG TTG AAC ACA CTT CGG T- 
3’ 
                                                Primer length: 34 
                                           Tm 58°C 
 
 
Primers for Northern blotting                                                              (Operon) 
 
Sense primer                 5’-ATGGTAACGT GGGCGCTGAA GTAT- 3’ 
                                                Primer length: 24 
                                                Tm 64.57°C 
 
Anti-sense primer        5’-CTAACACGTTGAACACACTTCGGTA- 3’ 
                                               Primer length: 25 
                                               Tm 62.94°C 
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2. Protein sequence of TbPLA2 from databank  
 
The following protein sequence of TbPLA2 was chosen from GeneDB for peptide synthesis  
 
Tb 09.211.3650, phospholipase A2-like protein, putative, T. brucei, chr 9 
 
MVTWALKYFV RVVRWSTEAF LIWPTRPLFD YATSLHCVPI SGTFITSVLL CFYGFPLFWS 
TAMVAVGFII SGVLFLVSPL PLLKPIGGRY SVGLVHMNGC RSQSIPPVAV FYPTNMVPEK 
KGLPYVPFGD DRFLRGVAAY ANVPFFFIRD FSFVRISASR NAVPAALLNQ YERVPPIVVF 
SHGLAGYHLF YSCFALDLAA RGAIVICLGH CDNSASFMRD SSGKESEVPL KDYGWEVPAR 
EAQVAQRVSE VRGTLQRLTE KDFWTTLGYI NSDIDKFLSK PLQVHLAGHS FGGATVLAAA 
LEENQNPVKG VSVKSVYTFD PWMVPIQNEH FCNPLSDGRK SYTVPTVTVH SDDWVKDSES 
WEFFKRMKAL VLEQSAYASL NEVEKQALFG IVVTKNTNHL SLVDVSVLSP VMHGNIWATV 
SPRVQIMEWC NALLRFAKQN TEVCSTC 
 
Peptide sequences for antibody production against TbPLA2 in rabbit: 
 
Peptide 1:   LEENQNPVKGVSVKSVYTFD 
 
Peptide 2:   TVSPRVQIMEWCNALLRFAKQNTEV 
 
The underlined peptides in the protein sequence were selected for antibody production as they 
revealed significant hydrophilic properties. These were analyzed using hydrophilic (Kyte-
Doolittle) and surface (Emini) probability calculations.  
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3. Experimental organisms 
 
3.1 Escherichia coli 
 
Bacterial strains XL-1 (subcloning) and BL-21 (DE3) (expression) competent cells were 
bought from Stratagene, Germany and stored at -70°C. One shot TOP 10 and MAX 
Efficiency®DH10 Bac competent cells were bought from Invitrogen, Germany and stored at -
70°C. 
 
3.2 Spodoptera frugiperda (Sf9)  
 
Insect cells Sf9 (fall armyworm) stabilates were bought from Invitrogen, Germany, stored at -
70°C and propagated at 27°C in an incubator. 
 
3.3 Trypanosoma brucei 
 
In this work two forms of trypanosomes, bloodstream and procyclic form were used. 
Bloodstream forms were from a monomorphic strain known as strain EATRO 427 clone 
MITat 1.2 (Molteno Institute Trypanozoon antigenic type, Cambridge) with the VSG 
(Variable Surface Glycoprotein) antigen variant 221 (Cross, 1975). Procyclic form was 
obtained from MITat 1.2 using a standard transformation protocol (Overath et al., 1986). 
 
3.4 Animals 
 
Stabilates of bloodstream form trypanosomes were prepared with infection in Wistar rats 
bought from Charles River Laboratories, Germany in an animal model to propagate 
trypanosomes. The animals were maintained in the animal house facility of the Interfaculty 
Institute of Biochemistry, University of Tuebingen.  
 
4.  General chemicals 
 
Acetone analytical grade                                                  Fluka, Buchs (Switzerland) 
Acrylamide/bisacrylamide (Rotiphorese Gel 30)            Roth, Karlsruhe 
Adenosine                                                                        Sigma, Deisenhofen 
Agar-agar                                                                         Roth, Karlsruhe 
Agarose (Rotigarose)                                 Roth, Karlsruhe 
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Ampicillin                                                                        Sigma, Deisenhofen 
Ammonium persulfate (APS)                                          Merck, Eurolab,GmBH, Mannheim 
L- Arginine                                                                      Sigma, Deisenhofen 
Bathocuproinedisulfonic acid disodium salt (BCS)        Sigma, Deisenhofen 
Bovine serum albumin (BSA), Fat free                           Sigma, Deisenhofen 
Bradford protein assay reagent                                        Bio-Rad, Munich 
5-Bromo-4-chloro-3-indolyl phosphate   (BCIP)            Sigma, Deisenhofen 
Calcium chloride                                                             Merck, Eurolab,GmBH, Mannheim 
Canusal® (Heparin-Na)                                                   CP Pharmac. Ltd. Wrexham (UK) 
Cellfectin® Reagent                                                         Invitrogen, Karlsruhe 
Chloroform                                                                      Merck, Eurolab,GmBH, Darmstadt 
Coomassie brilliant blue R-250                                       Serva, Heidelberg 
5´- [32P] dATP                                                                 Amersham Biosciences, Freiburg 
DEAE-Sephacel                                                              Sigma,Deisenhofen 
Dimethyl formamide                                                       Sigma, Deisenhofen 
Disodium hydrogen phosphate                                       Merck, Eurolab,GmBH, Darmstadt 
DNA ladder 1kb                                                              Fermentas, St. Leon-Rot 
Dilinoleoyl phosphatidylcholine (DL-PC)                      Sigma, Deisenhofen 
dNTP mix                                                                        Fermentas, St. Leon-Rot 
Dulbecco’s PBS (1X)                                                      PAA Labs., GmBH, Pasching, Austria 
Ethanol                                                                            VWR International, Darmstadt 
Ethidium bromide                                                            Roth, Karlsruhe 
Ethylenediamine tetraacetic acid (EDTA)                       Roth, Karlsruhe 
EX-CELL 420 serum free medium w/ L-Glutamine       Invitrogen, Karlsruhe 
Fetal bovine serum (FBS)                                                Invitrogen, Karlsruhe 
Formaldehyde (37 %)                                                      Sigma, Deisenhofen 
Hydrogen chloride                                                           Merck, Eurolab,GmBH, Darmstadt 
Gentamicin                                                                      Sigma, Deisenhofen 
D-Glucose monohydrate                                                 Sigma, Deisenhofen 
L-Glutamine                                                                    Sigma, Deisenhofen 
L-Glutamic acid                                                               Sigma, Deisenhofen 
Glycerine      87%                                                            Sigma, Deisenhofen 
L-Glycine                                                                         Sigma, Deisenhofen 
Haemin                                                                             Sigma, Deisenhofen 
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HEPES                                                                             Sigma, Deisenhofen 
L- Histidine                                                                      Sigma, Deisenhofen 
Hypoxanthine                                                                   Sigma, Deisenhofen 
Iscove’s Dulbecco’s medium                                           Sigma, Deisenhofen 
L- Isoleucine                                                                     Sigma, Deisenhofen 
Isopropanol                                                                       Merck, Eurolab,GmBH, Darmstadt 
IPTG (Isopropyl-beta-D-thiogalactopyranoside)             Fermentas, St. Leon-Rot  
Kanamycin                                                                       Merck, Eurolab,GmBH, Darmstadt  
Leupeptin                                                                         Sigma, Deisenhofen 
Lipoxygenase                                                                   Sigma, Deisenhofen 
L- Lysine                                                                          Sigma, Deisenhofen 
Magnesium chloride                                                         Merck, Eurolab,GmBH, Darmstadt 
Magnesium sulfate                                                           Merck, Eurolab,GmBH, Darmstadt 
MEM amino acids                                                            Sigma, Deisenhofen 
MEM vitamin solution                                                     Sigma, Deisenhofen 
Mercaptoethanol                                                              Merck, Eurolab,GmBH, Darmstadt 
Methanol                                                                          Merck, Eurolab,GmBH, Darmstadt 
L- Methionine                                                                  Sigma, Deisenhofen 
Myristic acid                                                                    Sigma, Deisenhofen 
Nitro blue tetrazolium (NBT)                                          Sigma, Deisenhofen 
L- Ornithine                                                                     Sigma, Deisenhofen 
Paraformaldehyde                                                            Fluka, Buchs 
Penicillin/ Streptomycin                                                  Sigma, Deisenhofen 
Pepstatin                                                                          Sigma, Deisenhofen 
Phenol red                                                                        Sigma, Deisenhofen 
L- Phenylalanine                                                              Sigma, Deisenhofen 
Phospholipase A2 from porcine pancreas                        Sigma, Deisenhofen 
Pfu DNA polymerase                                                      Stratagene Europe Netherlands 
Potassium chloride                                                          Merck, Eurolab,GmBH, Darmstadt 
Potassium dihydrogen phosphate                                    Merck, Eurolab,GmBH, Darmstadt 
Prestained protein ladder                                                 Fermentas, St. Leon-Rot 
Protein G                                                                         Roche Diagnostics GmBH, Mannheim 
Protein molecular marker                                                Sigma, Deisenhofen 
L- Proline                                                                         Sigma, Deisenhofen 
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Pluronic® F-68                                                                 Invitrogen, Karlsruhe 
Restriction enzymes and buffers                                     Fermentas, St. Leon-Rot 
Roti-Load 1(4 X, non-reducing)                                     Roth, Karlsruhe 
Roti-Load 1(4 X, reducing)                                            Roth, Karlsruhe 
Sodium azide                                                                  Sigma, Deisenhofen 
Sodium acetate                                                                Sigma, Deisenhofen 
Sodium chloride                                                              Fluka, Buchs 
Sodium dihydrogen phosphate                                        Merck, Eurolab,GmBH, Darmstadt   
Sodium dodecyl sulfate                                                   Sigma, Deisenhofen 
Sodium hydroxide                                                           Sigma, Deisenhofen 
Taq DNA polymerase                                                      Invitrogen, Karlsruhe 
T4 DNA ligase                                                                 Fermentas, St. Leon-Rot 
TEMED                                                                           Roth, Karlsruhe 
Tetracycline                                                                     Sigma, Deisenhofen 
L- Threonine                                                                    Sigma, Deisenhofen 
Tris                                                                                   Roth, Karlsruhe 
Triton X- 100                                                                   Roth, Karlsruhe 
Trypan blue                                                                      Sigma, Deisenhofen 
L- Tryptophan                                                                  Sigma, Deisenhofen 
Tween 20                                                                          Roth, Karlsruhe 
L- Tyrosine                                                                       Sigma, Deisenhofen 
L- Valine                                                                          Sigma, Deisenhofen 
Yeast extract                                                                    Roth, Karlsruhe 
 
5.  Plasmids  
  
pCR®2.1-TOPO (3931 bp)                                              Invitrogen, Karlsruhe                                                         
pMalC2e (6646 bp)                                                         New England Biolabs, Frankfurt 
pFastBac 1 (4775 bp)                                                      Invitrogen, Karlsruhe 
Bacmid (bMON14272)                                                   Invitrogen, Karlsruhe 
 
6.  Kits 
AccuPrime Taq DNA polymerase high fidelity              Invitrogen, Karlsruhe 
Hot Star Taq master mix kit                                            Qiagen GmbH, Hilden 
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Pfu DNA polymerase                                                      Stratagene Europe, Netherlands 
QIAquick gel extraction kit                                            Qiagen GmbH, Hilden 
QIAprep spin MiniPrep test kit                                       Qiagen GmbH, Hilden 
NucleoBond AX (MaxiPrep)                                          Macherey-Nagel GmbH, Dueren 
NucleoBond AX (MidiPrep)                                           Macherey-Nagel GmbH, Dueren 
 
7.  Antibodies 
Anti-rabbit IgG alkaline phosphatase conjugate             Sigma, Deisenhofen 
Alexa Flour 594 goat anti-rabbit IgG                              Invitrogen, Karlsruhe 
Anti-VSG (antigen variant 221, rabbit) 
 
8. Materials and Equipments 
Amicon microcentrifuge MC 13                                     Heraeus, Osterode 
Analytical plus fine weighing maschine                         Ohaus  
Beckman TL-100 ultracentrifuge                                    Beckman, Munich 
Biofuge A                                                                        Heraeus, Osterode 
Biometra standard power pack P25 power supply          Biometra analytik GmbH 
Bluemarine 100 agarose electrophoresis                         Serva electrophoresis 
Centrifuge Sigma 3K12                                                   Sigma, Deisenhofen 
Cell culture flasks (T-12; T-25; T-75; T-175) sterile      Greiner, Frickenhausen 
Chromatography paper 3MM Chr                                   Whatman GmbH, Dassel 
Cuvettes semi-micro                                                         Sarstedt, Nuembrecht 
Cuvettes UV-micro                                                          Brand GmBH, Wertheim 
Electrophoresis minigel mighty small II SE 250             Hoefer, San Francisco 
Eppendorf and PCR cups                                                 Greiner, Frickenhausen 
Falcon tubes (15 and 50 ml)                                             Greiner, Frickenhausen 
Flouresence microscope Olympus BH2 RFCA                Olypmus, Hamburg 
Gene power supply GPS 200/400                                     Pharmacia 
GFL water bath shaker                                                     Hampshire, UK 
Glass slides with cover glass                                            Roth, Karlsruhe 
Heidolph MR 2002 IKA RCT classic magnetic stirrer     IKA Labortechnik, Staufen  
HLB 2448 GS weighing maschine                                    Mettler 
Hybond –ECL nitrocellulose membrane                           Amersham Biosciences, Freiburg 
Inverted microscope ID 02                                                Zeiss, Oberkochen 
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Inverted microscope Axiostar plus                                   Zeiss,  Oberkochen 
Incubator Hera cell with CO2 and 37°C                            Hereaus, Osterode 
Incubator with 27°C                                                          Koettermann, Uetze-Haenigsen 
Incubator                                                                           INFORS AG, Bottmingen 
Lab shaker model Kuehner                                               B. Braun, Melsungen 
Microtiter plates (6- well)                                                 Greiner, Frickenhausen  
Micropippetes SL-PetteXE                                               Nichiryo 
Microwave oven                                                                Panasonic 
Neoblock 1                                                                        Neolab Miggie,Heidelberg 
Neubauer  Haemocytometer                                              Brand, Wertheim 
Orbital shaker                                                                                           
PCR minicycler PTC-150 MJ research                            Biozyme, Oldendorf 
PCR sprint                                                                         Hybaid, USA 
pH meter (pH 539)                                                            WTW, Weilheim 
PP- sterile test tubes (15 ml, 50 ml)                                 Greiner, Frickenhausen 
Pressure cooker                                                                CS Solingen, Solingen                                               
Round filter paper MN 615                                              Macherey-Nagel GmbH, Dueren 
SFCA sterile filter membrane                                           Nalge, Hereford, UK 
Shaker                                                                               Infors AG 
Sonifier® Cell disruptor B-30                                           G. Heinemann, Schwaebisch Gmünd 
Sterile pump                                                                      Microgon Inc., USA   
Vaccum centrifuge                                                            Bachofer, Reutlingen 
Vortex genie                                                                      Bender & Hobein AG, Switzerland 
Ultracentrifuge TL-100                                                     Beckman, USA 
Ultrospec 3000 spectrophotometer                                   Pharmacia Biotech, Cambridge, UK 
Water bath                                                                         Schott, Mainz              
 
9. Databank and softwares 
THMM server version 2.0                                                http://www.cbs.dtu.dk/services/TMHMM/ 
Brenda Enzyme Information System                                          http://www.brenda-enzymes.info/ 
DNAMAN  GATC Biotech DNA sequencing/ viewer           http://www.gatc-biotech.com/de/ 
GeneDB   Hosted by Sanger Institute                                      http://www.genedb.org/ 
Invitrogen Primer OligoPerfect Designer                                http://www.invitrogen.com/ 
PubMed (NCBI Homepage)                                                    http://www.ncbi.nlm.nih.gov/ 
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2. Media, Buffers and solutions 
 
2.1 Media for different organisms 
2.1.1   Escherichia coli 
 
Luria-Bertani medium (LB-medium) pH 7.0 
 
Tryptone                                                                              10 g 
Yeast extract                                                                         5 g                                
NaCl                                                                                    10 g 
 
All components were mixed in distilled water and adjusted to pH 7.0 using NaOH. 
Afterwards, the final volume was made upto 1 liter and then autoclaved. 
 
Transformation medium for E. coli (TSS) 
 
Supplemented in LB-medium 
DMSO                                                                                 5 % 
MgCl2 X 6 H2O (50 mM)                                              10.2 g/l 
PEG 6000                                                                          10 % 
 
SOB medium  
Tryptone                                                                           20 g 
Yeast extract                                                                       5 g 
NaCl                                                                                0.5 g 
 
Distilled water was added to above chemicals and mixed. The final volume of the solution 
was made to 1 liter and then autoclaved. Afterwards, 10 ml of filter-sterilized 1 M MgCl2 and 
10 ml of filter-sterilized 1 M MgSO4 was added to this solution prior to use. 
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SOC medium  
 
To the autoclaved SOB medium, 1 ml of filter-sterilized 2 M glucose was added to a final 
volume of 100 ml. Subsequently, aliquots of 5 ml of the medium were made and stored at – 
20°C till further use. 
 
Ampicillin stock solution (1000 X) 
Ampicillin (50 mg/ ml) was dissolved in 70 % ethanol and stored at -20°C. 
 
X-Gal stock solution (500 X) 
X-Gal (20 mg/ ml) was dissolved in dimethyl formamide and stored at -20°C. 
 
Culture plates  
Agar-Agar in LB-medium                                                         1 % 
 
IPTG dioxane free, freshly prepared 
IPTG (0.1 M) was dissolved in sterile distilled water and filtered.                                          
 
Column buffer pH 7.4 
Tris                                                                                         20 mM 
NaCl                                                                                     200 mM 
EDTA                                                                                       1 mM 
 
The solution was adjusted to pH 7.4 using HCl. 
 
2.1.2 Baculovirus Expression Vector System 
 
Ex-Cell 420 Serum-Free with L-Glutamine liquid medium 
 
The medium was bought from SAFC Biosciences. Before propagating and infection in Sf9 
insect cells, the medium was supplemented with following additives under sterile conditions  
 
Fetal Bovine Serum (FBS)                                                        10 % 
Pluronic® F-68                                                                        0.01 % 
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Penicillin/ Streptomycin solution                                            5 ml/l 
 
RIPA (Radio-Immunoprecipitation Assay) Lysis buffer pH 7.4 
 
Tris                                                                                        50 mM 
NaCl                                                                                    150 mM  
NP-40                                                                                      1% 
Sodium deoxycholate                                                           0.5 % 
EDTA                                                                                      1 mM 
SDS                                                                                       0.1 % 
Sodium azide                                                                       0.01 % 
 
The solution was adjusted to pH 7.4 using NaOH  
 
2.1.3 Trypanosoma brucei 
 
2.1.3.1 Citrate-Glucose-Anticoagulant (CGA) pH 7.7 
 
Sodium citrate X 2H2O                                                     100 mM 
Glucose                                                                                40 mM 
 
2.1.3.2 Separation buffer pH 8.0 (Lanham and Godfrey, 1970) 
 
NaHPO4 X H2O                                                                  57 mM 
KH2PO4                                                                                3 mM 
NaCl                                                                                    44 mM 
Glucose                                                                               55 mM 
 
2.1.3.3 Cell culture medium 
 
2.1.3.3.1 Basic medium or Minimum Essential Medium (MEM) pH 7.4 
 
The medium was prepared according to Eagle (1959) which was modified by Duszenko et al., 
(1985 and 1992).  
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                                                                                         [mg/ ml] 
CaCl2 X H2O                                                                        265 
KCl                                                                                      400 
MgSO4 X 7 H2O                                                                  200 
NaH2PO4 X H2O                                                                  140 
NaCl                                                                                   6800 
HEPES                                                                               7140 
 
Above chemicals were dissolved in distilled water and adjusted to pH 7.4 using NaOH. 
 
                                                                                          [mg/ ml] 
L-Arginine/ HCl                                                                    126 
L-Cysteine                                                                               24 
L-Histidine/ HCl X H2O                                                         42 
L-Isoleucine                                                                            52 
L-Leucine                                                                                52 
L-Lysine                                                                                  73 
L-Methionine                                                                          15 
L-Phenylalanine                                                                    100 
L-Threonine                                                                            48 
L-Tryptophan                                                                         10 
L-Tyrosine                                                                            100 
L-Valine                                                                                 46 
L-Ornithine/ HCl                                                                   10 
Adenosine                                                                              12 
The amino acids and adenosine were dissolved in distilled water and then added the following 
commercial stock solutions: 
                                                                                          [mg/ l] 
    MEM non-essential amino acids solution                         10  
    MEM vitamin solution                                                      10 
    Phenol red                                                                          10 
 
The medium was sterile filtered using pump and filter (SFCA membrane) and stored at 4°C. It 
can be used for up to 3 months. 
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2.1.3.3.2 Complete bloodstream culture medium (BF-medium) pH7.4 
 
The following stock solutions were added to the basic medium for preparation of a complete 
culture medium: 
                                                                                                           [ml/ l] 
NaHCO3                        (750 mg/10ml distilled water)                        30 
L-Cysteine                     (30.3 mg/10 ml distilled water)                      10 
BCS                               (5.6 mg/10ml distilled water)                           1 
Hypoxanthine                (13.6 mg/10ml with 0.1N NaOH)                  10 
2’-Desoxythymidine      (3.9 mg/10 ml distilled water)                        10 
L-Glutamine                   (292 mg/10 ml distilled water)                      10 
BSA/ Myristic acid         (50 X)                                                            20 
FBS                                 (Heat inactivated: 30 min. 56°C)                 150 
Penicillin/ Streptomycin solution                                                           5 
Glucose                                                                                                5.4 g 
 
Preparation of myristic acid linked to defatted BSA (Ferguson and Cross, 1984): 24 mg 
myristic acid was dissolved in 100 µl ethanol (95%) and gradually added to a BSA solution (1 
g defatted BSA/ 20 ml distilled water). The aliquots of 20 ml were made and stored at – 20°C. 
 
The BF-medium was adjusted to pH 7.4 using NaOH. Afterwards, it was sterile filtered and 
stored at 4°C which can be used for up to 4 weeks. 
 
2.1.3.3.3 Procyclic culture medium pH 7.4 
 
The following substances were added to the basic medium for the cultivation of procyclic 
parasites: 
                                                                                                           [mg/ ml] 
L-Glutamine              (29.2 mg/ ml distilled water)                               10 
Haemin                     (2.5 mg/ ml in 0.1 M NaOH)                                 3 
Pyruvate                      (22 mg/ ml distilled water)                                10 
L-Proline                     (60 mg/ ml distilled water)                                10 
FBS                (Heat inactivated: 30 min. at 56°C)                              100 
Penicillin/Streptomycin solution                                                              5 
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The medium was adjusted to pH 7.4 using NaOH. Afterwards, it was sterile filtered and 
stored at 4°C which can be used for up to 4 weeks. 
 
Trypanosoma Dilution Buffer (TDB) pH 7.7 
 
Na2HPO4 X 12 H2O                                                                         18 mM 
NaH2PO4 X H2O                                                                                2 mM 
KCl                                                                                                    5 mM 
NaCl                                                                                                80 mM 
MgSO4 X 7 H2O                                                                                1 mM 
Glucose X H2O                                                                                20 mM 
 
Freezing medium for stabilates (TDB-Glycerin) 
 
TDB                                                                                                  77 ml 
87 % Glycerin (20 % end concentration)                                         23 ml 
 
Phosphate Buffered Saline (PBS) pH 7.4 
Na2HPO4 X 12 H2O                                                                        10 mM 
KH2PO4                                                                                          10 mM 
NaCl                                                                                              120 mM 
KCl                                                                                                 8.7 mM 
 
Protease inhibitor mix (1000 X) 
Pepstatin                                                                                           1 mM 
Chymostatin                                                                                     1 mM 
Leupeptin                                                                                         1 mM 
 
All three inhibitors were dissolved in DMSO and stored as aliquots at -20°C. 
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Cell lysis buffer 
 
Na2HPO4 X 12 H2O                                                                     10  mM 
KH2PO4                                                                                                                                   10  mM 
Protease inhibitor mix                                                                     1 % 
Triton X-100                                                                              0.15 % 
 
Both the phosphate components were dissolved in deionized water and titrated to pH 7.4. The 
protease inhibitor mix was added to the solution. Triton X-100 was only added for membrane 
fraction isolation. 
 
ZnCl2 stock solution (50 X) 
 
ZnCl2              6.85 mg / ml    (end concentration 0.2 mM)               10 mM 
 
 
2.2 Buffers and solutions  
 
2.2.1 Buffers and solutions for molecular biology 
 
TE-buffer pH 8.0 
Tris                                                                                             40 mM 
EDTA                                                                                           2 mM 
 
DNA gel electrophoresis 
 
DNA sample buffer pH 8.0 
Glycerol                                                                                           5 % 
Bromophenol blue                                                                    0.025 % 
EDTA                                                                                          0.1 M 
 
TAE buffer pH 8.0 (50 X) 
Tris                                                                                            0.04 M 
EDTA                                                                                      0.002 M 
Acetic acid                                                                                57.1 ml 
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The solution was adjusted to pH 8.0 with acetic acid. 
 
2.2.2 SDS-PAGE (SDS-PolyAcrlyamide Gel Electrophoresis)  
 
2.2.2.1 Resolving gel and separating gel solutions (according to Laemmli, 1970) 
 
Stock solutions 
APS    (freshly prepared)                                                   0.1 g/ ml in deionized water 
1 M Tris-HCl pH 8.8 
Tris                                                                                   24.2 g/ 200 ml in deionized water 
1 M Tris-HCl pH 6.8  
Tris                                                                                   12.1 g/ 100 ml in deionized water 
SDS    10 %                                                                        10 g/ 100 ml in deionized water 
 
Resolving gel  
                                                                                        (12 % T for 1 gel) 
Acrylamide/ Bis (Rotiphorese gel 30)                                 2.15 ml 
Deionized water                                                                   1.27 ml 
1 M Tris-HCl pH 8.8                                                           2.28 ml 
10 % SDS                                                                          0.057 ml 
10 % APS                                                                          0.019 ml 
TEMED                                                                             0.006 ml 
 
 
Stacking gel  
                                                                                   (5.1 % T for 1 gel) 
Acrylamide/ Bis (Rotiphorese gel 30)                                  0.5 ml 
Deionized water                                                                    2.1 ml 
1 M Tris-HCl pH 6.8                                                        0.375 ml 
10 % SDS                                                                           0.03 ml 
10 % APS                                                                         0.015 ml 
TEMED                                                                            0.003 ml 
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Running buffer pH 8.3 
Tris                                                     3.03 g/l                  (25 mM)  
Glycine                                              14.4 g/l                 (192 mM) 
SDS                                                     1 g/l                         (0.1 %)      
     
2.2.2.2 Coomassie staining 
 
Staining solution 
Coomassie Brilliant Blue R-250                                           1 g/ l     
Ethanol                                                                            400 ml/ l 
Acetic acid                                                                       100 ml/ l 
Distilled water                                                                 500 ml/ l 
 
Coomassie Brilliant Blue R-250 was dissolved in ethanol. Subsequently, other solutions were 
added after Coomassie was completely solublized and the volume was made up to 1 liter. 
 
Destaining solution 
Ethanol                                                                           400 ml/ l 
Acetic acid                                                                      100 ml/ l 
Distilled water                                                                500 ml/ l 
 
2.2.2.3 Silver staining 
 
Fixation solution  
Acetic acid                                                                       12 %                       
Ethanol                                                                            40 % 
Formaldehyde (37 %)                                                   0.05 % 
 
Wash solution                  
Ethanol                                                                           50 % 
Distilled water                                                                50 % 
 
Pretreatment 
Na2S2O3 X 5H2O (10% in distilled water)                    0.2 % 
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Impregnation          
AgNO3                                                                         0.2 % 
Formaldehyde (37 %)                                              0.075 % 
 
Development 
Na2CO3                                                                          6 % 
Na2S2O3 X 5H2O (10% in distilled water)              0.004 % 
Formaldehyde (37 %)                                             0.005 % 
 
Stop solution 
Ethanol                                                                       40 % 
Acetic acid                                                                 12 % 
 
All solutions were made in distilled water. 
 
 
2.2.2.4 Gel drying solution 
 
Glycerol 87 %                                                          2.3 % 
Ethanol                                                                     25 % 
 
The solution was made in distilled water and volume made up to 1 liter. 
 
 
2.2.3 Western blotting 
 
Transfer buffer pH 9.2 
Tris                                        5.82 g/ l               (48 mM) 
Glycine                                  2.93 g/ l               (39 mM) 
SDS                                       3.75 ml                   (10 %) 
Methanol                               200 ml/ l                (20 %) 
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Wash buffer pH 7.4 
Tris                                       1.21 g/ l               (10 mM) 
NaCl                                   8.766 g/ l            (150 mM) 
Tween 20                               1 ml/ l                   (0.1%) 
 
Tris Buffered Saline (TBS) pH 7.4 
Tris                                      5.82 g/ l               (25 mM) 
KCl                                       0.2 g/ l 
NaCl                                        8 g/ l 
 
Blocking solution  
Milk powder                        10 % in 2 X PBS 
 
2 X Phosphate Buffered Saline (PBS) pH 7.4 
Na2HPO4 X 12 H2O           7.26 g/ l 
KH2PO4                              0.48 g/ l 
NaCl                                      16 g/ l 
KCl                                     0.40 g/ l 
 
Alkaline phosphatase (AP buffer) pH 8.9 
Tris                                  2.42 g/ l                  (20 mM) 
NaCl                                8.77 g/ l                (150 mM) 
MgCl2                              2.03 g/ l                  (10 mM) 
 
Color development solutions 
BCIP, Toluidine salt (fresh solution in DMF)                7 mg/ 250 µl           (0.38 mM) 
NBT (fresh solution in 70% DMF)                         16.25 mg/ 500 µl            (0.40 mM) 
 
The BCIP and NBT solutions were dissolved in 50 ml AP buffer for each blot. 
 
Primary antibody (Anti-TbPLA2) in TBS 1:2000 
Secondary antibody (Anti-Rabbit IgG, alkaline phosphatase conjugated) in TBS 1:20 000 
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2.2.4 Northern blotting 
 
10 X FA gel buffer pH 7.0 
MOPS                                    41.86 g/ l        (200 mM) 
Sodium acetate                      4.10 g/ l            (50 mM) 
EDTA                                    3.72 g/ l            (10 mM) 
 
The solution was adjusted to pH 7.0 using NaOH 
 
1 X FA Running buffer 
10 X FA gel buffer                               100 ml/ l 
37% Formaldehyde                                20 ml/ l 
 
5 X Loading buffer  
Bromophenol blue solution                          16 µl 
EDTA (500 mM, pH 8.0)                             80 µl 
37 % Formaldehyde                                   720 µl 
100 % Glycerol                                        2000 µl 
Formamide                                               3084 µl 
10 X FA gel buffer                                   4000 µl 
Ampuwa                                                  volume made up to 10 ml 
 
The loading buffer was stored at 4°C which can be used for 3 months. 
 
20 X SSC pH 7.0  
NaCl                                                        175.3 g/ l             (3 M) 
Sodium citrate X 3 H2O                            88.2 g/ l          (0.3 M) 
 
500 mM sodium phosphate pH 7.2  
Na2HPO4 X 12 H2O                                                      (500 mM) 
 
The solution was adjusted to pH 7.2 using H3PO4. 
Hybridmix sodium phosphate 
SDS                                                                   70 g/ l        (7 %) 
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EDTA (pH 7.5, 93.05 mg/ml = 0.5 M)            4 ml/ l         
Sodium phosphate (500 mM)                       volume made up to 1000 ml 
 
Phosphate wash 
SDS                                                                  10 g/ l           (1%) 
Sodium phosphate (500 mM)                        80 ml/ l 
Ampuwa                                                         volume made up to 1000 ml 
 
Stripping buffer 
SDS                                                                10 g                (1%) 
Ampuwa                                                        volume made up to 1000 ml 
 
2.2.5 Immunoflouresence 
 
Fixation solution (Freshly prepared) 
Paraformaldehyde                                           0.4 g             (4 %) 
PBS                                      volume made up to 10 ml 
 
The solution was warmed (not boiled) in microwave oven till paraformaldehyde was 
solublized and put on ice.  
 
1% BSA solution (Freshly prepared) 
BSA                                                          10 mg/ml in PBS 
 
Sodium phosphate pH 7.2 containing Glycine 
Na2HPO4 X 12 H2O                               35.81 g/ l           
Glycine                                                    7.51 g/ l           (0.1 M) 
 
0.2% Triton solution (Freshly prepared) 
Triton X-100                                           2 mg/ml in PBS 
 
Bisbenzimide solution 
Bisbenzimide                                          1 mg/ml in distilled water 
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2.2.6 PLA2 enzyme assay 
All chemicals were solublized in deionized water 
 
Solubilization buffer for DL-PC  
Tris                                                           6.057 g/ l          (50 mM) 
Sodium deoxycholate                                4.15 g/ l           (10 mM) 
 
Dilinoleoyl phosphatidylcholine (DL-PC) stock solution 
DL-PC                                                          12.5 mg/ml in solubilization buffer 
 
Lipoxygenase stock solution  
Lipoxygenase                                                3.6 µg/ µl 
 
Stock solution was diluted to 1:100 with Ampuwa.  
 
Phospholipase A2 from porcine pancreas (stock solution) 
Phospholipase A2 from porcine pancreas      3 mg/ml 
 
Stock solution was diluted to 1:100 with Ampuwa to 30 µg/ ml. 
   
Reaction buffer 1: Tris-HCl pH 8.5 buffer 
Tris                                                        6.057 g/ l             (50 mM) 
 
Reaction buffer 2: Tris-HCl pH 8.5 containing sodium deoxycholate buffer 
Tris                                                        6.057 g/ l             (50 mM) 
Sodium deoxycholate                             2.49 g/ l               (6 mM) 
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II. Methods 
1. General methods 
 
1.1 Protein determination with Bradford method 
 
Protein concentrations were determined for all experiments using the Bradford method 
(Bradford, 1976) with BSA in 2 µg, 4 µg, 6 µg, 8 µg and 10 µg/ ml concentrations as 
standard. The concentrated Bradford reagent (Bio-Rad) was diluted to 1:5 with deionized 
water. The diluted reagent was pipetted in a volume of 900 µl in each cuvette. As reference, 
took 100 µl deionized water for standards or buffer for samples. All standards were performed 
in duplicate. The reaction mixtures were incubated for 5 min. at room temperature and then 
read against reference at 595 nm in an Ultrospec 3000 spectrophotometer. 
 
1.2 SDS-PAGE 
The glass plates, assembly, comb and spacers were cleaned with ethanol. The glass plates 
with spacers were fixed inside the assembly. As mentioned above in 2.2.2.1, resolving gel 
mixture was poured carefully in between glass plates taking care not to let air bubbles in the 
solution and the gel was polymerized (polymerization time was from 15 to 30 min.) with 
overlay of deionized water. After the gel had polymerized, stacking gel mixture was poured 
above the gel carefully and immediately added comb on top of it till completely immersed 
between plates. Polymerization time was 45 min. and during this time, protein samples were 
prepared after protein estimation from Bradford method (1.1) from 10 to 20 µg protein 
concentration per sample. Reducing sample diluting buffer was added to samples and adjusted 
the volume accordingly. The samples were boiled at 100°C for 5 min. and loaded into 
respective wells with protein molecular marker. The water cooling system was attached with 
the assembly and running buffer was added in upper and lower reservoir. The electrodes were 
attached accordingly into power supply and SDS-PAGE was run at constant voltage (160 V) 
till bromophenol boundary reached bottom of the gel. Gel was removed carefully from plates 
and placed in Coomassie staining solution for 1 h and then destained or in fixation solution 
for silver staining (2.2.2.3) or followed immediately for Western blotting. 
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1.3 Western blotting 
The protein samples were resolved in SDS-PAGE (1.2) and immediately blotted. The gel was 
placed on an anode plate in Semi-Dry apparatus. It was overlaid onto blotting paper 
(Hybond–ECL nitrocellulose membrane) sandwiched between three layers of Whatman filter 
papers soaked with transfer buffer (2.2.3) on each side respectively. It was carefully 
assembled to remove any air bubbles in between the membrane, gel and filter papers. The 
electro transfer was carried out at about 10 V (400 mA) for 1 h with cathode side above the 
assembly. Thereafter, the membrane was blocked with 10 % milk powder in 2 X PBS (2.2.3) 
for overnight at 4°C. After overnight blocking, the membrane was washed for 5 X 5 min. in 
wash buffer with gentle shaking. It was incubated with the first antibody diluted in TBS 
buffer for 1 h at room temperature in fresh disposable bags with gentle shaking. Subsequently, 
the membrane was washed as above and incubated with alkaline phosphatase conjugated 
secondary antibody diluted in TBS for 1 h with gentle shaking. The blot was washed and 
finally, it was developed (2.2.3) and color development was observed carefully. When the 
bands appeared, the reaction was stopped with PBS and blot was scanned after drying on filter 
paper. 
 
1.4 Northern blotting 
1.4.1 Sample preparation 
Samples of total RNA from bloodstream form out of the logarithmical and stationary phase 
were centrifuged at 3000 rpm for 5 min. Cells were washed twice in PBS (pH 7.4). The cell 
pellets were used for RNA isolation as per manufacturer’s instruction using the RNeasy Mini 
Kit (Qiagen, Gemany). The RNA was eluted with 40 µl Ampuwa (Fresenius, Germany) and 
stored in liquid nitrogen. 
  
1.4.2 RNA electrophoresis 
Gel was prepared by weighing 0.6 g agarose, which was dissolved in 50 ml 1 X FA running 
buffer (2.2.4) by heating in microwave. To the warm agarose solution, 900 µl 37 % 
Formaldehyde and 1 µl Ethidium bromide was added and gently mixed. The agarose solution 
was polymerized in the gel apparatus and cooled down for additional 30 min at 4°C. 
The RNA sample concentration was measured in an Ultrospec 3000 spectrophotometer 
(Pharmacia Biotech). A test agarose gel was loaded with the calculated amount of 1 µg RNA 
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in order to verify the measured concentrations. For experiments, samples of 10 -20 µg RNA 
were denatured at 65°C for 5 min. which were then cooled on ice. Samples were loaded in the 
gel for electrophoresis and run for 1-2 h at 80 V. Afterwards, the gel was photographed under 
UV light. The running pattern of three bands of rRNA (2250 bp, 1850 bp and 1350 bp) were 
used as control to monitor RNA loading and as an internal standard for the molecular weight. 
 
1.4.3 Sandwich diffusions blot 
 
For blotting, the gel apparatus was filled with 20 X SSC (2.2.4). The RNA capillary transfer 
was performed on Hybond N+ Nylon membrane (Amersham) as per standard protocol. After 
16- 24 h, the blot was taken out and washed twice in 20 X SSC and left under dark to dry. The 
cross linking for fixation of RNA on the membrane was done with UV Stratalinker 1800 
(program: Auto Cross Link). 
 
1.4.4 Hybridization and marking with [32P] dATP     
Following the reverse transcription of total RNA with the Omniscript reverse transcription kit 
(Qiagen), unlabelled probes were amplified by PCR using the HotStar Taq PCR kit (Qiagen) 
after the manufacturer’s instructions. The PCR product was run on a gel electrophoresis. The 
respective bands were cut out of the gel, purified with the QIAquick gel extraction kit and 
eluted with Ampuwa (deionized water). The probes were stored at -20°C and directly before 
hybridization, radioactively labeled with [32P] dATP (Amersham) using the HexaLabel DNA 
labeling kit (Fermentas). 
 
 
1.4.5 Development 
 
Hybridization was performed in 1 % BSA in Hybrid mix sodium phosphate (2.2.4) with 50 µl 
hybridized probe (1.4.4) at 68°C (water bath) overnight.  In order to prevent unspecific 
binding, 100 µg /ml Salmon sperm was added, which was previously denatured at 95°C. After 
hybridization, the membrane was washed three times for 20 min., once with 0.5 % BSA in 
phosphate buffer and then twice with washing buffer. For the development, the blot was 
packed in a fresh disposable bag, covered with an X-ray film and left at -70°C in a 
development cassette for 1-48 h. The development was done with X-ray film developer 
(SRX-101A, Konica). 
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1.4.6 Stripping 
 
The stripping of the hybridized membrane was done for 20 min at 68°C in a water bath with 
1% SDS (2.2.4). Afterwards, the membrane could be used for further hybridizations. 
 
1.4.7 Analysis 
 
The developed film was scanned and bands intensity was semi-quantitatively estimated with 
GelScan V5.1.  
 
2. Standard protocols for molecular biology 
The sense and anti-sense primers were solublized in TE buffer (2.2.1). 
 
2.1 Reverse transcriptase PCR (RT-PCR) 
 
Samples of total RNA from bloodstream form out of rat blood was isolated and following 
reaction mixture was prepared using Omniscript reverse transcription kit (Qiagen) according 
to manufacturer’s instructions   
 
Reaction mixture 
10 X RT Buffer                                             2 µl 
dNTP mix                                                      2 µl 
Oligo dT                                                        2 µl 
RNase inhibitor (10 U/µl)                             1 µl 
Template RNA (1.9 µg/µl)                           1 µl 
Reverse transcriptase                                    1 µl 
Deionized water                                          11 µl   volume made till 20 µl 
The reaction mixture was incubated at 37°C for 1 h and afterwards heat inactivated at 85°C 
for 5 min.    
Materials and Methods                                                                                                                            
                                                                                                                                                                                                                  
                                                                                                      
62 
                          
2.2 Polymerase chain reaction (PCR) 
 
The PCR reactions were performed using AccuPrime Taq DNA polymerase high fidelity kit 
(Invitrogen) according to manufacturer’s instructions. The reaction mixture was as follows 
 
Reaction mixture 
10 X AccuPrime PCR buffer 1                       10 µl 
Sense primer TbPLA2 (1:10 diluted)                2 µl 
Anti-sense primer TbPLA2 (1:10 diluted)        2 µl 
cDNA (1:100 diluted)                                       5 µl 
Distilled water (Fermentas)                          80.6 µl 
AccuPrime Taq DNA polymerase                  0.4 µl 
 
The following program for PCR reaction was used 
 
1. Initial denaturation                                     94°C                 2 min. 
2. Denaturation                                               94°C                30 sec. 
3. Annealing                                                   56°C                30 sec. 
4. Extension                                                    68°C                 2 min. 
   30 cycles to step 2 
5. Final extension                                           68°C                10 min. 
6. End                                                               4°C                   72 h 
  
2.3 DNA digestion with restriction enzymes 
 
The restriction enzymes and respective buffers (Fermentas or New England Biolabs) were 
used to digest plasmid DNA and constructs. According to required analysis, the plasmid and 
plasmid constructs with gene of interest were checked for suitable restriction enzyme using 
DNAMAN software.  The reaction mixture consisted of DNA, respective buffer for each 
enzyme, restriction enzyme and elution buffer to make up the volume till 20 µl. The reaction 
mixture was incubated at 37°C and for different time span depending on enzyme and DNA 
concentration. 
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2.4 Agarose gel electrophoresis for DNA 
 
The gel was polymerized by weighing 0.5 g agarose (1 % agarose gel) dissolved in 50 ml 1X 
TAE buffer (2.2.1) by heating in microwave oven until agarose was completely solublized 
and solution was clear. The solution was left to cool and immediately added 0.5 µg/ml 
Ethidium bromide. The solution was poured in gel casting tray with sample comb and allowed 
to solidify at room temperature. The sample was prepared by adding sample buffer (2.2.1) to 
the calculated amount of DNA. The sample was loaded into gel with 1 kb DNA ladder 
(Fermentas). The electrophoresis was run at 80 V constant for 1 h until the blue boundary 
reached the bottom of the gel. The gel was photographed under the UV light transilluminator 
(312 nm). The DNA bands were visualized and migration of DNA was estimated against 
DNA ladder.  
2.5 DNA extraction 
After DNA was resolved in agarose gel, the gel was placed on a UV transilluminator and 
immediately the required DNA band was cut out from the gel with the help of clean scalpel 
and placed in pre-weighed sterile eppendorf. The gel mass was measured and QIAquick gel 
extraction kit (Qiagen) used as per manufacturer’s instruction. Finally, DNA was eluted with 
specific volume of elution buffer (Qiagen). 
 
2.6 DNA estimation 
After gel extraction, DNA purification and for DNA sequencing, DNA was quantitatively 
measured at λ = 260 nm, 280 nm and 320 nm with different volumes using an Ultrospec 3000 
spectrophotometer (Pharmacia Biotech). 
 
2.7 Ligation 
 
The vectors (pCR®2.1–TOPO, pMal-c2E, pFastBac-1) in concentration of 50 ng with DNA of 
interest (TbPLA2) in different ratios of 1 to 3 or 1 to 6 were used for ligation reaction. The 
Rapid DNA ligation and transformation kit (Fermentas) was used according to manufacturer’s 
instruction. 
 
Ligation was performed using following reaction mixture 
 
Vector DNA (50 ng)            volume depending on DNA concentration 
Insert DNA                           volume depending on DNA concentration 
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10 X ligation buffer                                          2 µl 
Deionized water                                    up to 20 µl 
T4 DNA ligase (5 U)                                       1 µl                 
 
The reaction mixture was incubated for 1 h at 22°C or for 17 h at 16°C.  
 
2.8 Transformation 
The freshly ligated DNA construct in a volume of 2 µl was transformed into One shot TOP 10 
E. coli (Invitrogen) or expression  grade BL-21 (DE3) competent cells using protocol from 
Stratagene. The competent cells were thawed on ice for 5 min. Then, the cells were gently 
flicked and 50 µl of competent cells were transferred into pre-chilled tubes. 
The calculated amount of 50 ng experimental DNA construct was added into pre-chilled tubes 
with competent cells. As a control, pUC19 was added to other tube with competent cells and 
immediately swirled the tubes gently. The tubes were incubated on ice for 20 min. The cells 
were heat-shocked at 42°C in water bath for 45 seconds (One shot TOP 10 cells were treated 
at 42°C for 30 seconds). The duration for the heat shock was critical for maximum efficiency. 
Afterwards, the tubes were left on ice for 2 minutes. Prewarmed SOC medium in a volume of 
250 µl was added to each tube and incubated at 37°C for 1 h with shaking at 225-250 rpm. 
The transformation mixture in volumes of 100 µl and 200 µl was streaked on two prewarmed 
LB-agar selective plates containing appropriate antibiotic (and containing X-gal and IPTG if 
blue-white screening was desired). The plates were incubated at 37°C for overnight (at least 
17 h for blue-white color screening). The blue color of colonies was enhanced by further 
incubating the plates for 2 h at 4°C following the overnight incubation at 37°C. 
 
2.9 Bacterial culture stabilates 
The fresh starter culture of tested clones and sterile glycerol (50 %) were added in volumes of 
700 µl and 300 µl respectively in cryo vials. The tubes were immediately frozen in liquid 
nitrogen and stored at -70°C.  
 
2.10 DNA purification  
 
   2.10.1 MiniPreparation (MiniPrep) 
After transformation, the colonies were selected and were inoculated into respective 3 ml 
liquid LB medium with ampicillin (50 mg/ ml). The cultures were propagated at 37oC with 
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shaking at 225-250 rpm for overnight (17 h). All the buffers used were from QIAprep spin 
Miniprep test kit (Fermentas).The starter culture was harvested by centrifugation at 13,000 
rpm (Amicon microcentrifuge MC 13) for 2 min. The supernatant was discarded and the 
pellet was re-suspended in 150 µl P1 buffer, incubated for 5 min. at room temperature. The 
re-suspended cells were lysed by adding 150 µl alkaline P2 buffer, gently inverting the 
solution 4 -6 times and stand for 5 min. The solution was neutralized with 210 µl N3 buffer, 
inverted and left on ice for 5 min. It was centrifuged for 10 min. at 13,000 rpm and the 
supernatant was pipetted out in new eppendorf. To this solution, 900 µl ice cold analytical 
grade (100 %) ethanol was added and centrifuged for 10 min. at 13,000 rpm. The supernatant 
was removed and the pellet was washed with 1 ml ice cold 70 % ethanol by centrifuging for 
10 min. at 13,000 rpm. The supernatant was discarded and the pellet was left to dry for 30 to 
45 min. by inverting the eppendorf with open lid. Finally, the DNA pellet was gently 
solublized in 50 µl elution buffer. The DNA was stored at -20°C which can be further used 
for gel extraction, restriction enzyme digestion or verification of DNA band on agarose gel 
electrophoresis. 
 
   2.10.2 MidiPreparation (MidiPrep) 
The fresh starter culture of either selected colony or from stabilates were inoculated and 
cultivated in specific volume of liquid LB medium with ampicillin (50 mg/ml) in flask under 
shaking 225-250 rpm for overnight (17 h) at 37oC. NucleoBond AX (MidiPrep) plasmid DNA 
purification kit from Macherey-Nagel was used. The main culture was harvested by 
centrifugation at 5000 rpm for 15 min. at 4oC. 
The medium was discarded and the cell pellet in falcon was carefully re-suspended in 8 ml 
buffer S1 with RNase A. Cells were lysed by adding 8 ml buffer S2 to the suspension. The 
suspension was mixed gently by inverting the tube for 6- 8 times. The mixture was incubated 
at room temperature for 5 min. without vortex, as this releases contaminating chromosomal 
DNA from the cellular debris into the suspension. The pre-cooled (4oC) 8 ml buffer S3 was 
added to the suspension and immediately mixed the lysate by inverting the falcon 6 -8 times 
until a homogenous suspension containing an off-white flocculate was formed and incubated 
on ice for additional 5 min. 
The lysate was clarified by centrifuging at 5000 rpm for 25 min. at 4oC and simultaneously, 
the column AX 100 (Midi) included in the kit was equilibrated with buffer N2. The column 
was allowed to empty by gravity flow and flow through was discarded. The cleared lysate 
after centrifugation was filtered using folded filter paper pre-wet with buffer N2 in a small 
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funnel. The lysate was loaded onto the wet filter paper and flow through was collected. The 
clear lysate was loaded onto the column. The flow though from this step was saved for 
analysis. The column was washed with 12 ml buffer N3 and flow through was discarded. 
Finally, the plasmid DNA was eluted with 5 ml buffer N5. The DNA was immediately 
precipitated with 3.5 ml isopropanol and centrifuged at 10,000 rpm for 30 min. at 4oC. The 
supernatant was discarded and the pellet was washed with 2 ml (70 %) ethanol, vortexed 
briefly and centrifuged at 10,000 rpm for 10 min. at room temperature. The supernatant was 
carefully removed and allowed the pellet to dry at room temperature for 30 min. The DNA 
pellet was reconstituted in appropriate volume of elution buffer with constant flicking till 
pellet was completely dissolved. The solublized DNA was used for further analyses like 
agarose gel electrophoresis, DNA estimation, restriction digestion with enzymes, 
transformation or DNA sequencing.   
 
   2.10.3 Bacterial colony PCR 
The PCR was performed using HotStar Taq master mix kit from Qiagen. The following 
master mix was prepared 
 
Master mix 
                                                      For 8 reactions (12.5 µl master mix/ reaction) 
HotStar Taq master mix                          100 µl 
Sense primer                                                8 µl 
Anti-sense primer                                        8 µl 
RNase free water                                       84 µl 
 
The master mix in volume of 25 µl was added to each PCR tube including positive and 
negative controls. The colonies were picked from LB-agar plates and inoculated into 
respective PCR tube. Simultaneously, the selected colony after inoculation was streaked on 
LB agar plates with ampicillin. The agar plates were incubated at 37oC for overnight (17 h). 
The PCR reaction was performed as follows: 
 
Program 
1. Initial activation                                     95 oC                   15 min. 
2. Denaturation                                          94 oC                    30 sec. 
3. Annealing                                              56 oC                    30 sec. 
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4. Extension                                               72 oC                     1 min. 
    35 cycles to step 2 
5. Final extension                                      72 oC                   10 min. 
6. End                                                         4 oC                          9 h 
 
After PCR reaction, 10 µl from each sample was loaded and run in agarose gel with DNA 
ladder in order to identify correct clones.  
 
2.11 DNA sequencing 
The isolated plasmid constructs after verification on agarose gel electrophoresis (2.4) and 
DNA quantification (2.6) were send for sequencing to GATC Biotech using single Run 24 
supreme reaction in concentration of 30 -100 ng/ µl in a total volume of 30 µl.  The results of 
sequenced DNA were analyzed with DNAMAN software by alignment with plasmid 
construct. 
 
3. Cultivation and handling of organisms 
 
   3.1 Escherichia coli 
    
    3.1.1Cultivation on agar plates 
 
The bacterial cells were cultivated on agar-agar with LB-medium and ampicillin (2.1.1). LB-
medium was prepared as 2 X stock solution and mixed with pre-warmed 2 X agar-agar under 
sterile conditions. After cooling to room temperature, ampicillin (1 ml/ l) and X-gal (2 ml/ l) 
were immediately added and poured into culture plates. The plates were left to solidify. When 
the agar was solidified, the plates were packed under sterile conditions and stored at 4°C till 
further use. 
 
   3.1.2 Preparation of competent cells (Chung et al., 1989) 
 
A single bacterial colony of XL-1 competent cells were picked from LB-agar culture plate 
containing tetracycline (5 mg/ ml in 70 % ethanol) that had been incubated at 37°C for 
overnight (17 h ). This clone was inoculated into 3 ml liquid LB-medium with tetracycline 
and incubated at 37°C with shaking at 225 rpm for overnight (17 h). After the overnight 
incubation, 1 ml of the starter culture was inoculated into 100 ml LB-medium with 
tetracycline and propagated at 37°C with shaking at 225 rpm till the absorbance reached 0.8 at 
600 nm. Then the cells were harvested at 5000 rpm for 5 min. at 4oC and the cell pellet was 
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re-suspended in 10 ml TSS medium (2.1.1). Subsequently, 100 µl aliquots were made in 
cryogenic vials which were immediately frozen in liquid nitrogen and stored at -70°C. 
 
   3.2 Spodoptera frugiperda (Sf9) 
    
    3.2.1 Culturing of Insect cells 
 
Insect cells (Sf9) were bought from Invitrogen as frozen master stocks which were used as the 
host for the baculovirus transfer vector. The culture stabilates were washed with pre-warmed 
serum-free medium by centrifuging at 1700 rpm for 5 min. at 4°C. The cells were re-
suspended in fresh pre-warmed serum-free medium in volume of 20 ml at a cell density of 8 
X 105 cells/ ml. Insect cells were propagated under serum-free conditions at 27°C grown in 
passages of increasing concentration of FBS which provides protection from cellular shear 
forces in suspension culture. The growing passage of insect cells was grown till cell density of 
4 X 106 cells/ ml reached. After which, cells were diluted with serum-free medium including 
Pluronic® F-68 and penicillin/ streptomycin. These cells were used for transfection or further 
propagated till 30 passages. 
The stabilates of the insect cells were made by using culture passages. The cells were 
monitored to ensure that they were healthy and growing exponentially in the medium. The 
medium was replaced when the monolayer of cells reached 80 % confluence. Pre-warmed Ex-
Cell 420 serum-free medium (2.1.2) including Pluronic® F-68 and penicillin/ streptomycin 
was added to the cells after harvesting with centrifugation. The cells were dispersed with 
careful pipetting. The viable cells were counted and adjusted the cell density to 4 X 106 cells/ 
ml with serum-free medium and were cooled to 4°C. Serum-free medium containing 20 % 
DMSO (v/v) was prepared. The cells were carefully suspended in serum-free medium 
containing DMSO. The suspension was cooled at 4°C and aliquots of 1 ml were made in 
cryogenic vials. The aliquots were placed immediately in liquid nitrogen. The vials were 
frozen at - 20°C for 12 h and then at -70°C for overnight. Afterwards, the vials were 
transferred to liquid nitrogen immediately and after a week, the viability of the stabilates were 
tested with cultivation in fresh Ex-Cell 420 serum-free medium (2.1.2) with increasing 
concentration of serum. 
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   3.2.2 Vitality assay with trypan blue 
 
The trypan blue (0.4 %) solublized in PBS was mixed with 100 µl cell suspension. The cells 
were then counted in Hemocytometer. Only the dead cells absorbed the trypan blue and 
therefore, cell vitality should be more than 80 % for transfection.  
 
   3.2.3 Transfection     
 
The recombinant bacmid with the gene of interest was isolated and purified from DH10 Bac 
competent cells. The recombinant bacmid was used for transfection in insect cells. The main 
culture of insect cells passage was diluted with serum-free medium with defined cell density 
and seeded at 1 X 106 cells/ ml per well of  6 well tissue culture plate in 2 ml of growth 
medium containing antibiotics as stated above.  The cells were allowed to attach at 27°C for 1 
h and then bacmid DNA: Cellfectin® Reagent complex was prepared for each sample 
including negative control and Cellfectin® only. The recombinant bacmid and Cellfectin® in a 
volume of 6 µl were mixed separately in 100 µl serum-free medium. Both the solutions were 
combined to 200 µl total volume, gently mixed and incubated for 1 h at room temperature. 
During this incubation, the media from the attached cells were carefully washed twice with 2 
ml of serum-free medium without antibiotics. Serum-free medium without antibiotics in a 
volume of 800 µl was added to each tube containing DNA: lipid complexes and gently mixed. 
This mixture was then added carefully to each well containing cells and the plate was 
incubated for 4 h at room temperature. Afterwards, the DNA: lipid mixture was removed and 
2 ml of medium containing FBS and antibiotics were added to each well. The plate was 
incubated at 27°C for 72 h until there were microscopically signs of viral infection. 
 
3.3 Trypanosoma brucei 
 
 
 3.3.1 Isolation from rat blood and stabilates production of bloodstream form 
 
Trypanosome strain BF-221 kept as frozen rat stabilates in liquid nitrogen were used for the 
propagation of the parasites in Sprague-Dawley rats. The rat stabilates with cell density of 5 X 
107 cells were intraperitoneally injected in anesthetized rat. After 3 days of infection, the 
parasitemia in rat at a cell density of 1 X 109 cells/ ml was achieved. The animal was prepared 
for sacrifice in CO2 environment. The thorax of the animal was cut opened and washed with 2 
ml CGA (2.1.3). The vena cava inferior was cut and the blood was sterile collected with 
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Pasteur pipette into fresh falcon tube. The rest blood was collected by puncturing 5 ml CGA 
in left ventricle and again collecting it in fresh falcon tube. Afterwards, the blood was 
centrifuged (Sigma 3K12) at 3000 rpm at 4°C for 10 - 15 min.  
The blood plasma and erythrocytes were removed from top of the visible phase of buffy coat 
which consisted of parasites. The buffy coat was loaded onto DEAE-Sephacel in a column 
prepared with filter paper on lower and upper layer of material pre-equilibrated with 
separation buffer (2.1.3.2). The flow through was collected which was turbid due to the 
presence of parasites and this flow through was centrifuged (Sigma 3K12) at 3000 rpm at 4°C 
for 5 min. The supernatant was discarded and the cells were re-suspended in 5 ml TDB 
(2.1.3). The cells were washed twice by centrifuging  (Sigma 3K12) at 3000 rpm at 4°C for 5 
min. and then the cells were used for further experiments. 
For stabilates production, the buffy coat was carefully transferred with the help of sterile 
Pasteur pipette and re-suspended in 4 ml CGA. Furthermore, 6 ml BF-medium (2.1.3.3.1) and 
2 ml Canusal® (200 U, Heparin-Na) were added to the suspension and cell density was 
calculated. The cell density was adjusted at 2 X 108 cells/ ml and mixed in 1: 1 with freezing 
medium for stabilates (2.1.3). The aliquots were pipetted in volume of 1 ml each in cryo vials 
on ice. Finally, the stabilates were frozen at -20°C for 1 h and then at -70°C for overnight. 
Next day, the stabilates were transferred to liquid nitrogen until further use. 
 
3.3.2 In vitro cultivation of bloodstream form 
 
Trypanosome bloodstream form frozen stabilates were used for axenic cultivation. The 
stabilates were thawed under warm water and cell suspension was transferred into falcon tube 
with 9 ml pre-warmed bloodstream form medium (2.1.3.3.1) and washed by centrifugation 
(Sigma 3K12) at 3000 rpm at 4°C for 5 min. The supernatant was removed carefully till 
approximately 1 ml was left. The cells were re-suspended and counted. For counting the cells, 
10 µl of the cell suspension were diluted to 1: 100 and counted in Hemocytometer. The starter 
culture in culture flask with bloodstream form medium was adjusted to cell density of 2.5 X 
105 cells /ml and cultivated in an incubator at 37°C with 5 % CO2. After 20 h incubation, the 
cell density in starter culture reached till 1 X 106 cells/ml. The starter culture was diluted with 
medium to main culture and this was propagated accordingly to experimental requirements to 
cell density of 2.5 X 105 cells/ ml. After 40 h incubation, the main culture reached a cell 
density of 2 X 106 cells/ ml (stationary phase) which was used for further experiments. 
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3.3.3 In vitro cultivation of procyclic form  
 
The procyclic form frozen stabilates were used for axenic cultivation. The stabilates were 
thawed under warm water and running culture of procyclic form was prepared in procyclic 
culture medium (2.1.3.3) using the same procedure as described for bloodstream form (3.3.1). 
The culture cell density was adjusted at 5 X 105 cells/ ml and cultivated in an incubator at 
27°C without CO2. The running culture was diluted to a cell density of 2.5 X 105 cells/ ml 
during the week either for running or main culture depending on the experiment. 
 
4. Cloning of phospholipase A2 gene from Trypanosoma brucei 
 
The complete gene of  TbPLA2 was cloned using total  cDNA from bloodstream form with 
sense and anti-sense primers (see Materials 1.2) which were synthesized using DNA sequence 
(see Materials 1.1) from GeneDB , hosted by Sanger Institute ( http://www.genedb.org/). This 
gene sequence included signal peptide and transmembrane sequence of protein.  
 
 4.1 Sub-cloning of TbPLA2 gene in competent cells 
 
After PCR with AccuPrime Taq DNA polymerase, the reaction product was verified on 
agarose gel electrophoresis and then it was used to clone into sub-cloning plasmid pCR®2.1-
TOPO (Invitrogen). The following ligation reaction mixture was prepared according to the kit 
(Invitrogen)  
 
PCR product                                          4 µl 
Salt solution                                           1 µl 
TOPO vector                                          1 µl  
 
The reaction was gently mixed in PCR tube and incubated for 30 min. at 22°C in pre-
programmed PCR machine with program ending at 4°C. The PCR tube was placed on ice. 
One Shot TOP 10 (Invitrogen) competent cells were thawed on ice and transformation 
protocol proceeded (2.8). The plates were incubated at 37°C for 17 h and thereafter, white 
colonies appeared. These colonies were selected, inoculated into starter culture and incubated 
at 37°C for overnight. MiniPrep (2.10.1) was performed and finally, the DNA plasmid was 
solublized in specific volume of elution buffer. The DNA was analyzed with restriction 
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analysis with Nde1 to confirm for correct orientation of insert DNA and verified on agarose 
gel electrophoresis. The correct clone DNA was further double digested with BamH1 and 
Pst1 enzymes to cleave out the insert DNA with these specific sites. The reaction mixture was 
run on agarose gel electrophoresis and insert DNA band was cut out and proceeded with gel 
extraction protocol using QIAquick gel extraction kit (Qiagen) (see 2.5). The insert DNA was 
solublized in specific volume of elution buffer and DNA was quantified (see 2.6) and send for 
DNA sequencing (2.11) and verification. The stabilates of correct clone were made (see 2.9) 
and stored in liquid nitrogen till further use. 
 
4.2 Cloning of TbPLA2 gene in competent cells 
 
The insert DNA was ligated with expression vector pMal-c2E (NEB) using ligation kit 
(Fermentas) (see 2.7) performed at 16°C for 17 h. Afterwards, the ligase was inactivated for 
10 min. at 65°C. The ligation product was further used in transformation into One Shot TOP 
10 (Invitrogen) sub-cloning competent cells using the transformation protocol (2.8). The 
colonies were picked from selective agar plate and verified with bacterial colony PCR 
(2.10.3). The reaction mixture was run on agarose gel electrophoresis to identify the correct 
clone. The correct clone with plasmid construct with gene of TbPLA2 was picked and starter 
culture was cultivated for overnight. The starter culture 1.5 ml was used simultaneously for 
stabilate production and the rest of culture was used for MiniPrep. The construct DNA in a 
volume of 3 µl was used to transform (2.8) into BL-21(DE3) or Rossetta 2 expression 
competent cells. The colonies were picked and bacterial colony PCR (2.10.3) was performed 
to verify for correct insert DNA including positive and negative controls. These products were 
run on agarose gel electrophoresis and verified the correct clone. The starter culture of the 
clone was cultivated for stabilates and stored in liquid nitrogen until further use. 
The gene of TbPLA2 was also cloned into baculovirus expression system. The construct of 
TbPLA2 with pMal-c2E and baculovirus vector pFastBac-1 were digested with BamH1 and 
Pst1 enzymes simultaneously to cleave out the insert DNA with these specific sites. 
Afterwards, pFastBac-1 and insert DNA was purified from agarose gel using QIAquick gel 
extraction kit (Qiagen) (see 2.5). The purified insert DNA and pFastBac-1 were used to 
perform ligation reaction (2.7) at 16°C for 17 h and then left at 4°C. The ligation reaction 
product of pFastBac-1 with TbPLA2 was used to transform (2.8) into XL-1 competent cells. 
The colonies were verified by bacterial colony PCR (2.10.3) and starter culture cultivated for 
MiniPrep (2.10.1). The colonies were also verified for correct clone using restriction digestion 
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with Nde1, HindIII and Eam1105 1. The correct DNA construct was used to transform into 
MAX Efficiency®DH10Bac competent cells by using transformation protocol (2.8) on 
selective LB-agar plates containing kanamycin, gentamicin and tetracycline. The white 
colonies were picked and analyzed to verify successful transposition to the bacmid. The 
recombinant bacmid DNA with insert was analyzed by PCR using M13 sense and anti-sense 
primers with HotStar Taq master mix kit from Qiagen and run on agarose gel electrophoresis. 
Finally, correct clone was picked and starter culture cultivated for MiniPrep (2.10.1). The 
DNA from MiniPrep was solublized in a specific volume of elution buffer and another starter 
culture from the same clone was used for stabilates.  
 
5. Heterologous expression of phospholipase A2 gene from 
Trypanosoma brucei in Escherichia coli and Spodoptera frugiperda 
(Sf9) 
5.1 Expression in bacteria 
The starter culture of construct of TbPLA2 with pMal-c2E in either BL-21(DE3) or Rosetta 2 
expression competent cells was cultivated for overnight (17 h) at 37°C with shaking at 225 
rpm. The logarithmic phase growing bacterial cells from starter culture were used to inoculate 
into LB liquid medium (with ampicillin for BL-21(DE3) or chloramphenicol and ampicillin 
for Rosetta 2) in the ratio of 1:100. The cells were cultivated at 37°C with shaking at 225 rpm 
till the absorbance of culture reached 0.8 at 600 nm. Subsequently, the culture was divided 
into portions, one portion of the culture was designated as control culture (without induction) 
and other remaining cultures were induced with IPTG to final concentrations ranging from 
0.1mM to 1mM. All the cultures were additionally grown for different experiments at 
different temperatures at 16°C, 27°C or 37°C for time span of 9 h. 
The cells were harvested subsequently by centrifugation at 5000 rpm for 15 min. at 4°C. The 
medium was discarded from control and induced cells. The cell pellets were frozen at -20°C. 
These were re-suspended in 5 ml of column buffer (2.1.1) and sonicated the suspensions for 
short pulses of 10 sec. for 5 times on ice in a Sonifier® Cell disruptor B-30 with following 
specifications: 
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Timer                         Hold 
Output control              5 
Duty cycle               50 % 
Continuous 
 
The lysates were centrifuged at 5000 rpm for 20 min. at 4°C. The supernatant was separated 
and protease inhibitors mix (2.1.3) was added immediately after centrifugation. The pellet 
was re-suspended in 5 ml column buffer with protease inhibitors mix (2.1.3). All supernatants 
and pellets were estimated with Bradford method (1.1) and analyzed on 12 % SDS-PAGE 
(1.2) in reducing conditions. 
 
5.2 Expression in Sf9 insect cells 
 
5.2.1 Isolation of P1 viral stock 
 
The transfected cells from well of plate with signs of late stage infection were collected with 
the medium containing virus in a volume of approximately 2 ml and sterile transferred to 
falcon tube. The suspension was centrifuged at 1700 rpm for 5 min. at 4°C to remove cells 
and large debris. The clarified supernatant containing viruses was sterile transferred to another 
falcon tube and this was labeled the P1 (low viral titer) stock which was protected from light 
and stored at 4°C. 
 
5.2.2 Amplification of Baculovirus stock 
The culture passage of insect cells was diluted with serum-free medium with defined cell 
density and seeded at 2 X 106 cells/ ml. The multiplicity of infection (MOI) was calculated, 
whereas MOI ranges from 0.05 to 0.1: 
  
 
Inoculum required (ml) =     MOI (pfu /ml) X number of cells 
                                              __________________________ 
                                                Titer of viral stock (pfu / ml) 
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                                      =        0.1 pfu /ml X (2 X 107) cells 
                                                  ___________________ 
                                                           5 X 106 pfu /ml 
 
Inoculum required (ml) = 0.4 ml 
 
The diluted 20 ml insect cells were infected with 0.4 ml P1 viral stock and incubated with 
shaking at 27°C for 72 h. After 72 h infection, the medium was collected by centrifugation at 
1700 rpm for 5 min. at 4°C and the supernatant was transferred to fresh falcon tube and this 
was labeled the P2 (high viral titer) stock. The P2 viral stock was used for further infections 
for large scale volumes from 30 ml, P3 (highest viral titer) cultures. After every infection, the 
supernatant and cell pellet was preserved at 4°C. 
 
Cell lysis 
 
The cell pellet was washed twice with PBS pH 7.4 by re-suspending the cells. The cell 
suspension was centrifuged at 1700 rpm for 5 min. and the wash solution was carefully 
removed. After removal of the final wash solution from the cells, a volume of 1 ml RIPA lysis 
buffer was added. The cells were re-suspended and vortexed briefly. The cell suspension was 
incubated on ice for 5 min.  
The lysate can be either used immediately or frozen at -20°C for further use. The lysate was 
centrifuged at 10,000 rpm for 10 min. at 4°C to pellet the cell debris and membranes. The 
supernatant was carefully transferred to fresh tube. Both the supernatant and the cells pellet 
were stored at -20°C till further use. 
 
6. Immunoprecipitation 
 
The insect cells lysate was centrifuged at 10,000 rpm for 10 min. at 4°C and immediately 
transferred the supernatant to an another eppendorf. The pellet was re-solublized in RIPA 
lysis buffer. Protein G agarose was prepared by washing the beads twice with PBS and then 
restored the suspension to 50 % slurry with PBS. The soluble pellet fraction was pre-cleared 
by adding 100 µl of washed Protein G agarose bead slurry (50 %) per 1 ml of cell lysate and 
incubating on an orbital shaker for 10 min. at 4°C. The Protein G beads were removed by 
centrifugation at 10,000 rpm for 10 min. at 4°C and transferred the supernatant to another 
eppendorf. The protein concentration of the supernatant was determined by Bradford method 
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by diluting it with PBS because of the interference of detergents from RIPA buffer. The 
protein concentration of supernatant was set at 500 µg. The anti-TbPLA2 antibody in 
concentration of 10 µg was added to the supernatant. The mixture was gently rocked on an 
orbital shaker for overnight at 4°C.  
Afterwards, the immunocomplex was captured by adding washed 100 µl Protein G agarose 
bead slurry (50 µl packed beads) and gently rocked on orbital shaker for overnight at 4°C. 
The agarose beads were collected by pulse centrifugation (i.e. at 10,000 rpm for 5 secs.). The 
supernatant was discarded and washed the beads 3 times with 800 µl PBS. The agarose beads 
were re-suspended in 50 µl PBS. The immunocomplex with beads were analyzed by adding 4 
X reducing sample diluting buffer and gently mixed. The suspension was boiled for 5 min. to 
dissociate the immunocomplex from the beads. The beads were collected by centrifugation 
and either SDS-PAGE was performed with the supernatant or was frozen at -20°C for later 
use. The frozen supernatant was re-boiled prior to be loaded on SDS-PAGE. 
 
7. Isolation of cytosolic and membrane fraction for analysis from 
bloodstream and procyclic form 
 
 
The starter culture of Trypanosoma brucei BF-221 bloodstream form was cultivated (3.3.2). 
After 20 h, the starter culture reached a cell density of 1 X 106/ ml in 50 ml culture. The cells 
were harvested by centrifugation at 3000 rpm for 5 min. at 4oC. The cell pellet was washed 
twice with 5 ml TDB (2.1.3) containing 100 µl 0.2 mM ZnCl2 (10 mM stock solution) per 1 
ml. The cells were lysed in 200 µl of first lysis buffer which consisted of 10 mM phosphate 
buffer containing ZnCl2 and protease inhibitor for 15 sec. in sonicator and verified 
microscopically for lysis of cells. The lysate was incubated on ice for 1 h and centrifuged at 
10,000 rpm for 15 min. at 4oC. The supernatant was separated and the soluble cytosolic 
protein fraction was stored at 4oC.  
The cell pellet was washed twice in 10 mM phosphate buffer containing ZnCl2 and protease 
inhibitor mix in a volume of 200 µl. The buffer was carefully added onto cell pellet and was 
not re-suspended. The pellet was washed by centrifugation at 10,000 rpm for 15 min. at 4oC 
and the supernatant was discarded. The second lysis buffer consisted of 10 mM phosphate 
buffer containing protease inhibitor mix in a volume of 200 µl was added to cell pellet and 
vortexed for 1 min. at room temperature. Subsequently, the suspension was incubated for 20 
min. at room temperature. The solution was centrifuged (Ultracentrifuge TL-100) at 60,000 
rpm for 1 h at 4oC. The supernatant was separated and stored at 4°C. The pellet was again 
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washed in 200 µl of 10 mM phosphate buffer
 
containing protease inhibitor mix and was not 
re-suspended. The pellet was centrifuged at 60,000 rpm at 4oC for 1 h. The supernatant was 
discarded and the pellet was re-suspended in 200 µl third lysis buffer consisted of 10 mM 
phosphate buffer containing protease inhibitor mix and 0.1 % Triton X-100. The solution was 
vortexed and left at 4oC for overnight. All the fractions were precipitated with ice cold 
acetone in 1:3 ratio and left at -20oC for 30 min. The fractions were centrifuged at 10,000 rpm 
for 15 min. The pellet was solublized in 10 mM phosphate buffer containing protease 
inhibitor mix in a volume of 20 µl. The protein estimation was done with Bradford method. 
Subsequently, all fractions were stored at 4°C till further use. 
 
8. Immunoflouresence microscopy 
 
 
The trypanosomes from starter culture at a cell density of 1-5 X 106 cells per reaction were 
harvested by centrifugation and the medium was carefully removed. The cells were washed 
twice and carefully re-suspended in 200 µl PBS pH 7.4. Subsequently, the fixation solution 
(2.2.5) in volume of 300 µl was added to the cell pellet and carefully inverted. The cells were 
fixed for overnight at 4oC. 
The fixed cells were centrifuged (Biofuge A) at 13,000 rpm for 20 sec. and the supernatant 
was carefully removed. The cell pellet was carefully washed in 1 ml PBS with centrifugation. 
Afterwards, the supernatant was discarded and the cells were re-suspended in 500 µl glycine-
sodium phosphate buffer and the suspension was incubated for 15 min. at room temperature. 
The permeabilization was achieved by adding 500 µl 0.2 % Triton X-100 solution. The 
solution was inverted, incubated for 5 min and then centrifuged. The supernatant was 
discarded and the cell pellet was re-suspended in 100 µl primary antibody diluted in different 
concentrations in BSA/ PBS, thereafter incubated for 1 h at 4oC. After incubation, the cells 
were washed twice in 250 µl BSA/ PBS in bench top centrifuge. The cell pellet was re-
suspended in 100 µl secondary antibody Alexa Flour 594 anti-rabbit in a working dilution of 
1: 500 and incubated for 1 h in dark at 4oC. For visualization of nucleus and kinetoplast, 
freshly prepared 1 µl Bisbenzimide stock solution was added to each sample tube and 
incubated for additional 5 min. Finally, the pellet was carefully washed once with BSA/ PBS 
and then twice or thrice with 200 µl distilled water. The pellet was re-suspended in 
approximately 100 µl distilled water and pipetted out 10 µl from each sample on object slide 
and let it dry in dark under aluminium foil. After samples were dried on Immunomount object 
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slide, the samples were observed under the microscope (Olympus BH2 RFCA) and images 
were made with Olympus camera U-PMTVC and saved in computer.  
 
9. PLA2 enzyme activity assay  
 
The PLA2 enzyme activity assay was a modified assay from Jimenez et al., 2003. The assay 
was based on a coupled enzymes using dilinoleoyl phosphatidylcholine (DL-PC) as 
phospholipase substrate and lipoxygenase as coupling enzyme. The substrate was prepared by 
solubilizing 5 mg dilinoleoyl phosphatidylcholine (Sigma) in 400 µl chloroform (analytical 
grade) at 4oC taking care to pipette it in as quickly as possible and immediately vortexed. The 
aliquots were made with a final concentration of 1.28 mM and 80 µl each. The aliquots were 
then dried with speedvac to complete dryness for 15 min. and immediately re-suspended in 50 
mM Tris-HCl pH 8.5 containing 10 mM sodium deoxycholate (2.2.6) in a volume of 983.6 µl 
each. The resulting substrate solution was equilibrated for 10 min. at 25oC and stock substrate 
solutions were stored at -20°C. 
The total reaction medium 1 ml consisted of 19.23 µl DL-PC dissolved first in calculated 
volume of reaction buffer 1(2.2.6). Subsequently, equal volume of the reaction buffer 2 was 
added to the mixture and mixed. The coupling enzyme 6.4 µl lipoxygenase was added to 
reaction tube. Finally, the reaction mixture was transferred in cuvette. Before measurement, 
the volume was made up to either with buffer for control or samples and mixed by inverting.  
Controls without either phospholipase or lipoxygenase were carried out. The reaction was 
followed spectrophotometrically in an Ultrospec 3000 spectrophotometer for 0 to 60 min. by 
measuring the increase in absorbance at 234 nm due to the formation of the hydroperoxides. 
Absorbance values from sample were subtracted from control for calculation. Specific activity 
was calculated by using the formula: 
          
ε = A/ c.l 
c = A/ ε.l 
 
Where ε = 25000 M-1 cm-1, A = difference of absorbance, l = 1 cm.        
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 3. Results 
 
1. Characteristics of TbPLA2 protein 
 
The genome database of T. brucei contains the gene of a putative phospholipase A2-like 
protein (TbPLA2) and is located on chromosome 9. It has a gene length of 1344 base pairs 
(bp). Characteristically, this protein contains 447 amino acids in the open reading frame and 
has a molecular weight of 49.9 kDa including a signal and transmembrane sequence.  This 
phospholipase A2 does not contain a GPI anchor but has a predicted signal sequence. 
Sequence homology analysis shows 28.35 % sequence similarity with platelet-activating 
factor acetyl hydrolase (PAF-AH) from Canis familiaris.  
The protein sequence of TbPLA2 contains a conserved lipase motif of GHSFG as shown in 
Figure 3.1. It has a sequence identity with group VII PLA2 PAF-acetyl hydrolase isoform II 
from residue number 75 to 443 (underlined in Figure 3.1) and belongs to the phospholipase 
A2 family due to this similarity.  
 
 
 
 
Figure 3.1 Predicted protein sequence of T.brucei phospholipase A2-like protein 
(TbPLA2) from GeneDB  
 
N C 
447 
Transmembrane 
 sequences 
Signal 
anchor 
31                   77   78   1                   30 
MVTWALKYFVRVVRWSTEAFLIWPTRPLFDYATSLHCVPISGTFITSVLL 
CFYGFPLFWSTAMVAVGFIISGVLFLVSPLPLLKPIGGRYSVGLVHMNGC 
RSQSIPPVAVFYPTNMVPEKKGLPYVPFGDDRFLRGVAAYANVPFFFIRD 
FSFVRISASRNAVPAALLNQYERVPPIVVFSHGLAGYHLFYSCFALDLAA 
RGAIVICLGHCDNSASFMRDSSGKESEVPLKDYGWEVPAREAQVAQRV 
SEVRGTLQRLTEKDFWTTLGYINSDIDKFLSKPLQVHLAGHSFGGATVLA 
AALEENQNPVKGVSVKSVYTFDPWMVPIQNEHFCNPLSDGRKSYTVPTV 
TVHSDDWVKDSESWEFFKRMKALVLEQSAYASLNEVEKQALFGIVVTKN 
TNHLSLVDVSVLSPVMHGNIWATVSPRVQIMEWCNALLRFAKQNTEVCS 
TC  
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An alignment of predicted amino acid sequence (Figure 3.2) of phospholipase A2 from T. 
brucei with those of other putative phospholipase A2-like proteins from T. cruzi, Leishmania 
major and characterized human platelet-activating factor acetyl hydrolase from suggests that 
this protein is a phospholipase A2.  
The protein contains a conserved GHSFG lipase motif (indicated by bar, Figure 3.2) in 
comparison with above mentioned proteins and apart from lipase motif, a FSHGL motif 
which is also conserved among these proteins and significantly elaborates the sequence 
similarity and relates them with phospholipase A2 family. As calculated by TMHMM server 
2.0 (transmembrane helix topology prediction method), this protein possesses a 
transmembrane helix (46 amino acids) from amino acid 31 till 77 on its N-terminus as shown 
in Figure 3.3. The transmembrane sequence predicts that the protein is associated itself with 
either the cell or an organelle membrane. In addition, TbPLA2 contains 24 amino acids on its 
N-terminus which comprises a signal sequence used for targeted secretion after protein 
synthesis. The most likely cleavage site for signal sequence in this protein is between position 
19 and 20 as predicted by SignalP 3.0 server (signal peptide prediction). The analysis with 
OGPET v 1.0 (O-glycosylation prediction electronic tool) in this protein predicted that it is o-
glycosylated on T (Threonine), at position 266 in the sequence which suggest that it is a 
glycosylated protein. Analysis of the phylogenetic tree (Figure 3.4) indicates that TbPLA2 
(highlighted with light grey box) is closely related with other phospholipase A2 like proteins 
from different organisms.  
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    40TbPLA2
    27TcPLA2
    16LmPLA2
    16HsPAFAH
Consensus
MVTWALKYFVRVVRWSTEAFLIWPTRPLFDYATSLHCVPI
.............MSATAGFFAGAPNSFWDYVISPHLILL
........................MHPIFDYILSIHYLPA
........................MVPPKLHVLFCLCGCL
    80TbPLA2
    67TcPLA2
    56LmPLA2
    56HsPAFAH
Consensus
SGTFITSVLLCFYGFPLFWSTAMVAVGFIISGVLFLVSPL
FAFFPLSMILRIFGLGAVFFLPIIPLGIIGAAVMFILLPV
GASVLLSCLAAAWGVDWKVCIMMTCVGSLVTCAVFYVQPL
AVVYPFDWQYINPVAHMKSSAWVNKIQVLMAAASFGQTKI
f
   120TbPLA2
   107TcPLA2
    96LmPLA2
    92HsPAFAH
Consensus
PLLKPIGGRYSVGLVHMNGCRSQSIPPVAVFYPTNMVPEK
PILEPVGGHYHVGIVHVHSRHSQTMPPLAVYYPTNETPRR
QCFSPLGGSFNVGTREVCGERGAMKPPVTIVYPTASGTPR
PRGN...GPYSVGCTDLMFDHTNKGTFLRLYYPSQDND.R
g vg yp
   160TbPLA2
   147TcPLA2
   136LmPLA2
   130HsPAFAH
Consensus
KGLPYVPFGDDRFLRGVAAYANVPFFFIRDFSFVRISASR
KGIQYIPFNDVRFMSGLSSRAGVPLYLMRDFLFVRLRATE
SGIQYIPFGERSYLVGIASYSKVPYALVKDLWLLRKKMRP
LDTLWIPNKE..YFWGLSKFLGTHWLMGNILRLLFGSMTT
p g
   200TbPLA2
   187TcPLA2
   176LmPLA2
   169HsPAFAH
Consensus
NAVPAALLNQYERVPPIVVFSHGLAGYHLFYSCFALDLAA
GAKPIPLINSSGIPLPVIIFSHGLYGYHRLYSALQADLAS
NAEPAPLFQRDGMPRPMIVFSHGLGGFPHLYSTLLMDLAV
PANWNSPLRP.GEKYPLVVFSHGLGAFRTLYSAIGIDLAS
a p fshgl ys dla
   234TbPLA2
   221TcPLA2
   210LmPLA2
   209HsPAFAH
Consensus
RGAIVICLGHCDNSASFMRDS......SGKESEVPLKDYG
RGAVVVSVGHCDGSASFMRDS......ERGGKEFFLRQVD
RGAVVFALSHMDGSAAFCRDA......EREIRIPLNTQVG
HGFIVAAVEHRDRSASATYYFKDQSAAEIGDKSWLYLRTL
g v h d sa
   268TbPLA2
   255TcPLA2
   244LmPLA2
   249HsPAFAH
Consensus
WEVP...AREAQVAQRVSEVRGTLQRLT...EKDFWTTLG
WDSP...VCEEALAQRVMETRRTLKRLS...EKEFWKELG
WTSE...DRAPQLEVRIRETLNTIKRIR...SGELLLALG
KQEEETHIRNEQVRQRAKECSQALSLILDIDHGKPVKNAL
r e
   306TbPLA2
   293TcPLA2
   282LmPLA2
   289HsPAFAH
Consensus
YINSDIDKFLSKPLQ..VHLAGHSFGGATVLAAALEENQN
FADLDAEQYLRQSPR..VHLSGHSFGGATALVAAMQEEQE
YDKETVDKYIEKEPR..IHLLGHSFGGATCLAAALADTQA
DLKFDMEQLKDSIDREKIAVIGHSFGGATVIQTLSEDQRF
ghsfggat
   341TbPLA2
   329TcPLA2
   322LmPLA2
   327HsPAFAH
Consensus
P...VKGVSVKSVYTFDPWMVPIQNEHFCNPLSDGRK..S
SK..PNENPVQSVIVFDPWHKPLQNELFLKPIEEGRN..R
ASERGGVSSIASTVVYDPWMIPLQKTMFYDKLTDRKQPVH
R..CGIALDAWMFPLGDEVYSRIPQPLFFINSEYFQYPAN
d f
   375TbPLA2
   363TcPLA2
   362LmPLA2
   367HsPAFAH
Consensus
YTVPTVTVHSDDWVKDSESWEFFKRMKALVLEQS......
YTTPTLMVHSDAWVQDRSIWNFFQRITTLLLSQP......
FTTPTLQIFSEEWVRSKEQHAFFEEVKAIVDAQPRTTEES
IIKMKKCYSPDKERKMITIRGSVHQNFADFTFATGKIIGH
   411TbPLA2
   399TcPLA2
   402LmPLA2
   407HsPAFAH
Consensus
....AYASLNEVEKQALFGIVVTKNTNHLSLVDVSVLSPV
....SISSLSEREKRMRFVTEKTGSTNHYSVSDVVLLSPV
ALVSAVDAKLKVMKTSWYTIKDYRGTGHLTCTDVSLFSPV
MLKLKGDIDSNVAIDLSNKASLAFLQKHLGLHKDFDQWDC
h
   446TbPLA2
   438TcPLA2
   442LmPLA2
   441HsPAFAH
Consensus
MHGNIWATVSPRVQIMEWCNALLRFAKQNTEVCST.....
IHGCKNSILSPRVQIMEWSNTCLRFIKEHAMYTSRTSAR.
LYRAAYMTASPRGCIVAFAAETMRFIEKVSGPLPLDTKLL
LIEGDDENLIPGTNINTTNQHIMLQNSSGIEKYN......
p i
   446TbPLA2
   438TcPLA2
   453LmPLA2
   441HsPAFAH
Consensus
...........
...........
NDSALAAALRG
...........
 
 
Figure 3.2 Amino acid sequence alignment of TbPLA2 with phospholipases A2 from TcPLA2 (T. cruzi), 
LmPLA2 (Leishmania major) and HsPAF-AH (human platelet activating factor-acetyl hydrolase). 
Conserved motifs are marked with black boxes and lipase consensus motif labeled with a bar above it. 
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Sequence length: 447 
Sequence number of predicted transmembrane helices (TMHs):  2 
Sequence expected number of amino acids (AAs) in TMHs: 46.75847 
Possible N-terminal signal sequence 
 
Sequence TMHMM2.0 outside      1    30 
Sequence TMHMM2.0 TMhelix     31    53 
Sequence TMHMM2.0 inside     54    54 
Sequence TMHMM2.0 TMhelix     55    77 
Sequence TMHMM2.0 outside     78   447 
 
 
Figure 3.3 Predicted transmembrane and helix analysis in TbPLA2 
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Figure 3.4 Phylogenetic tree analysis of TbPLA2. The tree was calculated using the NCBI 
BLAST tree view widget. The arrow indicates the location and homology of TbPLA2with 
other phospholipases A2. Maximum sequence difference and distance is 0.85. Bar represent 
distance of 0.85. 
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2. Cloning of TbPLA2 in E.coli  
 
The PCR reaction with AccuPrime Taq polymerase using sequence-specific primers yielded a 
product between 1000 and 1500 bp which corresponded to the open reading frame (ORF) of 
TbPLA2 (Figure 3.5). After gel extraction, this PCR product was ligated into subcloning 
vector pCR 2.1 using the TOPO-TA cloning kit (Invitrogen). The DNA construct was 
transformed into TOP 10 competent cells and this yielded colonies. Positive clones were 
propagated and the DNA was isolated from the cells using the method of MiniPreparation 
(MiniPrep) (see Material and methods). The DNA construct obtained was verified using 
restriction enzyme Nde1.Analysis on agarose gel revealed bands at 4453 bp and 841 bp as 
expected (Figure 3.6). The clone containing this DNA construct was further propagated and 
the DNA was obtained by the method of MiniPreparation. Afterwards, this DNA was 
analyzed and digested with BamH1 and Pst1 to cleave out the TbPLA2 gene fragment. 
Additionally, TbPLA2 was extracted from the agarose gel and the DNA concentration was 
estimated spectrophotometrically at λ = 260 nm. 
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 Figure 3.5 PCR analysis on 1 % agarose gel of TbPLA2 with AccuPrime Taq 
polymerase  
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Figure 3.6 Analysis on agarose gel of plasmid constructs of pCR 2.1 containing TbPLA2 from clones in 
TOP 10 competent cells after NdeI digestion  
 
The TbPLA2 was ligated into the expression vector pMal-c2e which was previously digested 
with BamH1 and Pst1. The ligated construct was successfully transformed into XL-I 
competent cells and propagated. Positive clones from this transformation were picked and 
further cultivated. The DNA construct from the clones were obtained using the method of 
MiniPrep and analyzed using BamH1 and Pst1 (Figure 3.7). The confirmed clone was further 
selected and cultivated to gain the respective DNA construct which was further transformed 
into BL-21 (DE3) expression competent cells. The clones obtained were analyzed and 
verified using the method of bacterial colony PCR (see Material and method). As shown in 
Figure 3.8, this was performed including a negative control (without any template DNA), a 
positive control (template DNA for primers) and the respective clones to be analyzed. The 
obtained DNA construct was sequenced by GATC Biotech. and aligned with known gene 
database sequence to confirm sequence homology. Using DNAMAN®, this DNA sequence 
was converted into the respective protein sequence and aligned with known database 
sequence in order to evaluate and verify the sequence. 
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Figure 3.7 Plasmid constructs of TbPLA2 in pMal-c2E from clones in XL-1 competent cells after BamH1 
and Pst1 digestion analysis on 1 % agarose gel                         
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Figure 3.8 Bacterial colony PCR of clones from BL-21 (DE3) competent cells with construct of pMal-c2E - 
TbPLA2 analysis on 1 % agarose gel 
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As a result of unsuccessful heterologous over-expression attempt, the verified pMal-c2E-
TbPLA2 construct was transformed into Rosetta 2 expression competent cells and positive 
clones obtained were verified with bacterial colony PCR (see Material and method) as shown 
in Figure 3.9.                                           
 
                                                                      DNA   Positive  Clone 1    2          3          4                                                                                                                                     
                                                       ladder control 
                                              Lane      1       2          3       4        5        6      
 
 
 
 
Figure 3.9 Bacterial colony PCR of clones from Rosetta 2 competent cells with construct of pMal-c2E -
TbPLA2 analysis on 1 % agarose gel 
 
3. Gene and protein sequence alignment of clones 
 
The multiple gene sequence alignment of clones from different cloning experiments indicated 
constant alterations (point mutations) at three positions as compared to the known gene 
sequence from GeneDB of T. brucei (Figure 3.10). These alterations had been verified by 
translating the several sequenced TbPLA2 gene (Figure 3.10) to amino acid sequence using 
the software DNAMAN®. The amino acid multiple sequence alignment showed that there was 
not only a single but rather three constant amino acids alterations as compared with known 
database which included, instead of phenylalanine (F) to leucine (L), isolecine (I) to serine (S) 
and valine (V) to leucine (L) as indicated with asterisks in Figure 3.11. The conserved 
sequence was highlighted in black in Figure 3.11. On the other hand, characterized T. brucei 
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88 
phospholipase A1 (TbPLA1) (Richmond and Smith, 2007), had also contained alteration at 
two position as compared to database sequence before its characterization. The TbPLA1 
amino acid sequence reported had alterations from known database instead of proline (P) to 
serine (S) and alanine (A) to glycine (G). This suggests that the amino acid sequence of 
TbPLA2 as indicated in database can have alterations. Similar to TbPLA1 in the case of 
TbPLA2, the clones having alterations at three positions instead of F, I and V to L, S and L 
respectively are constant as verified from several separate clone sequences. 
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   5602007.03.26
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Consensus a
A
A
A
A
A
A
a
A
A
A
A
A
A
c
C
C
C
C
C
C
g
G
G
G
G
G
G
c
C
C
C
C
C
C
g
G
G
G
G
G
G
g
G
G
G
G
G
G
t
T
T
T
T
T
T
g
G
G
G
G
G
G
c
C
C
C
C
C
C
c
C
C
C
C
C
C
c
C
C
C
C
C
C
g
G
G
G
G
G
G
c
C
C
C
C
C
C
c
C
C
C
C
C
C
g
G
G
G
G
G
G
c
C
C
C
C
C
C
t
T
T
T
T
T
T
t
T
T
T
T
T
T
t
T
T
T
T
T
T
g
G
G
G
G
G
G
c
C
C
C
C
C
C
t
T
T
T
T
T
T
c
C
C
C
C
C
C
a
A
A
A
A
A
A
a
A
A
A
A
A
A
c
C
C
C
C
C
C
c
C
C
C
C
C
C
a
A
A
A
A
A
A
a
A
A
A
A
A
A
t
T
T
T
T
T
T
a
A
A
A
A
A
A
t
T
T
T
T
T
T
g
G
G
G
G
G
G
a
A
A
A
A
A
A
g
G
G
G
G
G
G
a
A
A
A
A
A
A
g
G
G
G
G
G
G
a
A
A
A
A
A
A
g
G
G
G
G
G
G
t
T
T
T
T
T
T
g
G
G
G
G
G
G
c
C
C
C
C
C
C
c
C
C
C
C
C
C
A
G
G
G
G
G
c
C
C
C
C
C
C
c
C
C
C
C
C
C
t
T
T
T
T
T
T
a
A
A
A
A
A
A
t
T
T
T
T
T
T
t
T
T
T
T
T
T
g
G
G
G
G
G
G
t
T
T
T
T
T
T
t
T
T
T
T
T
T
g
G
G
G
G
G
G
t
T
T
T
T
T
T
g
G
G
G
G
G
G
t
T
T
T
T
T
T
t
T
T
T
T
T
T
c
C
C
C
C
C
C
a
A
A
A
A
A
A
g
G
G
G
G
G
G
t
T
T
T
T
T
T
c
C
C
C
C
C
C
a
A
A
A
A
A
A
c
C
C
C
C
C
C
g
G
G
G
G
G
G
g
G
G
G
G
G
G
t
T
T
T
T
T
T
c
C
C
C
C
C
C
t
T
T
T
T
T
T
t
T
T
T
T
T
T
g
G
G
G
G
G
G
c
C
C
C
C
C
C
c
C
C
C
C
C
C
g
G
G
G
G
G
G
g
G
G
G
G
G
G
a
A
A
A
A
A
A
t
T
T
T
T
T
T
a
A
A
A
A
A
A
   640TbPLA2
   6402007.02.22
   6402007.03.26
   6382007.05.18
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Figure 3.10 Gene sequence alignment of different clones in comparison to TbPLA2 
database sequence and constant alterations are marked with asterisks in sequence   
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Figure 3.11 Protein sequence alignment from several sequenced clones in comparison 
with TbPLA2 known database sequence. The constant alterations at three positions 
instead of F, I and V to L, S and L respectively are marked with asterisks 
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4. SDS-PAGE analysis of heterologous bacterial expression 
 
Heterologous expression of TbPLA2 in pMal-c2E plasmid within the correct clone was 
attempted in BL-21 (DE3) and Rosetta 2 expression competent cells at different conditions by 
induction of IPTG at final concentrations of 0.1 mM, 0.3 mM, 0.5 mM and 1mM as well as 
varying temperatures of 16°C, 27°C and 37°C for time period of 9 h and 12 h. The induced 
bacterial cells were harvested by centrifugation, lysed in buffer (see Material and method) and 
fractionated into soluble and membrane fractions. The fusion protein MBP (Maltose binding 
protein) with TbPLA2 expression was expected to be at the molecular size of 100 kDa in the 
fractions of the induced cells as compared to the control cells. The corresponding fractions 
obtained from different parameters were resolved on SDS-PAGE as shown in Figures 3.12, 
3.13, and 3.14. The SDS-PAGE gels did not showed the expected band at a molecular size 
100 kDa in induced cells. Although at low temperature condition, the bacterial growth is not 
optimum as compared to 37°C but there was no expression of target fusion protein. On the 
whole, the expression of TbPLA2 in BL-21 (DE3) competent cells was not successful as seen 
in SDS-PAGE gels. 
          
             
 
 
      
                                 
 
Figure 3.12 Coomassie stained 10 % SDS-PAGE to analyze heterologous expression of 
TbPLA2 in BL-21 (DE3) competent cells induced with 0.3 mM IPTG at room temperature 
for 12 h. (A) control and induced cells lysate soluble fraction in different protein 
concentrations.  
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Figure 3.12 (B) Control and induced cell lysates membrane fraction in different protein 
concentrations. 
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Figure 3.13 SDS-PAGE 10 % gel coomassie stained of heterologous expression in BL-21 
(DE3) competent cells. Cells were induced with IPTG and incubated at room temperature for 
12 h. Lanes (1) protein molecular marker (2) control cell lysates soluble fraction, (3) induced 
cell lysates soluble fraction with 0.1 mM, (4) induced cell lysates soluble fraction with 0.2 
mM, (5) induced cell lysates soluble fraction with 0.5 mM, (6) protein molecular marker, (7) 
control cell lysates membrane fraction, (8) induced cell lysates soluble fraction with 0.1 mM, 
(9) empty, (10) induced cell lysates soluble fraction with 0.5 mM 
 
 
 kDa 
 
120 
100 
85 
70 
60 
50 
 
40 
 
30 
 
25 
 
20 
 
 
(B)  
 
                                Control                                          Induced 
                   5µg  10µg  20 µg                         5µg   10µg  20 µg 
 
kDa 
 
116  
 
 
66 
 
 
45 
 
 
35 
 
 
25 
 
 
17 
 
 
 kDa 
 
 
120 
100 
85 
70 
60 
 
50 
 
40 
 
30 
 
25 
 
20 
 
 
Results                                                                                                                 
                                                                                                                                                                                                                  
                                                                                                      
93 
 
                                     
 
                                    Lane   1       2          3            4      5    6      7         8         9       10 
 
Figure 3.14 Heterologous over-expression in BL-21 (DE3) competent cells and resolved 
on 10 % SDS-PAGE Coomassie stained. Cells were induced with 1 mM IPTG for 12 h. 
Where lanes (1 and 2) were control and induced cell lysates soluble fraction at 37°C, lanes (3 
and 4) control and induced cell lysates soluble fraction at 25°C, lane (5) empty, lane (6) 
protein molecular marker, lanes (7 and 8) control and induced cell lysates membrane fraction 
at 37°C and lanes (9 and 10) control and induced cell lysates membrane fraction at 25°C.  
 
Due to toxic nature of the protein and possibly membrane lytic activity of the TbPLA2, the 
BL-21 (DE3) competent cells were not able to over-express this protein. This led to an 
attempt to express the protein in Rosetta 2 expression competent cells. As Rosetta 2 cells 
contained specific tRNAs for the codons rarely found in E. coli for enhanced eukaryotic 
protein expression. Therefore, the construct of TbPLA2 in pMal-c2E was transformed into 
Rosetta 2 competent cells. The cells were induced at varying IPTG concentrations, 
temperatures and for the time period of 9 h. Afterwards, both the control and induced cells 
were harvested by centrifugation and lysed with hypotonic buffer (see Material and method) 
.The cell lysates were split into soluble and membrane fractions. These fractions each from 
control and induced cells were resolved on 12 % SDS-PAGE under reducing conditions as 
shown in Figure 3.15, 3.16 and 3.17.The fusion protein band of MBP and TbPLA2 in all gels 
was expected at a molecular size of 100 kDa. The gels did not show this band of 100 kDa in 
induced cell lysates as compared to control cell lysates. These competent cells were also 
unable to over-express the TbPLA2 protein due to toxic nature of this protein for the bacteria.  
On the whole, the heterologous expression of TbPLA2 in bacterial cells was not successful 
although the cloning of the gene was confirmed. So, the problem remained to express the 
protein in a suitable host or use another expression system for this eukaryotic membrane 
protein.  
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Figure 3.15 Analysis of heterologous expression in Rosetta 2 competent cells on 
coomassie stained 12 % SDS-PAGE. The cells were induced with IPTG in the concentration 
of 1 mM for 9 h. where lanes (1 and 2) were control cell lysates soluble and membrane 
fractions at 16°C, lanes (3 and 4) induced cell lysates soluble and membrane fractions at 
16°C, lane (5) empty, lanes (6 and 7) control cell lysates soluble and membrane fractions at 
37°C and lanes (8 and 9) induced cell lysates soluble and membrane fractions at 37°C. 
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Figure 3.16 Heterologous expression in Rosetta 2 competent cells and fractions resolved 
on coomassie stained 12 % SDS-PAGE. The cells were induced with 0.1 mM IPTG for 9 h. 
Lane (1) control cell lysate after 3 h, lanes (2-3) control cell lysates soluble and membrane 
fraction at 16°C, lanes (4-5) induced cell lysates soluble and membrane fraction at 16°C, lane 
(6) protein molecular marker, lanes (7-8) control cell lysates soluble and membrane fraction at 
37°C and lanes (9-10) induced cell lysates soluble and membrane fraction at 37°C. 
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Figure 3.17 Analysis of heterologous expression in Rosetta 2 competent cells on 12 % 
SDS-PAGE stained with coomassie brilliant blue. The cells were induced at 27°C for 9 h. 
Lane (1) control cell lysate after 3 h, lanes (2 and 3) control cell lysates soluble and 
membrane fractions, lanes (4 and 5) 0.1 mM IPTG induced cell lysates soluble and membrane 
fractions, lanes (7 and 8) 0.5 mM IPTG induced cell lysates soluble and membrane fractions 
and lanes (9 and 10) 1 mM IPTG induced cell lysates soluble and membrane fractions.  
 
 
5. Expression of TbPLA2   in Sf9 insect cells  
 
The Bac-to-Bac Baculovirus expression system provides the efficient method to generate 
recombinant baculoviruses and permits the high-level expression of protein in insect cells. 
This method utilizes the site-specific transposition properties of the Tn7 transposon to 
simplify and enhance the process of recombinant bacmid DNA that can be used to infect 
insect cells for large-scale expression of the protein. For this purpose, the sequenced construct 
of TbPLA2 in pMal-c2E and the pFastBac-1 plasmid for Baculovirus expression were 
simultaneously restriction digested with BamH1 and Pst1 as shown in Figure 3.18 (A) and (B) 
respectively. The pFastBac-1 after digestion revealed a band of 4692 bp and 83 bp as 
expected. This TbPLA2 gene after digestion from construct revealed a size of 1344 bp and 
then utilized for gel extraction. The purified DNA of pFastBac-1 and TbPLA2 were 
spectrophotometrically estimated to determine the concentration. This DNA of TbPLA2 was 
used for cloning in the Baculovirus expression system. Afterwards, this TbPLA2 gene was 
ligated into pFastBac-1 plasmid. The ligated construct was verified by restriction digestion 
with Nde1 with expected bands at 5214 bp and 841 bp. The expected bands were confirmed 
on agarose gel as seen in Figure 3.19. The ligation construct from lane 5 in Figure 3.19 was 
used for transformation into XL-1 competent cells. The colonies obtained were selected for 
confirmation of correct construct and orientation of gene. 
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Figure 3.18 Analysis of restriction digestion on 1% agarose gel (A) lane (1) DNA ladder, 
lane (2) empty, lane (3) pFastBac-1 double digested with BamH1 and Pst1, lane (4) pFastBac-
1 digested with Eam11051. (B) lane (1) DNA ladder, lane (2) empty, lane (3) construct of 
TbPLA2 in pMalC2E double digested with BamH1 and Pst1. Note the band at 1344 bp. 
 
 
                                                  Lane     1        2        3         4         5         6 
Figure 3.19 Ligation reaction of TbPLA2 with pFastBac-1 analyzed l and digested with 
Nde1 on 1 % agarose gel. Lane (1) DNA ladder, lane (3 and 4) contains ligation reactions 
which were performed at 16°C with ratio of insert to plasmid in 1:3 and 1:6 respectively, lane 
(5 and 6) contains ligation reactions which were performed at 22°C with ratio in 1:3 and 1:6 
respectively. 
 
The colonies were verified for correct constructs with the method of bacterial colony PCR. 
This reaction included negative control (without any template DNA) and positive control 
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(pMal-c2E-TbPLA2). The correct clones were verified on agarose gel as shown in Figure 
3.20.  
                              
                              Lane 1     2    3     4    5     6   7    8   9     10    11   12  13   14  15  
 
  
Figure 3.20 Bacterial colony PCR of construct of TbPLA2 in pFastBac-1transformed 
into Xl-1 competent cells on 1 % agarose gel. Lanes: (1) DNA ladder, (2) negative control, 
(3) positive control, (4-9) clones, (10) DNA ladder, (11-15) clones. 
 
The clone containing the correct construct from lane 5 was selected. This clone was 
propagated in LB-medium with ampicillin and the method of MiniPrep was performed to 
obtain DNA construct. The DNA orientation was verified using restriction enzymes like Nde1 
and Eam11051. After the digestion with Nde1, the bands were expected at 5214 bp, 841bp 
and for Eam11051 at 4559 bp, 1496 bp (Figure 3.21). This implicated that the gene was 
ligated in correct orientation in the plasmid which can be further utilized. 
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Figure 3.21 Analysis on 1 % agarose gel verification of construct of TbPLA2 in 
pFastBac-1. The construct was digested with Nde1 (lane 3) and Eam11051 (lane 5).  
 
After confirmation of the correct construct, this recombinant plasmid of TbPLA2 in pFastBac-
1 was transformed into DH10Bac competent cells. The clones containing recombinant bacmid 
transposed with TbPLA2 were verified with the help of PCR method using M13 sense and 
anti-sense primers with HotStar Taq polymerase. This PCR reaction yielded a product with 
the size of 3644 bp. Furthermore, these recombinant bacmids were purified with Qiagen PCR 
purification kit and verified with PCR using M13 sense and anti-sense primers as depicted in 
Figure 3.22 (A). The recombinant bacmid was further verified using restriction enzyme 
EcoR1 which depicted a band at 3644 bp as shown in Figure 3.22 (B). Certainly, this confirms 
the correct orientation of the gene of TbPLA2 in the plasmid which was utilized for infection 
in insect cells. 
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Figure 3.22 Analysis of transposed recombinant bacmid in DH10Bac competent cells on 
1 % agarose gel. (A) PCR using M13 sense and anti-sense primers for recombinant bacmid 
in clones. Lane (1) DNA ladder, lanes (2 and 3) contains purified recombinant bacmids with 
Qiagen gel extraction kit. (B) lane (1) DNA ladder, lanes (2 and 3) contains recombinant 
bacmid digested, analyzed with EcoR1 and purified with Qiagen gel extraction kit.  
 
6. Insect cell expression analysis with SDS-PAGE  
 
The purified recombinant bacmid transposed with plasmid containing TbPLA2 was used for 
infection in Sf9 insect cells. The insect cells were grown at a cell density of 2.8 X 106/ ml and 
infected with the recombinant bacmid. After 72 h of infection, the cells were centrifuged and 
the P1 (low viral titer) supernatant was used for further infections. Exponentially growing Sf9 
insect cells were infected with the P1 viral stock. Following an established infection, the 
suspension was centrifuged and the P2 (high viral titer) supernatant was separated and pellet 
was stored at 4°C. Furthermore, this P2 viral stock supernatant was utilized in infection in 
growing cultured Sf9 insect cells for P3 (higher viral titer). After this, the culture was 
centrifuged to separate supernatant and cell pellet. The P3 viral stock supernatant and pellet 
were preserved at 4°C for further analysis. The infected cells from all infections were lysed 
with RIPA buffer (see Material and method). After the lysis, cell lysates were centrifuged at 
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13.000 rpm for 15 min. at 4ºC to separate the soluble and membrane fractions which were 
analyzed including the supernatant of infected cells by SDS-PAGE using a 12 % gel (Figure 
3.23). The gel depicted a prominent band at molecular size of 58 kDa in only the membrane 
fraction of P2 viral stock cell lysates (lane 7 in Figure 3.23). 
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Figure 3.23 Heterologous expression of TbPLA2 in insect cells after 72 h infection and 
resolved on 12 % SDS-PAGE gel stained with coomassie brilliant blue. Lane (1) protein 
molecular marker, lane (2) Sf9 cells supernatant, lane (3) Sf9 cell lysates soluble fraction, lane 
(5) P1 viral stock supernatant, lane (6) P2 viral stock supernatant, lane (7) P2 cell lysates 
membrane fraction, lane (8) P3 viral stock supernatant and lane (9) P3 viral stock cell lysates 
membrane fraction. 
 
For the optimization, the exponentially growing insect cells were infected with the 
recombinant bacmid transposed with TbPLA2 for the time period of 120 h. After 120 h of 
infection, the culture was centrifuged and supernatant and cell pellet were separated. Similar 
procedure was followed for 72 h infected insect cells. The P2 and P3 viral stocks supernatant 
and cell pellet were preserved at 4°C.On the whole, the cells were lysed with RIPA buffer as 
described in Material and method. The cell pellets from each infection were fractionated into 
soluble and membrane fractions. These fractions including the supernatant of infected cells 
were analyzed on 12% SDS-PAGE as stated in Figure 3.24. Additionally, this gel suggested a 
band of 58 kDa in P3 viral stocks cell lysates membrane fraction (lane 7, Figure 3.24). This 
certainly meant that the infection period may play a role in the expression of protein in insect 
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cells. This comparative infection period was intended to evaluate the expression level of this 
protein and to determine the optimum time for infection to yield the maximum expression of 
TbPLA2 in insect cells.  
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Figure 3.24 Analysis of heterologous expression in Sf9 insect cells after 120 h on silver 
stained 12 % SDS-PAGE. Lane (1) Sf9 control cells supernatant, lane (2) P2 viral stock 
supernatant, lane (3) P2 cell lysates membrane fraction, lane (4) empty, lane (5) protein 
molecular marker, lane (6) P3 viral stock supernatant, lane (7) P3 cell lysates membrane 
fraction, lane (8) P3 cell lysates pellet. 
 
7. Western blot analysis of heterologous expression  
 
In order to ascertain that this protein band in the gel (Figure 3.23 and 3.24) was definitely 
TbPLA2, the Western blot analysis was performed. The soluble and membrane fractions from 
P1, P2 and P3 viral stocks after 72 h of infection in insect cells were analyzed by Western 
blotting using an anti-TbPLA2 in a working dilution of 1: 2000. The SDS-PAGE Coomassie 
stained gel and blot of the gel certainly defines that the band observed at molecular size of 58 
kDa (denoted with an arrow, Figure 3.25) was the band of TbPLA2. The band was observed 
only in the membrane fraction of cell lysate from P2 viral stock. 
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Figure 3.25 Heterologous expression of TbPLA2 in insect cells after 72 h and analysis 
with 12 % SDS-PAGE coomassie stained and Western blot; lane (1) protein molecular 
marker, lane (2) P2 viral stock membrane fraction, lane (3) P2 viral stock cell supernatant, (4) 
P2 viral stock membrane fraction, lane (5) P2 viral stock cell supernatant, (6) protein 
molecular marker. 
 
 
In comparison, insect cells after 120 h of infection were analyzed with Western blot. The cell 
pellets from P2 and P3 viral stocks were lysed and fractionated into soluble and membrane 
fractions. These fractions and the cell supernatant from each infection were resolved on 12 % 
SDS-PAGE. Then the gel was blotted and analyzed using anti-TbPLA2. The soluble and 
membrane fractions from P2 and P3 viral stocks after 120 h from two independent infections 
were verified to determine the intensity of expression of this protein as shown in Figure 3.26. 
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Figure 3.26 Detection of TbPLA2 with 12 % SDS-PAGE silver stained and Western blot 
analysis of heterologous expression in insect cells after 120 h. lanes: (1) empty lane, (2) 
cell supernatant, (3) P2 infected cells supernatant, (4) P2 infected cell lysates membrane 
fraction, (5) protein molecular marker, (6) P3 (independent infection 1) infected cell lysates 
membrane fraction, (7) P3 (independent infection 1) infected cell lysates soluble fraction, (8) 
P3 (independent infection 2) infected cell lysates membrane fraction, (9) P3 (independent 
infection 2) infected cell soluble fraction. 
 
 
8. Immunoprecipitation 
 
The insect cell lysates membrane fraction was solublized in RIPA lysis buffer and subjected 
to immunoprecipitation. The anti-TbPLA2 antibody was used to capture the expressed protein 
from insect cell lysate. For this purpose, Protein G coupled agarose bead was utilized. After 
immunoprecipitation of the lysate with antibody, the immunocomplex was obtained. The 
fractions obtained at every step of this method were resolved on 10 % SDS-PAGE under 
reducing conditions. Two different bands were observed in lane 6 which contained 
immunocomplex at the molecular size of 50 kDa and 25 kDa respectively (Figure 3.27).                             
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Figure 3.27 Immunoprecipitation of TbPLA2 from infected insect cells. Resolved on 10 % 
SDS-PAGE and silver stained. Lanes (1) P3 supernatant, (2) P3 soluble membrane fraction, 
(3) P3 supernatant of immunocomplex, (4) P3 insoluble pellet, (6) immunocomplex of protein 
with anti- TbPLA2 antibody.   
 
 
9. Western blot analysis of bloodstream and procyclic form cells for TbPLA2 
 
 
The bloodstream and procyclic form cells were cultivated at a cell density of 1 X 107 cells/ 
ml. The cells were centrifuged and afterwards lysed with hypotonic buffer. The lysates 
obtained from both forms of cells were used for further analysis. The cell lysates were 
fractionated into soluble, membrane and VSG fractions for bloodstream form using the 
protocol described (Material and method). The procyclic form cell lysates were fractionated 
into soluble and membrane fractions. These fractions from both forms of parasites were 
resolved on 12 % SDS-PAGE and subsequently analyzed using Western blot with anti-
TbPLA2 to identify TbPLA2 in both forms of the parasites. Both forms of parasite cell lysates 
were analyzed separately onto two blots. The blots revealed a single band at a molecular size 
of 50 kDa and visible only in membrane fraction of both parasite forms, indicated in Figure 
3.28 (A) and (B). Bloodstream form membrane fraction from rat blood in the cell density at 3 
X 109 was analyzed on the blot as shown in Figure 3.29 lane 2 depicting a band at 50 kDa.  
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Figure 3.28 Western blot analysis of TbPLA2 in T.brucei bloodstream and procyclic 
form. (A) blot showing bloodstream form cells lysate fractions; lanes: (1) protein molecular 
marker, (2) empty lane, (3) cell lysates membrane fraction, (4) empty, (5) VSG fraction, (7) 
cell lysates soluble fraction, (8) empty lane, (9) PLA2 from porcine pancreas. (B) blot with 
procyclic form cell lysates fractions; lanes (3) cell lysates soluble fraction, (9) cell lysates 
membrane fraction. 
 
 
 
Figure 3.29 Western blot analysis of TbPLA2 in T.brucei bloodstream form. Blot showing 
(1) protein molecular marker, (2) membrane fraction.  
 
For a comparative study, logarithmic and stationary phases bloodstream as well as procyclic 
form cell lysates were analyzed. The lysates were fractionated into cytosolic and membrane 
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fractions simultaneously analyzed on the same blot. The blot revealed a prominent band at a 
molecular size of 50 kDa in only membrane fractions in all analyzed forms (Figure 3.30). A 
single band at the molecular size of 50 kDa was observed on the blot in the cell lysates 
membrane fraction (lane 3, Figure 3.31). This experiment was performed several times 
(results not shown) till the same reactivity at a molecular size of 50 kDa was observed. This 
revealed that this protein is expressed in every life stage of the parasite. In spite of antibody 
recognition of the protein in cell lysates, it was imperative to investigate the preimmune 
serum from rabbit and its reactivity with the parasite cell lysates. The preimmune serum was 
analyzed on blot with the cell lysates from bloodstream form. The bloodstream form cell 
lysates were fractionated as described previously. Figure 3.32 depicts the analysis of 
preimmune serum against the membrane fraction from bloodstream form from rat blood in the 
cell density at 3 X 109 showing a band at 36 kDa only in the cytosolic fraction. 
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Figure 3.30 Comparative Western blot of bloodstream and procyclic form. 12 % SDS-
PAGE gel ; lanes: (1) protein molecular marker, (2) cell lysates soluble fraction from 
logarithmic phase of bloodstream form, (3) cell lysates membrane fraction from logarithmic 
phase of bloodstream form, (4) empty lane (5) cell lysates soluble fraction from stationary 
phase bloodstream form, (6) cell lysates membrane fraction from stationary phase 
bloodstream form, (7) empty lane, (8) cell lysates soluble fraction from procyclic form, (9) 
cell lysates membrane fraction from procyclic form. 
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Figure 3.31 Analysis of bloodstream form cell lysates against anti-TbPLA2. Lanes: (1) 
protein molecular marker, (2) empty lane, (3) cell lysates soluble fraction from bloodstream 
form, (4) empty lane, (5) membrane fraction from bloodstream form. 
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Figure 3.32 Analysis of bloodstream form cell lysates against preimmune serum. Lanes: 
(1) protein molecular marker, (2) empty lane, (3) cell lysates soluble fraction from 
bloodstream form, (4) empty lane, (5) membrane fraction from bloodstream form. 
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10. Transcription of TbPLA2 gene from T. brucei 
 
The expression level of TbPLA2 gene in different life cycle stages of the parasite was also 
determined using Northern blot analysis. The monomorphic strains of T. brucei 221 cells 
were obtained from rat blood as well as from in vitro grown cultures in logarithmic and 
stationary phase were recovered and their total RNA was obtained (see Material and 
Methods). The total RNA from these stages was used for Northern blot analysis. The 
sequence specific-primers for the gene of TbPLA2 were used for the probe as stated in 
Material and method. This definitely indicated the transcriptional expression and level of this 
protein throughout all growth phases of the parasites as depicted in Figure 3.33 (A). The 
comparison of band intensities in case of TbPLA2 in three stages (Figure 3.33 B) showed that 
the expression of TbPLA2 was significantly regulated in in vitro cultured logarithmic phase of 
the parasites as compared to other growth stages. Therefore, it can be proposed that TbPLA2 
gene is expressed throughout the life stages of parasite and specifically prominent in 
logarithmic phase. The Northern blot complemented the data of Western blot with T.brucei 
cell lysates indicating the transcriptional and translational expression of this protein 
throughout the life cycle of this parasite. On the whole, this speculates the significance of this 
protein in the parasitic life cycle. 
 
 
 
 
Results                                                                                                                 
                                                                                                                                                                                                                  
                                                                                                      
109 
 
A 
 
                                           Rat blood   log phase stationary phase 
 
                                         
                                       
                                         
 
         
 
 
 
 
   3700 bp 
   3500 bp 
 
 
 
   1329 bp 
 
 
 
   2250 bp 
   1850 bp 
   1350 bp 
 
                 
 
Figure 3.33 (A) Comparison of transcriptional expression of TbPLA2 in rat blood, 
logarithmic phase and stationary phase of T.brucei. (A) Blot with TbPLA2, loading control 
as beta tubulin and rRNA of T.brucei from rat blood, bloodstream log phase (16 h) and 
stationary phase (40 h) respectively.              
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Figure 3.33 (B) Semi-quantitative analysis of blots with GelScan V5.1 and value of the most 
intense band as standard was taken as 1. 
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 11. PLA2 enzyme activity assay with cell lysates of bloodstream and procyclic 
forms of T. brucei 
 
The phospholipase A2 activity was determined using a coupled assay which utilizes 
dilinoleoyl phosphatidylcholine (DL-PC) as a substrate and lipoxygenase as a coupling 
enzyme. The PLA2 activity was constantly monitored spectrophotometrically at λ = 234 nm. 
The phospholipase A2 activity released the product linoleic acid which was further oxidized 
by lipoxygenase giving rise to the corresponding hydroperoxide derivative. The standard 
reaction mixture contained 25 µM DL-PC, 0.23 mg/ ml and lipoxygenase in 50 mM Tris-HCl 
pH 8.5 containing 3 mM deoxycholate. The reaction was started by adding either known 
phospholipase A2 from porcine pancreas or bloodstream as well as procyclic form cell lysates 
soluble and membrane fractions. The control was taken as the buffer in which the cell lysate 
was prepared. The reaction was proceeded for 5 min. with measurement at λ = 234 nm. Then, 
the value of specific activity was calculated (see Material and method) using the absorbance 
values. This activity assay was established with PLA2 from porcine pancreas in increment of 
concentrations (Figure 3.34). This standard curve obtained was to demonstrate the optimum 
condition for the assay and further utilize this assay for activity estimation in parasite cell 
lysates. 
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Figure 3.34 Activity assay standard curve for known and commercially available PLA2 
from porcine pancreas. Different concentrations of PLA2 used for the activity assay. The 
PLA2 from porcine pancreas in concentration of 0.0625 µg, 0.083 µg, 0.125 µg, 0.25 µg and 
0.375 µg were used. 
 
The soluble and membrane fractions from T. brucei bloodstream and procyclic forms were 
used for comparative activity assay to determine the expression and activity level of 
phospholipase A2 in both forms. Both the forms of parasite were cultured at a cell density of 1 
X 106 /ml. The bloodstream form cells from two phases namely logarithmic and stationary 
phase were taken and cell lysates were prepared. The cell lysates of both forms of parasites 
were fractionated into soluble and membrane fractions in order to evaluate the regulation of 
activity of this protein in different fractions of cells and throughout the life cycle of this 
parasite (Figure 3.35). 
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Figure 3.35 Comparative activity assay for PLA2 with different cell phases of parasites. 
BF stands for bloodstream form and PC for procyclic form. Whereas BF 17s was cell lysates 
soluble fraction after 17 h cultivation, BF 17m was cell lysates membrane fraction after 17 h 
cultivation, BF 40s was cell lysates soluble fraction after 40 h cultivation, BF 40 m was cell 
lysates membrane fraction after 40 h cultivation, PCs and PCm were cell lysates soluble and 
membrane fractions respectively. Each fraction’s activity was measured with 25 µg protein 
concentration. 
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4. Discussion 
 
4.1 Characterization of TbPLA2  
 
The phospholipase A2 superfamily constitutes enzymes which are ubiquitous in nature. They 
have several functions in living organisms, like remodeling membrane phospholipids and 
formation of lipid-derived second messengers. Considering the vast distribution and 
significance in nature, phospholipase A2 is a valuable target and worth to be studied in detail 
in T. brucei. Especially, as it has not been identified or investigated till now in this organism.  
PLA2 is important for the liberation of arachidonic acid from phospholipids and synthesis of 
prostaglandins in T. brucei, which urged for a thorough investigation into the characterization 
of this enzyme. Trypanosomes produce prostaglandins from free arachidonic acid (Kubata et 
al., 2000) and prostaglandin synthesis has also been discovered in T. cruzi (Kubata et al., 
2002) and Leishmania (Kabututu et al., 2003), which gives an idea of distinct similarity 
among most of the kinetoplastids. Figarella et al., (2005 and 2006) reported that the 
prostaglandin D2 and its metabolites are involved in apoptosis and population density 
regulation in T. brucei. Involvement of prostaglandins in host-parasite interactions and 
virulence of the parasite could help to understand the various pathways. Prostaglandin F2α 
synthases from T. brucei (Kubata et al., 2000 and Okano et al., 2002), T. cruzi (Kubata et al., 
2002) and Leishmania (Handman et al., 1995 and Kabututu et al., 2003) have been identified, 
which show analogy in the kinetoplastids. In T. cruzi and Leishmania, the putative 
phospholipase A2-like protein has not been characterized until now but bioinformatic analysis 
has predicted that respective proteins are encoded within the genome of these organisms. This 
surely indicates that the kinetoplastids have evolved a metabolism for arachidonic acid and 
prostaglandin similar to higher eukaryotes. The existence of these enzymes in kinetoplastids 
elaborate further that these parasites do not completely depend on the host’s metabolic 
machinery for prostaglandin synthesis and regulation (Kubata et al., 2007).  
T. brucei procyclic form synthesizes the largest fatty acid (FA) product which is stearate 
(C18), however in the bloodstream form is predominantly myristate (C14) (Morita et al., 
2000). It has been revealed that T.brucei make the bulk of their fatty acids by a mechanism 
involving endoplasmic reticulum (ER)-based elongases (ELOs) which is a type II FA-
synthase system and has a specialized role in these parasites. Four ELOs have been found in 
these parasites encoded by ELO 1-4 genes. It has been shown that the genes ELO 1-3 together 
account for synthesis of saturated FAs up to a chain length of C18. ELO1 converts C4 to C10, 
ELO 2 extends the chain length from C10 to myristate (C14), and ELO 3 extends myristate to 
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C18 (Lee et al., 2006). One remarkable feature of the trypanosome ELO system is that it 
utilizes short-chain acyl-CoA primers and this distinguishes the ELOs of trypanosomes from 
conventional ELOs and allows the former to synthesize FAs de novo. 
ELOs synthesize lipids containing polyunsaturated FAs (PUFA). T.brucei expresses ELO 4 
which is specific for PUFAs and elongates arachidonate (C20:4) by two carbon atoms. 
Although arachidonate is available for salvage from the host serum, other PUFAs must be 
synthesized which are incorporated into phospholipids. The myristate requirement for VSG 
production by the T.brucei bloodstream form and the need for longer de novo synthesized 
FAs in membrane phospholipid biosynthesis, and the nutrients available in the environment, 
are all factors that have to be balanced by the parasite when regulating the ELO pathway 
(Englund et al., 2007). Regulation of the ELO pathway in these parasites could also influence 
the FA composition of membrane phospholipids. As the membrane lipid composition is 
altered when the parasite moves between the different temperatures that exist in the insect 
vector and the mammalian host consequently the lipid composition changes are needed to 
adjust for the effects of temperature on membrane fluidity. Triacylglycerols and steryl esters 
have been proposed to act as FA reservoirs in T.brucei. The nutrient-rich environment of the 
host, the parasite stockpiles lipids by uptake, synthesis or both. However, despite these FA 
reserves, it seems that the ELO pathway of T.brucei provides an essential supply of FAs for 
incorporation into phospholipids (Englund et al., 2007).  
Apart from this, Richmond and Smith (2007) have identified and characterized a cytosolic 
phospholipase A1 from T. brucei. It has a specific activity towards sn-1 esters of diacyl 
phospholipids, exhibits lysoPLA1 activity and shows very little activity towards neutral lipid 
substrates. This study proposed that T. brucei PLA1 has 21 % homology with PLA1 from 
proteobacterium Sodalis glossinidus; a bacterial secondary endosymbiont of Glossina (tsetse) 
flies (Toh et al., 2006). Furthermore, it has been postulated that T. brucei acquired this 
enzyme through horizontal gene transfer (HGT) after/during its adaptation to a parasitic 
lifestyle in its tsetse host (Richmond and Smith, 2007). Similar sequence homology to 
phospholipase A1 is absent from the protein databases for T. cruzi and Leishmania. Due to 
this observation, it has been proposed that this HGT did occur only in T. brucei because the 
other kinetoplastids do not use Glossina as a host. HGT between prokaryote-eukaryote is still 
presumed to be rather rare and atypical but is most common in the protists (Boucher and 
Doolittle, 2000; Field et al., 2000; de Koning et al., 2000). PLA1 in T. brucei has been 
extensively studied and biochemically characterized (Richmond and Smith, 2007) and its 
preferred substrate is Glycerophosphatidylcholine (GPCho). One important observation is that 
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the amino acid sequence of T. brucei PLA1 is not homologous to T. brucei PLA2. They have 
sequence identity only within the lipase conserved motif GXSXG. 
It has been claimed by Richmond and Smith (2007) that a search of the T. brucei genome 
database did not reveal any cytosolic PLA2 homologues. However, our study found that the T. 
brucei genome database does contain a putative PLA2-like protein, which possesses a 
transmembrane domain in its sequence designating it most probably as a membrane protein 
rather than a cytosolic protein. Indeed, the enzyme was characterized by us using cloning and 
heterologous expression in insect cells and with the measurements of the respective enzyme 
activity. In addition, our study has identified a TbPLA2 in the membrane fractions of T. brucei 
bloodstream and procyclic forms.  
TbPLA2 amino acid sequence from database shows ~40 % homology with phospholipases A2 
from T. cruzi and Leishmania major as well as with human PAF-acetyl hydrolase. Apart from 
these phospholipases A2, TbPLA2 shows considerable homology with PLA2s from bacteria, 
ciliates, nematodes and plants as seen from BLAST tree view widget (see page 78 in Results). 
The amino acid sequence of TbPLA2 contains the lipase consensus motif GHSFG, which 
indicates that it might be a member of the lipase family. The identification of phospholipase 
A2 in T. brucei plays a significant role in understanding the metabolic pathway of arachidonic 
acid and formation of prostaglandins in these parasites.  
 
 
4.2 Heterologous expression of TbPLA2 
 
Heterologous expression of a recombinant protein is an extremely powerful tool in the 
analysis of membrane proteins and several expression systems have been developed so far. 
Most proteins from a variety of organisms have been heterologously expressed either in 
bacterial cells (Laage and Langosch, 2001) or insect cells (Luckow et al., 1993; Ciccarone et 
al., 1997). The general strategy is to genetically fuse to the N- or C-terminus of the protein of 
interest with certain tags, e.g. His-tag, GFP (Green fluorescent protein) or MBP (Maltose 
binding protein). These fusions are designed to allow for efficient expression, detection and 
especially affinity purification of the expressed protein (Laage and Langosch, 2001). Both of 
the above stated heterologous expression systems were utilized for expression of TbPLA2 in 
this work. 
Efficient expression requires the use of an efficient promoter driving transcription of the 
plasmid-borne protein and the choice of an appropriate expression host cell system. In case of 
bacteria, combination of the bacteriophage T7 promoter with BL-21 (DE3) or Rosetta 2 cells 
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are the most frequently used expression systems. Cloning of the TbPLA2 gene into bacterial 
subcloning and expression plasmids was successful, as judged by restriction enzyme 
digestion. Bacterial colony PCR with sequence-specific primers was used to confirm the 
correct plasmid construct and its correct orientation. Sequence identity of the TbPLA2 gene in 
the construct was verified by DNA sequencing. The interesting finding from these cloning 
experiments was that the gene sequences of the constructs from several independently derived 
clones possessed constantly altered bases at 20 positions in comparison with the known 
database sequence. When these base alterations (point mutations) were translated in silico, 
then it was interpreted into only three constant amino acid residue alterations in the one 
construct analyzed. Translation of these alterations into the amino acid residues indicated that 
these three constant alterations were at positions 58 (F to L), 270 (I to S) and 324 (V to L). 
These constant alterations did not appear in the active center of the enzyme (i.e. GHSFG) and 
probably the activity of this enzyme. The clone carrying the confirmed construct was used for 
heterologous expression in bacteria, BL-21 (DE3) and Rosetta 2 competent cells. Protein 
expression was carried out using final concentrations of IPTG ranging from 0.1 to 1 mM and 
varying temperatures. The induced cell were lysed hypotonically and separated into cytosolic 
and membrane fractions by centrifugation. Unfortunately, however, neither fraction contained 
the fusion protein when resolved on SDS-PAGE, at 100 kDa in case of the MBP. 
The unsuccessful attempts to express TbPLA2 in bacterial cells were most likely due to the 
toxic nature of this protein for bacteria. It might be that the transmembrane sequence of this 
protein was toxic to the bacterial cells and the bacterial protease system may have degraded 
this protein immediately upon its synthesis to prevent the cells from its deleterious effects. A 
high-level expression of membrane proteins containing hydrophobic protein domains remains 
a difficult task in E.coli due to their toxic effects exerted on the host cells (Laage and 
Langosch, 2001). Therefore, the bacterial expression of membrane proteins had frequently 
been restricted to their soluble domains. On the other hand, over-expression of full-length 
membrane proteins is highly desirable since their transmembrane domains (TMD) often 
contain important structural information for folding, oligomerization or subcellular sorting 
(Laage and Langosch, 2001). Consequently, it was decided to heterologously express the 
protein in the Baculovirus expression system using Sf9 insect cells. The verified TbPLA2 
construct from previous cloning experiments in the bacterial system was obtained and the 
TbPLA2 gene fragment was extracted out of the plasmid. This gene fragment was introduced 
into the Baculovirus plasmid by subcloning in bacterial cells. After successful cloning, the 
recombinant construct was transposed into a bacmid, using transformation into DH10Bac 
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competent bacterial cells. The recombinant bacmid was extracted and confirmed by bacterial 
colony PCR using sequence-specific primers. The purified recombinant bacmid was then 
introduced into the growing culture of insect cells by viral infection. 
The infected insect cells were cultured in passages to increasing volumes in order to generate 
high viral titers. The supernatant from infected cells and the cell pellet were separated by 
centrifugation and stored at 4ºC for further analysis. According to the amplification rate of the 
viral titer, the supernatants from recombinant Baculovirus stocks were labeled P1 (low viral 
titer), P2 (higher viral titer) and P3 (highest viral titer). In order to establish the optimum 
conditions of infection, the time span for infection was established to be best at 120 h. After 
the infection period, the infected cells were lysed and fractionated into soluble and membrane 
fractions. These fractions along with control insect cell supernatants were analyzed on SDS-
PAGE. The infected insect cell lysates membrane fraction depicted a prominent protein band 
at 58 kDa on SDS-PAGE which revealed the over-expression of a protein. This protein band 
had an increased molecular size in comparison to the expected size of 50 kDa. This difference 
in molecular weight could be due to post-translational modifications of the protein within 
insect cells. The expressed TbPLA2 from membrane fraction of the infected insect cells was 
further verified by Western blotting using a polyclonal antibody. The TbPLA2 antibody 
reacted with the prominent band seen at 58 kDa on Western blots.  It can thus be concluded 
that the T. brucei PLA2 protein was cloned, over-expressed and identified. 
 
4.3 Biochemical and immunological characterization in T. brucei 
cells 
 
In order to investigate whether
 
phospholipase A2 is expressed in T.brucei bloodstream and/or 
procyclic forms, biochemical characterization methods were used to determine its function. 
Cells from the logarithmic and stationary phase of bloodstream and procyclic forms were 
analyzed by Western blot to evaluate the presence of TbPLA2 and by immunoflouresence to 
determine the possible localization in the cell. Western blots of membrane fractions from 
bloodstream and procyclic forms showed evidence of TbPLA2 by reaction of the protein with 
the anti-TbPLA2 antibody. Furthermore, this analysis revealed that TbPLA2 was expressed in 
both the logarithmic and the stationary phases in bloodstream as well as in procyclic forms. 
As judged from Western blots, the protein is expressed in rather low concentrations in 
membrane fractions of different life cycle stages. Hypothetically, when the level and 
activation of this enzyme reaches a high concentration inside the cell, then it could potentially 
lyse the parasite from within by producing excess amounts of fatty acids and 
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lysophospholipids. The appropriate level of TbPLA2 and consequently the products of this 
enzyme should be crucial for the normal functioning in T. brucei. The detection and 
recognition of TbPLA2 with specific antibodies in the membrane fractions of bloodstream and 
procyclic cells at a molecular size of 50 kDa apparently directs towards the presence of this 
protein in these parasites. The membrane fractions of bloodstream form cells at a cell density 
of 3 X 109 depicted the similar molecular size and intensity band. The band on the blot 
appeared with less intensity due to low level of this protein in the cells and even though with 
prolonged development time period of the blot to enhance but could not intensify the band. 
To further elaborate and ascertain that TbPLA2 is a true phospholipase A2, a specific activity 
assay (Jimenez et al., 2003) was established using the known and commercially available 
phospholipase A2 from porcine pancreas. This activity assay utilizes a coupled enzymatic 
assay in which phospholipase A2 releases linoleic acid from the sn-2 position of DL-PC 
substrate. Linoleic acid is then a substrate for lipoxygenase, which further oxidizes it into 
hydroperoxides. This activity was followed spectrophotometrically by measuring the increase 
in absorbance at λ = 234 nm due to the appearance of hydroperoxides as products of the 
assay. Cell lysate fractions from bloodstream and procyclic forms corresponding to a cell 
density of 1 X 106/ ml were examined using this assay to determine the level of activation of 
the phospholipase A2 in the parasites. Cell lysates from the logarithmic and stationary phases 
of bloodstream form as well as from the procyclic form were fractionated into soluble and 
membrane fractions. The specific activities of these fractions in nM/min were measured as 
shown below in the Table 3:  
 
 
                        Bloodstream  form 
                                      
                                   nM/ min 
 
Procyclic form 
 
nM/ min 
 
Membrane 
 
Cytosolic Membrane Cytosolic 
 
 
 
Logarithmic 
phase 
 
 
0.25 
 
0.15 
 
0.57 
 
0.12 
 
Stationary 
phase 
 
 
0.25 
 
0.13 
 
n.d. 
 
n.d. 
 
Table 3 Phospholipase A2 specific activity values with cell lysate fractions from bloodstream 
and procyclic forms 
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The specific activity of the procyclic form membrane fraction was 0.57 nM/min as compared 
to the cytosolic fraction which was 0.12 nM/min. On the other hand, the specific activity of 
bloodstream form logarithmic phase and stationary phase membrane fractions determined 
were both 0.25 nM/min. In comparison, the specific activities of the cytosolic fractions from 
logarithmic and stationary phases were 0.15 nM/min and 0.13 nM/min respectively.  
The specific activity in membrane fraction of procyclic to both phases of bloodstream form 
has activity factor of 2.28. The cytosolic fraction of procyclic to bloodstream form has 
activity factor of 1.25. In addition, procyclic form membrane to cytosolic fraction has specific 
activity factor of 4.75 and both phases of bloodstream form membrane to cytosolic fraction 
has specific activity factor of 1.92. This indicates that the specific activity is high in 
membrane fraction of procyclic as compared to bloodstream form. The cytosolic fractions in 
both procyclic and bloodstream form contains equal specific activities. On the whole, the 
results suggest that there is a phospholipase A2 activity in T. brucei logarithmic and stationary 
phases of bloodstream and procyclic forms as determined from the specific activities. 
In order to inhibit TbPLA2 specifically it has been attempted to find an appropriate specific 
inhibitor (Lucas and Dennis, 2005). However, since each phospholipase A2 has a group-
specific inhibitor, the search for TbPLA2 specific inhibitor/s was so far unsuccessful.  
 
 
4.4 Regulation and expression of TbPLA2 in T. brucei 
 
Mature mRNA production in trypanosomes is a step-wise process that differs in several 
aspects from the biogenesis of mRNA in most eukaryotes (Ullu et al., 1996). The 
trypanosome gene arrangement is highly compact with small intergenic regions separating 
one gene from the next. Trypanosome protein-coding genes are organized as polycistronic 
rather than monocistronic transcription units. Furthermore, the 5´ ends of all mature mRNAs 
are formed by trans-splicing contrary to transcription initiation. The partners in trans-splicing 
are the polycistronic pre-mRNA, which contains the mRNA coding regions preceded by a 3´ 
splice site, and the spliced leader (SL) RNA, which provides the capped SL sequence and the 
5´ splice site (Mair et al., 2000). Individual mature mRNAs are generated from polycistronic 
precursors by 5´ trans-splicing of a 39-nt capped leader RNA and 3´ polyadenylation. There is 
no consensus polyadenylation signal in the 3´-untranslated region (3´-UTR). Instead, 
experimental evidence suggests that polyadenylation occurs within a short region of 100-400 
nt upstream of the polypyrimidine trans-splice signal (Benz et al., 2005). 
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T. brucei phospholipase A1 (TbPLA1) production from mRNA level to the protein translation 
was examined in detail (Richmond and Smith, 2007) and it had been stated that it is 
controlled at a certain required level considering the potential damage a membrane lytic 
enzyme such as TbPLA1 can invoke, if it was allowed to be expressed at uncontrollable levels 
in the cell. Similarly, the evidence for phospholipase A2 in T. brucei at the transcriptional 
level and the regulation in different life stages of the parasite could give a clue to the 
synthesis of arachidonic acid and its metabolites. In order to compare and evaluate the 
transcriptional regulation of the TbPLA2 gene in the bloodstream form, the transcriptional 
expression level was analyzed using the total RNA from the logarithmic and stationary phases 
as well as the logarithmic phase isolated from rat blood. The experiment was conducted with 
the beta-tubulin gene from bloodstream form cells as a loading control. The rRNA from each 
of the bloodstream form cells were obtained and it showed the three expected bands at 
positions of 2250 bp, 1850 bp and 1350 bp .  
Using sequence-specific probes, Northern analysis of TbPLA2 showed two bands at 
approximately 3,700 bp and 3,500 bp in each stage mentioned above. The transcripts from 
TbPLA2 blot showed two mRNAs which had different sizes, positions and strengths of 
signals. These two transcripts may be alternate splicing forms of a single gene, which are 
expressed in the bloodstream forms. In addition, multiple alternatively processed products 
could be produced from intergenic regions with several polypyrimidine tracts (Benz et al., 
2005). In addition, it can be postulated that the different mRNA transcripts (Benz et al., 2005) 
could be due to the transcription of complete length of intergenic regions starting from 5´ 
UTR including ORF of the gene and 3´ UTR region downstream till the next ORF of other 
gene as seen in the gene database (GeneDB). 
The band intensity of the transcripts from each stage stated above was performed with semi-
quantitative densitometric calculations of the respective gene. The results indicated that the 
most intense band among the three respective stages of parasite was from logarithmic stage of 
parasite which was depicted as the lower band designated with an intensity value of 1, and the 
size of 3,500 bp as compared to the upper band having an intensity value of 0.7 and a size of 
3,700 bp. These values were calculated in comparison of bands from beta-tubulin as loading 
control which were similar in expression level in each life stage of the parasite.  
The Northern blot analysis indicated a stage-specific regulation of TbPLA2 gene transcripts. 
The gene was expressed at a low level in the stationary phase of parasites in culture and cells 
in the logarithmic phase isolated from rat blood. It was relatively more expressed and 
regulated in the logarithmic phase. This can be interpreted as the parasite’s requirement of 
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building up resistance against the host immune system during the infection stage or cell 
density regulation of the parasites. The expression profile of the transcripts indicates a distinct 
significance of TbPLA2 throughout the life cycle of the parasites. Although, these results 
brings us a step closer in understanding the expression level of TbPLA2 mRNA, it is still not 
proven that TbPLA2 functions in a pathway to release arachidonic acid from phospholipids 
within cell or organelle membranes, nor if this arachidonic acid liberation or TbPLA2 itself is 
essential for the cellular viability and stability of the cell. Moreover, there is a need for further 
experiments to understand and answer some fundamental questions concerning the nature of 
TbPLA2 and to resolve the structure-function relationship of this enzyme using site-directed 
mutagenesis, generation of deletion mutants for TbPLA2, as well as substrate-specificity and 
inhibitor kinetic analysis.  
 
Conclusion 
 
Sleeping sickness vector T.brucei is an eukaryotic organism whose metabolism is the subject 
of extensive searches for the possible targets in the drug development against this disease. On 
the other hand, there are several proteins involved in different pathways still not investigated 
or identified. One of such a pathway is the phospholipid metabolism and the enzymes 
involved in it. This study was conducted to identify and characterize a T. brucei 
phospholipase A2 which metabolizes phospholipid substrate from sn-2 position resulting in 
the production of arachidonic acid and eicosanoids. These products play a vital role in the 
intracellular metabolism and regulation of the parasite’s cell membrane. This work 
concentrated on the cloning, heterologous over-expression of the phospholipase A2 and 
simultaneously characterization of this enzyme in T. brucei. 
The cloning of TbPLA2 was successful in the bacterial plasmids. The heterologous expression 
of TbPLA2 in bacterial cells did not yield the expected protein as seen on SDS-PAGE. 
Eventually, the expression was attempted in Sf9 insect cells which yielded the expression of 
this protein and specifically in the membrane fraction. This expression was verified with 
Western blot analysis depicting a molecular size of 58 kDa. The expression at the 
transcriptional level regulation of TbPLA2 was analyzed with the Northern blot. The blot 
showed two transcript bands of different size, intensity and strengths in logarithmic, 
stationary phase from in vitro culture and T. brucei cells in logarithmic phase from rat blood. 
The transcript in the logarithmic stage from cell culture showed high expression level at a size 
of approximately 3500 bp. Phospholipase A2 activity assay with DL-PC substrate indicated 
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the evidence of specific activity in nanomole concentrations in cell lysates soluble and 
membrane fractions of logarithmic, stationary phase of bloodstream and procyclic forms of 
the parasites. The specific activity was relatively high in cell lysates membrane fractions of 
both the forms of parasites. Among the fractions, procyclic form membrane fraction had 
twofold activity in comparison to bloodstream form. In general, this study concludes the 
evidence of PLA2 in T. brucei through the cloning, over-expression and characterization in 
parasites.  
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5. Summary 
 
Human African trypanosomiasis or sleeping sickness is caused by infection with the tsetse-
fly-transmitted protozoan Trypanosoma brucei. It lives exclusively as an extra-cellular 
parasite unlike other Trypanosomatidae. The sub-species of this parasite include T. b. 
rhodesiense (in East and Southern Africa) and T. b.gambiense (in West and Central Africa). 
These parasites, along with the non-human infective T. b. brucei are zoonoses, and disease 
control is impeded by substantial wild and domestic animal reservoirs of infection. 
Historically, sleeping sickness had caused massive loss of life, and related animal diseases 
(Nagana) which have had a crucial impact on the development of sub-Saharan Africa 
(Sternberg, 2004). Currently, the incidence of sleeping sickness is rising, and the control is 
restricted due to inadequate development of drugs and these parasites are gaining resistance 
against current medicines. 
The parasite lacks various core metabolic pathways present in the mammalian hosts, but also 
shows a set of parasite specific pathways. The enzymes and their metabolites involved in the 
lipid metabolism have been proven to be potential targets for the development of novel 
chemotherapeutics. In this context, elucidation of the parasite's specific metabolism is a 
prerequisite for drug development (Borza et al., 2005; Van Hellemond et al., 2006; Ginger, 
2006). 
One of the enzymes of lipid metabolism which plays a significant role in the cell is the 
phospholipase A2. Phospholipases A2 are the enzymes which catalyzes the hydrolysis of the 
fatty acid ester at the sn-2 position of the phospholipids to produce free fatty acids, such as 
arachidonic acid and lysophospholipids. Both the products represent precursors for signaling 
molecules that can exert a multitude of biological functions (Schaloske and Dennis, 2006). 
The phospholipase A2 consists of 15 groups and includes five distinct types of classes, namely 
the secreted PLA2 (sPLA2), the cytosolic PLA2 (cPLA2), the Ca2+ independent PLA2 (iPLA2), 
the platelet-activating factor acetyl hydrolases (PAF-AH) and the lysosomal PLA2s (Burke 
and Dennis, 2009). They perform various functions in living organisms including lipid 
modification in the cell membrane, lipid-derived second messengers. The PLA2 releases 
arachidonic acid from phospholipid which is further metabolized to form prostaglandins, 
thromboxanes, or leukotrienes.  
Although a PLA1 was described in T. brucei earlier (Richmond and Smith, 2007), a PLA2 has 
not been investigated so far. Figarella et al., (2005 and 2006) have reported that the 
prostaglandin D2 and its metabolites exerted a role in apoptosis and cell density regulation in 
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T. brucei. This encourages in the investigation and identification of a PLA2 in these parasites. 
This work deals with the identification and characterization of PLA2 in T. brucei. The 
TbPLA2 gene sequence from GeneDB was utilized using sequence-specific primers to amplify 
the DNA which was sub-cloned in the bacterial cells. Furthermore, the verified recombinant 
plasmid was cleaved with restriction enzymes to extract the gene of TbPLA2. This gene 
fragment was inserted into the expression plasmid and transformed into the BL-21(DE3) and 
Rosetta 2 expression competent cells for heterologous expression. The attempt for 
heterologous expression in the bacterial cells did not yield the target protein due to the toxic 
nature of this protein for the bacterial cells. Due to this, another heterologous expression 
strategy was followed namely Baculovirus expression system using Sf9 insect cells. The 
verified fragment of TbPLA2 was introduced into the plasmid of Baculovirus system and 
amplified. The recombinant bacmid obtained containing TbPLA2 was used to infect the 
growing insect cells. After the completion of the infection period, the cells were lysed and 
fractionated. The insect cell lysates soluble and membrane fractions were resolved on SDS-
PAGE which showed a protein band only in membrane fraction at a molecular size of 58 kDa 
verified with Western blot using polyclonal antibody against TbPLA2. In general, the TbPLA2 
was successfully cloned and heterologously expressed in the Sf9 insect cells.  
In order to investigate the expression of phospholipase A2 during the course of the life cycle 
of T. brucei, cells from the logarithmic and the stationary phase (equivalent to slender and 
stumpy forms) of bloodstream trypanosomes and the procyclic form were analyzed by 
Western blotting to evaluate the presence of TbPLA2 within these cells. The respective blots 
showed that the enzyme is present in the membrane fractions from all forms at a molecular 
size of 50 kDa. As judged from these results, the protein is expressed in rather low 
concentrations, which seems to be a consequence of its high "toxicity", as its products (free 
fatty acids and lysophosholipids) are both membrane active and would inevitably lyse the 
cells from within by exceeding an acceptable threshold concentration. On the other hand, the 
appropriate level of TbPLA2 activity seems to be crucial for the parasite's survival.  
The Northern blots of different bloodstream forms revealed two bands at sizes of 3,500 bp 
and 3,700 bp, respectively. Interestingly, the latter band was rather similar in all forms, while 
the former band was strongly expressed only in cell culture forms from the logarithmic phase. 
These two transcripts are most probably alternate splicing forms of the single gene (Benz et 
al., 2005). The expression profile of the transcripts indicates a distinct significance of TbPLA2 
throughout the life cycle of the parasites.  
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To ascertain that the analyzed protein
 
is a true phospholipase A2, a specific activity assay was 
performed using commercially available PLA2 from porcine pancreas as control (Jimenez et 
al., 2003). Bloodstream and procyclic forms were used to determine the enzyme activity in 
different cell fractions. The results show that TbPLA2 is a membrane located enzyme 
expressed throughout the life cycle with a more than twofold higher expression in the 
procyclic insect form. From these observations together with the data from the Northern and 
Western blotting it can be postulated that TbPLA2 exists in T. brucei as a membrane protein. 
Because of its importance for the parasite throughout its life cycle, it seems to be a promising 
target for drug development to be explored in more detail.  
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Zusammenfassung 
 
Die Afrikanische Trypanosomiasis oder Schlafkrankheit wird ausgelöst durch die Infektion 
mit dem durch die Tsetsefliege übertragenen Trypanosoma brucei. Der Erreger lebt 
ausschließlich als ein extrazellulärer Parasit anders als andere Trypanosomatida. Die 
Unterarten dieses Parasiten bestehen aus T. b. rhodesiense (in Ost- und Südafrika) und T. b. 
gambiense (in West- und Zentralafrika). Diese Parasiten zusammen mit dem nicht 
humanpathogenen T. b. brucei sind Zoonosen und die Eindämmung der Krankheit wird 
erheblich erschwert durch substanzielle  Reservoirs in Wild- und Nutztieren. In der 
Vergangenheit hat die Schlafkrankheit zu einem massiven Verlust an Leben geführt und die 
verwandte Tierkrankheit (Nagana) hatte einen entscheidenden Einfluss auf die Entwicklung 
des Bereichs Afrikas südlich der Sahara (Sternberg, 2004). Zurzeit steigt die Anzahl der 
Erkrankungen wieder und die Bekämpfung ist limitiert durch fehlende 
Medikamentenentwicklung und durch die Tatsache, dass die Parasiten Resistenzen gegen 
aktuelle Medikamente entwickeln. 
Dem Parasiten fehlen verschiedene zentrale Stoffwechselwege verglichen mit dem 
Säugetierwirt, aber sie haben auch einige parasitenspezifische Wege. Die im Lipid-
Stoffwechsel beteiligten Enzyme und ihre Metaboliten haben sich als potentielle Ziele für die 
Entwicklung neuer Chemotherapeutika herausgestellt. In diesem Zusammenhang ist die 
Aufklärung der parasitenspezifischen Stoffwechselvorgänge eine grundlegende 
Vorraussetzung für die Medikamentenentwicklung (Borza, 2005; Van Hellemond, 2006; 
Ginger, 2006). 
Eines der Enzyme des Lipidstoffwechsels, das eine signifikante Rolle in der Zelle spielt, ist 
die Phospholipase A2. Phospholipasen A2 sind Enzyme, die die Hydrolyse von Fettsäureestern 
an der sn-2 Position des Phospholipids katalysieren um freie Fettsäuren, wie Arachidonsäure 
und Lysophospholipide herzustellen. Beide Produkte sind Vorläufer für Signalmoleküle die 
eine Reihe von biologischen Funktionen ausüben können (Schaloske and Dennis, 2006). Die 
Phospholipase A2 gliedert sich in 15 Gruppen und beinhaltet fünf eindeutig zu 
unterscheidende Typen von Klassen, nämlich die sekretierte PLA2 (sPLA2), die cytosolische 
PLA2 (cPLA2), die Ca2+ unabhängigen PLA2 (iPLA2), die Plättchenaktivierender Faktor 
Acetyl-hydrolasen (PAF-AH) und die lysosomale PLA2 (Burke and Dennis, 2009). Sie üben 
verschieden Aufgaben im lebenden Organismus aus, einschließlich der Modifikation von 
Lipiden in der Zellmembran und der Bildung von von Lipiden abstammenden Second 
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Messangern. Die PLA2 spaltet Arachidonsäure von Phospholipiden ab, welche weiter zu 
Prostaglandinen, Thromboxanen oder Leukotriene verstoffwechselt wird. 
Obwohl eine PLA1 in T. brucei schon beschrieben wurde (Richmond and Smith, 2007) wurde 
bis heute noch keine PLA2 untersucht. Figarella et al., (2005 and 2006) haben berichtet, dass 
Prostaglandin D2 und seine Metaboliten eine Rolle bei Apoptose und der Zelldichteregulation 
in T. brucei spielen. Dies ermutigt die Suche und Identifizierung der Phospholipase A2 in 
diesen Parasiten. 
Diese Arbeit beinhaltet die Identifikation und Charakterisierung von PLA2 in T. brucei. Die 
TbPLA2 Gensequenz von GeneDB wurde verwendet um mittels sequenzspezifische Primer 
die DNA zu amplifizieren, welche dann in Bakterienzellen subkloniert wurde. Weiterhin 
wurde das verifizierte rekombinante Plasmid mittels Restriktionsenzymen geschnitten um das 
PLA2-Gen herauszuschneiden. Diese Genfragment wurde in das Expressionsplasmid 
einligiert, in BL-21(DE3) und Rosetta 2 Zellen transformiert um für die heterologe 
Expression zur Verfügung zu stehen. Der Versuch der heterologen Expression in 
Bakterienzellen lieferte nicht das erhoffte Protein, sehr wahrscheinlich weil das Protein 
toxisch für Bakterien ist. Deshalb wurde eine andere Strategie für heterologe Expression 
verfolgt, nämlich das Baculovirus Expressionssystem unter Verwendung von Sf9 Insekten 
Zellen. Das überprüfte Fragment von TbPLA2 wurde in das Baculovirus System einkloniert 
und weiter amplifiziert. Das rekombinierte Bacmid mit PLA2 wurde mittels Infektion in die 
Insektenzellen gebracht. Nach Abschluss der Infektionsperiode wurden die Zellen lysiert und 
fraktioniert. Die lösliche und die Membranfraktion der Insektenzelllyse wurden auf einer 
SDS-Page aufgetrennt, welche nur in der Membranfraktion eine 58kDa Proteinbande zeigte. 
Die Membranfraktion der Insektenzellen zeigte auch im Western blot mit polyklonalen 
Antikörpern gegen TbPLA2 eine Bande bei 58kDa. Zusammenfassend lässt sich sagen, dass 
TbPLA2 erfolgreich kloniert und heterolog in Insektenzellen exprimiert wurde. 
Um die Expression der Phospholipase A2 während der verschiedenen Stadien des 
Lebenszyklus von T. brucei zu untersuchen wurden Zellen aus der logarithmischen und 
stationären Phase von Blutfom Trypanosomen (äquivalent zu slender und stumpy Formen) 
und aus prozyklischen Fliegenformen mittels Western blot untersucht, um die Level an 
TbPLA2 in den Zellen beurteilen zu können.  
Die entsprechenden Blots zeigen, dass das Enzym in der Membranfraktion aller 
Trypanosomenformen eine Bande bei 50 kDa vorliegt. Ausgehend von diesen Ergebnissen ist 
das Protein in eher geringer Konzentration exprimiert, was eine Folge seiner hohen 
‚Toxizität’ zu sein scheint. Seine Substrate (freie Fettsäuren und Lysophospholipide) sind 
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beide membranaktiv und bei zu hoher Konzentration (über einem vertretbaren Schwellenwert) 
würden sie unweigerlich zur Lyse der Zellen von innen heraus führen. Andererseits scheint 
ein gewisser Level an PLA2 Aktivität absolut notwendig für das Überleben des Parasiten zu 
sein. 
Der Northern blot der verschiedenen Blutform Trypanosomen zeigt je zwei Banden von 
3.500bp und 3.700bp Größe. Interessanterweise war die letztere Bande  in allen Formen sehr 
ähnlich, während die Bande bei 3.500bp nur in Blutform Trypanosomen aus Zellkultur stark 
exprimiert war. Diese zwei Transskripte sind höchstwahrscheinlich alternative Splicing 
Formen desselben Gens (Benz et al., 2005).  Das Expressionsprofil der Transskripte zeigt die 
eindeutige Signifikanz der TbPLA2 während des gesamten Lebenszyklus des Parasiten. 
Um sicher zu stellen, dass das untersuchte Protein wirkliche eine Phospholipase A2 ist, wurde 
ein spezifischer Enzymassay mit gekaufter PLA2 aus der Bauchspeicheldrüse eines Schweins 
als Kontrolle (Jimenez et al., 2003) durchgeführt. Blut- und Fliegenformen der Trypanosomen 
wurden verwendet um die Enzymaktivität in verschiedenen Zellfraktionen zu bestimmen. Die 
Ergebnisse zeigen, dass TbPLA2 ein in Membranen lokalisiertes Enzym ist das während des 
gesamten Lebenszyklus exprimiert wird, mit einer mehr als zweifach höheren Expression in 
Fliegenformen.  
Ausgehend von diesen Beobachtungen zusammen mit den Daten vom Northern blot und 
Western blotting kann man postulieren, das TbPLA2 in T. brucei als Transmembranprotein 
vorliegt. Wegen seiner Bedeutung für den Parasiten während des ganzen Lebenszyklus 
scheint TbPLA2 ein viel versprechendes Ziel für die Arzneimittelentwicklung zu sein, das es 
sich lohnt noch näher zu untersuchen. 
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